See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy
Publications for all members
Updated daily
Loading publication list...
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 39631209 | 0 | Tandon P, Thompson C, Li K, et al. Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism. Thromb Res. 2024 Nov 30;245:109234. doi: 10.1016/j.thromres.2024.109234. | |
| 39618296 | 0 | Tran A, Lutsey PL, Carrier M. Minor trauma and venous thromboembolism: the threshold for antithrombotic prophylaxis. Haematologica. 2024 Dec 1;109(12):3860-3867. doi: 10.3324/haematol.2023.284612. | |
| 39616700 | 0 | Garcia-Garcia V, Barca-Hernando M, Lopez-Ruz S, et al. Relevance of recurrent venous thromboembolism according to location of metastasis in patients with cancer-associated thrombosis. A cohort study. Thromb Res. 2024 Nov 23;245:109228. doi: 10.1016/j.thromres.2024.109228. | |
| 39603673 | 0 | Delluc A, Pradier M, Siegal DM, et al. Outpatient Management of Cancer-Associated Pulmonary Embolism: A Systematic Review and Meta-Analysis. Eur Respir J. 2024 Nov 27:2401596. doi: 10.1183/13993003.01596-2024. | |
| 39588564 | 0 | Bikdeli B, Leyva H, Muriel A, et al. Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries. Vasc Med. 2024 Nov 26:1358863X241292023. doi: 10.1177/1358863X241292023. | |
| 39581233 | 0 | Carlin S, Chan N, Godoy A, et al. JTH in Clinic - Choosing the optimal oral anticoagulant for stroke prevention in atrial fibrillation: direct oral anticoagulants vs. vitamin K antagonists. J Thromb Haemost. 2024 Nov 22:S1538-7836(24)00695-0. doi: 10.1016/j.jtha.2024.11.005. | |
| 39571935 | 0 | Escobar M, Lassila R, Bekdache C, et al. Use of antithrombotic therapy in patients with hemophilia: A selected synopsis of the EHA-ISTH-EAHAD-ESO Clinical Practice Guidance document. J Thromb Haemost. 2024 Nov 19:S1538-7836(24)00685-8. doi: 10.1016/j.jtha.2024.10.033. | |
| 39569543 | 0 | Brakel BA, Rebchuk AD, Ospel J, et al. International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis. Int J Stroke. 2024 Nov 21:17474930241304206. doi: 10.1177/17474930241304206. | |
| 39561373 | 0 | Todorovski A, Wang TF, Carrier M, et al. CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease. Blood Adv. 2024 Nov 19:bloodadvances.2024014430. doi: 10.1182/bloodadvances.2024014430. | |
| 39551436 | 0 | Warkentin TE, Geerts W, Sheppard JI, et al. High-dose IVIG and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune HIT. J Thromb Haemost. 2024 Nov 15:S1538-7836(24)00687-1. doi: 10.1016/j.jtha.2024.10.035. | |
| 39523979 | 0 | Field TS, Shu L, Kim DJ, et al. Lead-In Parenteral Anticoagulation Prior to Direct Oral Anticoagulation for Cerebral Venous Thrombosis. Can J Neurol Sci. 2024 Nov 11:1-6. doi: 10.1017/cjn.2024.325. | |
| 39519000 | 0 | Schulman S, Makatsariya A, Khizroeva J, et al. The Basic Principles of Pathophysiology of Venous Thrombosis. Int J Mol Sci. 2024 Oct 24;25(21):11447. doi: 10.3390/ijms252111447. | |
| 39515380 | 0 | Mithoowani S, Bungard TJ, Castellucci L, et al. Multidisciplinary Guidance for the Management of Severe Bleeding on Oral Anticoagulation: An Algorithm for Practicing Clinicians. Thromb Haemost. 2024 Nov 8. doi: 10.1055/a-2464-2887. | |
| 39495569 | 0 | Harel Z, Smyth B, Badve SV, et al. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial. J Am Soc Nephrol. 2024 Nov 4. doi: 10.1681/ASN.0000000000000495. | |
| 39480839 | 0 | Gyorffy VJ, Dwivedi DJ, Liaw PC, et al. Impact of sample processing delays on plasma markers of inflammation, chemotaxis, cell death, and blood coagulation. PLoS One. 2024 Oct 31;19(10):e0311921. doi: 10.1371/journal.pone.0311921. eCollection 2024. | |
| 39479325 | 0 | Leong DP, Fradet V, Niazi T, et al. Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes. JACC CardioOncol. 2024 Sep 3;6(5):761-771. doi: 10.1016/j.jaccao.2024.07.011. eCollection 2024 Oct. | |
| 39478423 | 0 | Roy PM, Penaloza A, Germini F, et al. The Emergency Advisory and Research international board on Thrombosis and Hemostasis (EARTH). Eur J Emerg Med. 2024 Dec 1;31(6):376-377. doi: 10.1097/MEJ.0000000000001194. Epub 2024 Oct 29. | |
| 39469374 | 0 | Khan F, Varma A, Negandhi PK, et al. A Comprehensive Review of Cryptogenic Stroke and Atrial Fibrillation: Real-World Insights Into the Role of Insertable Cardiac Monitors. Cureus. 2024 Sep 28;16(9):e70369. doi: 10.7759/cureus.70369. eCollection 2024 Sep. | |
| 39461724 | 0 | Goldenberg NA, Schulman S, Kittelson JM, et al. Duration of Anticoagulation for Venous Thromboembolism in Pediatric Patients: Kids-DOTT Trial Outcomes at Two Years. J Thromb Haemost. 2024 Oct 24:S1538-7836(24)00631-7. doi: 10.1016/j.jtha.2024.09.038. | |
| 39449526 | 0 | Shibeeb S, Al-Rayashi N, Shams N, et al. Factor V Leiden (R506Q), Prothrombin G20210A, and MTHFR C677T Variants and Thrombophilia in Qatar Biobank Participants: A Case Control Study. Pathophysiology. 2024 Oct 21;31(4):608-620. doi: 10.3390/pathophysiology31040044. | |
| 39447869 | 0 | Godier A, Lasne D, Pernod G, et al. Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network. Anaesth Crit Care Pain Med. 2024 Oct 22:101446. doi: 10.1016/j.accpm.2024.101446. | |
| 39442625 | 0 | Anuku D, Carrier M, Le Gal G, et al. Impact of limited language proficiency on participation in venous thromboembolism research: A retrospective analysis. J Thromb Haemost. 2024 Oct 21:S1538-7836(24)00562-2. doi: 10.1016/j.jtha.2024.09.014. | |
| 39437797 | 0 | Siegal DM, Tseng EK, Schunemann HJ, et al. ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary. Blood Adv. 2024 Oct 22:bloodadvances.2024014219. doi: 10.1182/bloodadvances.2024014219. | |
| 39437636 | 0 | Li S, Atkinson HM, Fusch G, et al. Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity. Biomater Adv. 2024 Oct 10;166:214067. doi: 10.1016/j.bioadv.2024.214067. | |
| 39434959 | 0 | Duijzer D, de Winter MA, Carrier M, et al. Impact of the VTE-PREDICT calculator on clinicians' decision making in fictional patients with venous thromboembolism: a randomized controlled trial. Res Pract Thromb Haemost. 2024 Sep 11;8(7):102569. doi: 10.1016/j.rpth.2024.102569. eCollection 2024 Oct. | |
| 39420740 | 0 | Raslan IA, Solh Z, Kuo KHM, et al. Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review. Hemoglobin. 2024 Oct 18:1-13. doi: 10.1080/03630269.2024.2371884. | |
| 39419325 | 0 | El-Sayed A, Murali N, Lee A, et al. Outcomes of surgical revascularisation for acute upper limb ischemia- a single-center retrospective analysis. Ann Vasc Surg. 2024 Oct 15:S0890-5096(24)00654-X. doi: 10.1016/j.avsg.2024.10.004. | |
| 39419079 | 0 | Elbaz C, Hollestelle MJ, Meijer P, et al. D-dimer-An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real World. Semin Thromb Hemost. 2024 Oct 17. doi: 10.1055/s-0044-1791700. | |
| 39415921 | 0 | Bohm A, Wan BA, Karin A, et al. Antiphospholipid syndrome, monoclonal gammopathy, and cryoglobulinemia overlap leading to recurrent cutaneous microvascular thrombosis: A case report and retrospective cohort study. EJHaem. 2024 Jul 28;5(5):971-975. doi: 10.1002/jha2.987. eCollection 2024 Oct. | |
| 39415373 | 0 | Gonzalez JM, Valenzuela A. Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis. Rheum Dis Clin North Am. 2024 Nov;50(4):661-681. doi: 10.1016/j.rdc.2024.07.006. Epub 2024 Sep 16. | |
| 39409956 | 0 | Leblanc K, Edwards SJ, Dranitsaris G, et al. Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus. Cancers (Basel). 2024 Sep 29;16(19):3336. doi: 10.3390/cancers16193336. | |
| 39401932 | 0 | Castellucci LA, Germain LS. Recognizing the 11th Year of World Thrombosis Day: A Call to Action for Health Care Professionals with a Focus on Women and Thrombosis. J Thromb Haemost. 2024 Oct 10:S1538-7836(24)00576-2. doi: 10.1016/j.jtha.2024.10.001. | |
| 39401736 | 0 | Hui S, Zeid K, Kou R, et al. Management and outcomes in patients with tumor thrombus: A retrospective cohort study. J Thromb Haemost. 2024 Oct 12:S1538-7836(24)00580-4. doi: 10.1016/j.jtha.2024.10.002. | |
| 39369655 | 0 | Asgari A, Franczak A, Herchen A, et al. Elevated levels of pro-thrombotic eNOS-negative platelets in COVID-19 patients. Thromb Res. 2024 Oct 3;244:109178. doi: 10.1016/j.thromres.2024.109178. | |
| 39362177 | 0 | Shaw JR, Almujalli AA, Xu Y, et al. Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery. Thromb Res. 2024 Nov;243:109172. doi: 10.1016/j.thromres.2024.109172. Epub 2024 Sep 24. | |
| 39333740 | 0 | Atkinson HM, Stevic I, Berry LR, et al. Effect of endothelium on the anticoagulant activity of a covalent antithrombin-heparin complex. Sci Rep. 2024 Sep 27;14(1):22335. doi: 10.1038/s41598-024-72458-0. | |
| 39328375 | 0 | Suleman A, Wine R, Carrier M, et al. The risk of venous thromboembolism in primary central nervous system lymphoma: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2024 Jul 14;8(6):102507. doi: 10.1016/j.rpth.2024.102507. eCollection 2024 Aug. | |
| 39321425 | 0 | Betensky M, Mosha M, Tarango C, et al. Outcomes in Children with Provoked Venous Thrombosis and Antiphospholipid Antibodies: Findings from the Kids-DOTT Trial. Blood Adv. 2024 Sep 25:bloodadvances.2024014415. doi: 10.1182/bloodadvances.2024014415. | |
| 39306544 | 0 | Bruwer D, de Lange-Loots Z, Koschinsky ML, et al. Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans. J Clin Lipidol. 2024 Aug 12:S1933-2874(24)00231-9. doi: 10.1016/j.jacl.2024.08.004. | |
| 39302109 | 0 | Boffa MB, Koschinsky ML. Lipoprotein(a) and cardiovascular disease. Biochem J. 2024 Oct 2;481(19):1277-1296. doi: 10.1042/BCJ20240037. | |
| 39299270 | 0 | Lanting V, Takada T, Bosch F, et al. Risk of recurrent venous thromboembolism in patients with cancer: an individual patient data meta-analysis and development of a prediction model. Thromb Haemost. 2024 Sep 19. doi: 10.1055/a-2418-3960. | |
| 39299256 | 0 | Wilson HP, Mosha M, Miller A, et al. Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial. Semin Thromb Hemost. 2024 Sep 19. doi: 10.1055/s-0044-1790572. | |
| 39290989 | 0 | Chornenki NLJ, McPhaden H, Peterson EA, et al. Dual direct oral anticoagulant therapy in challenging thrombosis: a case series. Res Pract Thromb Haemost. 2024 Aug 13;8(6):102546. doi: 10.1016/j.rpth.2024.102546. eCollection 2024 Aug. | |
| 39283934 | 0 | Weitz JI. Arterial Thrombosis: Present and Future. Circulation. 2024 Sep 17;150(12):905-907. doi: 10.1161/CIRCULATIONAHA.124.070541. Epub 2024 Sep 16. | |
| 39278694 | 0 | Del Giudice C, Mahe G, Thony F, et al. Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV). J Med Vasc. 2024 Sep;49(3-4):141-161. doi: 10.1016/j.jdmv.2024.06.002. Epub 2024 Aug 27. | |
| 39268352 | 0 | Ward C, Curry N, El-Ekiaby M, et al. Erratum to 'Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress' [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]. Res Pract Thromb Haemost. 2024 Jul 13;8(5):102498. doi: 10.1016/j.rpth.2024.102498. eCollection 2024 Jul. | |
| 39268016 | 0 | Ladak R, Sementilli M, Calandra J, et al. Physician practice patterns on the use of inferior vena cava filters in venous thromboembolism. Res Pract Thromb Haemost. 2024 Aug 5;8(6):102540. doi: 10.1016/j.rpth.2024.102540. eCollection 2024 Aug. | |
| 39249495 | 0 | Stuby J, Stalder O, Limacher A, et al. Baseline platelet count and long-term clinical outcomes in patients with acute venous thromboembolism: a prospective cohort study. Ann Hematol. 2024 Sep 9. doi: 10.1007/s00277-024-05982-8. | |
| 39243049 | 0 | Leon-Garcia M, Humphries B, Xie F, et al. Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study. Thromb J. 2024 Sep 6;22(1):81. doi: 10.1186/s12959-024-00648-x. | |
| 39239346 | 0 | Khan F, Carrier M, Rochwerg B. Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis. JACC CardioOncol. 2024 Jul 2;6(4):622-623. doi: 10.1016/j.jaccao.2024.03.014. eCollection 2024 Aug. | |
| 39238094 | 0 | Seadler MS, Ferraresso F, Bansal M, et al. Suppressing upregulation of fibrinogen after polytrauma mitigates thrombosis in mice. J Trauma Acute Care Surg. 2024 Sep 6. doi: 10.1097/TA.0000000000004442. | |
| 39229707 | 0 | McIntyre WF, Benz AP, Healey JS, et al. Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial. Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069903. | |
| 39222662 | 0 | Yin CY, Scott MM, Kimura M, et al. Oral Anticoagulant Use and Post-Fall Mortality in Long-Term Care Home Residents. J Am Med Dir Assoc. 2024 Dec;25(12):105233. doi: 10.1016/j.jamda.2024.105233. Epub 2024 Aug 31. | |
| 39221448 | 0 | Arunothai S, Sutherasan Y, Panpikoon T, et al. Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study. Res Pract Thromb Haemost. 2024 Jul 22;8(5):102522. doi: 10.1016/j.rpth.2024.102522. eCollection 2024 Jul. | |
| 39214801 | 0 | Jain SS, Mahaffey KW, Pieper KS, et al. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design. Am Heart J. 2024 Aug 27:S0002-8703(24)00206-0. doi: 10.1016/j.ahj.2024.08.011. | |
| 39214564 | 0 | Khalife R, Burnett AE, Tritschler T, et al. Practical Prescribing: Direct oral anticoagulants. BMJ. 2024 Aug 30;386:e079520. doi: 10.1136/bmj-2024-079520. | |
| 39211760 | 0 | Holodinsky JK, Kumar M, McNaughton CD, et al. An Interrupted Time-Series Analysis of the Impact of COVID-19 on Hospitalizations for Vascular Events in 3 Canadian Provinces. CJC Open. 2024 Apr 30;6(8):959-966. doi: 10.1016/j.cjco.2024.04.010. eCollection 2024 Aug. | |
| 39197347 | 0 | Wang TF, Mallick R, Noureldin A, et al. Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial. Thromb Res. 2024 Aug 20;242:109123. doi: 10.1016/j.thromres.2024.109123. | |
| 39192363 | 0 | Dzuko Kamga J, Floch R, Kerleguer K, et al. Case-control study of the characteristics and risk factors of hot clot artefacts on 18F-FDG PET/CT. Cancer Imaging. 2024 Aug 27;24(1):114. doi: 10.1186/s40644-024-00760-1. | |
| 39191449 | 0 | Ivankovic V, Delisle M, Stacey D, et al. Testing of a risk-stratified patient decision aid to facilitate shared decision-making for extended postoperative thromboprophylaxis after major abdominal surgery for cancer. Can J Surg. 2024 Aug 27;67(4):E320-E328. doi: 10.1503/cjs.014722. Print 2024 Jul-Aug. | |
| 39189664 | 0 | Kim H, Hong F, Mollica MY, et al. Filamin A regulates platelet shape change and contractile force generation via phosphorylation of the myosin light chain. Biochem J. 2024 Aug 27:BCJ20240114. doi: 10.1042/BCJ20240114. | |
| 39182756 | 0 | Carrier M, Bertoletti L, Girard P, et al. Preventative and curative treatment of venous thromboembolic disease in cancer patients. Presse Med. 2024 Aug 23:104242. doi: 10.1016/j.lpm.2024.104242. | |
| 39178882 | 0 | Glise Sandblad K, Svensson CJ, Svennerholm K, et al. Time trends and excess mortality compared to population controls after a first-time pulmonary embolism or deep vein thrombosis. Thromb Haemost. 2024 Aug 23. doi: 10.1055/a-2402-6192. | |
| 39174231 | 0 | Schulman S, Resnick HE. "2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": reply. J Thromb Haemost. 2024 Sep;22(9):2672-2673. doi: 10.1016/j.jtha.2024.06.009. | |
| 39167942 | 0 | Zabeida A, Bosch A, Uleryk E, et al. Recurrent thrombotic events in pediatric antiphospholipid syndrome: A systematic review and meta-analysis. Thromb Res. 2024 Aug 14;242:109116. doi: 10.1016/j.thromres.2024.109116. | |
| 39154384 | 0 | Vlachodimitropoulou E, Carrier M, Malinowski K, et al. Examining postpartum anticoagulation practices: An international survey of healthcare providers. Thromb Res. 2024 Aug 3;242:109113. doi: 10.1016/j.thromres.2024.109113. | |
| 39147240 | 0 | Shen C, Mackeigan DT, Shoara AA, et al. Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy. J Thromb Haemost. 2024 Nov;22(11):3249-3265. doi: 10.1016/j.jtha.2024.06.030. Epub 2024 Aug 13. | |
| 39122193 | 0 | Galanaud JP, Krebs-Drouot L, Genty-Vermorel C, et al. Very Long-term Risk of Moderate-Severe Post-Thrombotic Syndrome after Deep Vein Thrombosis. J Thromb Haemost. 2024 Aug 7:S1538-7836(24)00438-0. doi: 10.1016/j.jtha.2024.07.020. | |
| 39111636 | 0 | Chen J, Lynn EG, Sharma H, et al. Small Molecules Targeting GRP78 Mitigate Anti- GRP78 Autoantibody-Mediated Tissue Factor Procoagulant Activity in Cultured Endothelial Cells. J Thromb Haemost. 2024 Aug 5:S1538-7836(24)00432-X. doi: 10.1016/j.jtha.2024.07.015. | |
| 39086106 | 0 | Mancini A, Wong G, Bastas D, et al. Reliability, usability, and efficiency of video versus print instructions to teach parents a procedural task: A cross-sectional study. Pediatr Blood Cancer. 2024 Jul 31:e31237. doi: 10.1002/pbc.31237. | |
| 39083677 | 0 | Weatherald J, Wen C, Stickland MK, et al. Sex Differences in Venous Thromboembolism after Covid-19 Infection: A Retrospective Population-based Matched Cohort Study. Ann Am Thorac Soc. 2024 Jul 31. doi: 10.1513/AnnalsATS.202401-070RL. | |
| 39075719 | 0 | Porres-Aguilar M, Rivera-Lebron B, Kim NH, et al. Vascular Disease Patient Information Page: Post-pulmonary embolism syndrome, CTEPD, and CTEPH. Vasc Med. 2024 Jul 29:1358863X241258957. doi: 10.1177/1358863X241258957. | |
| 39055430 | 0 | Casares JA, Jaramillo AP, Nizamudeen S, et al. Evaluating the Effectiveness of Tranexamic Acid vs. Placebo in Cardiac Surgery: A Systematic Review and Meta-Analysis. Cureus. 2024 Jun 25;16(6):e63089. doi: 10.7759/cureus.63089. eCollection 2024 Jun. | |
| 39048267 | 0 | Vrotniakaite-Bajerciene K, Carrier M. Venous thromboembolism and estrogen-dance with the devil in thrombosis medicine. J Thromb Haemost. 2024 Aug;22(8):2150-2152. doi: 10.1016/j.jtha.2024.05.022. | |
| 39029742 | 0 | Levy JH, Shaw JR, Castellucci LA, et al. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2024 Jul 17:S1538-7836(24)00426-4. doi: 10.1016/j.jtha.2024.07.009. | |
| 39028040 | 0 | Najem MY, Rys RN, Laurance S, et al. Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury. J Am Heart Assoc. 2024 Jul 19:e034492. doi: 10.1161/JAHA.124.034492. | |
| 39002730 | 0 | Schulman S, Bhagirath V, Chan N, et al. Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors. J Thromb Haemost. 2024 Oct;22(10):2761-2766. doi: 10.1016/j.jtha.2024.07.002. Epub 2024 Jul 11. | |
| 38984712 | 0 | Carlin S, Jakovac M, Budaj A, et al. Factor XI inhibition in cardiovascular disease. Pol Arch Intern Med. 2024 Aug 8;134(7-8):16799. doi: 10.20452/pamw.16799. Epub 2024 Jul 9. | |
| 38969303 | 0 | Banerjee M, Rowley JW, Stubben CJ, et al. Prospective, International, Multisite Comparison of Platelet Isolation Techniques for Genome-Wide Transcriptomics: Communication from the SSC of the ISTH. J Thromb Haemost. 2024 Jul 3:S1538-7836(24)00376-3. doi: 10.1016/j.jtha.2024.06.017. | |
| 38964250 | 0 | Stewart KT, Jafari H, Pattillo J, et al. Avoiding the needle: A quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery. Gynecol Oncol. 2024 Jul 3;188:131-139. doi: 10.1016/j.ygyno.2024.06.013. | |
| 38961717 | 0 | Antonelli L, Wendel-Garcia PD, Deforth M, et al. Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding. BJU Int. 2024 Nov;134(5):781-788. doi: 10.1111/bju.16444. Epub 2024 Jul 3. | |
| 38957030 | 0 | Tikkinen KAO, Cartwright R, Jensen AG, et al. European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: Chapter 12: Urology. Eur J Anaesthesiol. 2024 Aug 1;41(8):618-621. doi: 10.1097/EJA.0000000000002012. Epub 2024 Jul 10. | |
| 38953913 | 0 | Konar SK, Dinesh YS, Shukla D, et al. Decompressive craniectomy in children: indications and outcome from a tertiary centre. Childs Nerv Syst. 2024 Jul 1. doi: 10.1007/s00381-024-06513-6. | |
| 38939758 | 0 | AlTurki A, Marafi M, Dawas A, et al. Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysis. J Arrhythm. 2024 May 6;40(3):440-447. doi: 10.1002/joa3.13051. eCollection 2024 Jun. | |
| 38938844 | 0 | Godoy LC, Neal MD, Goligher EC, et al. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Adv. 2024 Jan 26;3(3):100780. doi: 10.1016/j.jacadv.2023.100780. eCollection 2024 Mar. | |
| 38927943 | 0 | Xu Y, Carrier M, Kimpton M. Arterial Thrombosis in Patients with Cancer. Cancers (Basel). 2024 Jun 17;16(12):2238. doi: 10.3390/cancers16122238. | |
| 38917440 | 0 | Geerts WH, Jeong E, Robinson LR, et al. Venous Thromboembolism Prevention in Rehabilitation: a Review and Practice Suggestions. Am J Phys Med Rehabil. 2024 Jun 24. doi: 10.1097/PHM.0000000000002570. | |
| 38904133 | 0 | Mai V, Girardi L, de Wit K, et al. Chronic obstructive pulmonary disease exacerbation purulence status and its association with pulmonary embolism: protocol for a systematic review with meta-analysis. BMJ Open. 2024 Jun 19;14(6):e085328. doi: 10.1136/bmjopen-2024-085328. | |
| 38878942 | 0 | Shurrab M, Austin PC, Jackevicius CA, et al. Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Older Patients with Atrial Fibrillation: A Population-Based Cohort Study. Heart Rhythm. 2024 Jun 13:S1547-5271(24)02686-9. doi: 10.1016/j.hrthm.2024.06.010. | |
| 38875846 | 0 | Brown C, Tokessy L, Delluc A, et al. Risk of developing post thrombotic syndrome after deep vein thrombosis with different anticoagulant regimens: A systematic review and pooled analysis. Thromb Res. 2024 Jun 3;240:109057. doi: 10.1016/j.thromres.2024.109057. | |
| 38874073 | 0 | Tunehag KR, Thomas CD, Franchi F, et al. CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2024 Jun 14:e033791. doi: 10.1161/JAHA.123.033791. | |
| 38872827 | 0 | Fang X, Shen Y, Wang M, et al. Predictive value of Caprini risk assessment model, D-dimer, and fibrinogen levels on lower extremity deep vein thrombosis in patients with spontaneous intracerebral hemorrhage. Front Neurol. 2024 May 30;15:1370029. doi: 10.3389/fneur.2024.1370029. eCollection 2024. | |
| 38866248 | 0 | Guman NAM, Becking AL, Weijers SS, et al. Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study. J Thromb Haemost. 2024 Jun 10:S1538-7836(24)00323-4. doi: 10.1016/j.jtha.2024.05.031. | |
| 38861325 | 0 | Scarlatescu E, Iba T, Maier CL, et al. Deranged Balance of Hemostasis and Fibrinolysis in Disseminated Intravascular Coagulation: Assessment and Relevance in Different Clinical Settings. Anesthesiology. 2024 Sep 1;141(3):570-583. doi: 10.1097/ALN.0000000000005023. | |
| 38854821 | 0 | Ward C, Curry N, El-Ekiaby M, et al. Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress. Res Pract Thromb Haemost. 2024 May 3;8(4):102432. doi: 10.1016/j.rpth.2024.102432. eCollection 2024 May. | |
| 38847098 | 0 | Yaghi S, Shu L, Fletcher L, et al. Anticoagulation Versus Antiplatelets in Spontaneous Cervical Artery Dissection: A Systematic Review and Meta-Analysis. Stroke. 2024 Jul;55(7):1776-1786. doi: 10.1161/STROKEAHA.124.047310. Epub 2024 Jun 7. | |
| 38846991 | 0 | Del Toro Mijares R, Rojas Murguia A, Porres-Aguilar M, et al. Anticoagulation in the Management of Acute Pulmonary Embolism-A Review. Int J Angiol. 2024 Mar 12;33(2):95-100. doi: 10.1055/s-0044-1782537. eCollection 2024 Jun. | |
| 38843785 | 0 | Ospel JM, Singh N, Nguyen TN, et al. Endovascular therapy for cerebral venous thrombosis: Applying lessons learned from clinical trials of EVT in acute arterial ischemic stroke. Cerebrovasc Dis. 2024 Jun 6. doi: 10.1159/000539657. | |
| 38836280 | 0 | Shoskes A, Shu L, Nguyen TN, et al. Prevalence and Associations of Dural Arteriovenous Fistulae in Cerebral Venous Thrombosis: Analysis of ACTION-CVT. J Stroke. 2024 May;26(2):325-329. doi: 10.5853/jos.2023.02264. Epub 2024 May 30. | |
| 38830735 | 0 | Houston BL, McIsaac DI, Breau RH, et al. Hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery (TRACTION): protocol for a phase IV randomised controlled trial. BMJ Open. 2024 Jun 3;14(6):e084847. doi: 10.1136/bmjopen-2024-084847. | |
| 38830225 | 0 | Field TS. In cryptogenic stroke and atrial cardiopathy, apixaban did not reduce recurrent stroke vs. aspirin. Ann Intern Med. 2024 Jun;177(6):JC65. doi: 10.7326/ANNALS-24-00436-JC. Epub 2024 Jun 4. | |
| 38826076 | 0 | Field TS, Lindsay MP, Wein T, et al. Canadian Stroke Best Practice Recommendations, 7(th) Edition: Cerebral Venous Thrombosis, 2024. Can J Neurol Sci. 2024 Jun 3:1-57. doi: 10.1017/cjn.2024.269. | |
| 38823454 | 0 | Carlin S, Cuker A, Gatt A, et al. Anticoagulation for Stroke Prevention in Atrial Fibrillation and Treatment of Venous Thromboembolism and Portal Vein Thrombosis in Cirrhosis: Guidance from the SSC of the ISTH. J Thromb Haemost. 2024 May 30:S1538-7836(24)00311-8. doi: 10.1016/j.jtha.2024.05.023. | |
| 38820498 | 0 | Ballard-Kordeliski A, Lee RH, O'Shaughnessy EC, et al. 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model. Blood. 2024 Sep 5;144(10):1116-1126. doi: 10.1182/blood.2023022608. | |
| 38795872 | 0 | Raza S, Pinkerton P, Hirsh J, et al. The historical origins of modern international normalized ratio targets. J Thromb Haemost. 2024 Aug;22(8):2184-2194. doi: 10.1016/j.jtha.2024.05.013. Epub 2024 May 23. | |
| 38792286 | 0 | Stanciakova L, Othman M, Kubisz P. Management of Venous and Arterial Thrombosis. J Clin Med. 2024 May 7;13(10):2744. doi: 10.3390/jcm13102744. | |
| 38781706 | 0 | Girardi L, Ciuffini LA, Mai V, et al. Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism. Thromb Res. 2024 May 17;239:109037. doi: 10.1016/j.thromres.2024.109037. | |
| 38776611 | 0 | Wan T, Garland SJ, Drury CT, et al. Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients. Thromb Res. 2024 May 10;239:109036. doi: 10.1016/j.thromres.2024.05.009. | |
| 38773543 | 0 | McKechnie T, Ramji K, Saddik M, et al. PReoperative very low-Energy diets for obese PAtients undergoing non-bariatric surgery Randomized Evaluation (PREPARE): a protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2024 May 21;10(1):82. doi: 10.1186/s40814-024-01511-6. | |
| 38768631 | 0 | Roy DC, Wang TF, Lun R, et al. Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis. Thromb Haemost. 2024 May 20. doi: 10.1055/a-2330-1371. | |
| 38765325 | 0 | Sulli D, S C, Rao A. In Search of Optimal Practice: A Retrospective Comparative Study of Single- Versus Dual-Venous Anastomosis in Microvascular Flaps. Cureus. 2024 Apr 18;16(4):e58573. doi: 10.7759/cureus.58573. eCollection 2024 Apr. | |
| 38762021 | 0 | Vayne C, Rollin J, Clare R, et al. THE USE OF 1E12, A MONOCLONAL ANTI-PLATELET FACTOR 4 ANTIBODY TO IMPROVE THE DIAGNOSIS OF VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA. J Thromb Haemost. 2024 May 16:S1538-7836(24)00287-3. doi: 10.1016/j.jtha.2024.05.005. | |
| 38752349 | 0 | Malik RA, Zhou J, Fredenburgh JC, et al. Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice. Arterioscler Thromb Vasc Biol. 2024 May 16. doi: 10.1161/ATVBAHA.124.320899. | |
| 38744617 | 0 | Wing SM, Mavrakanas TA, Harel Z. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review. Semin Nephrol. 2024 May 14:151517. doi: 10.1016/j.semnephrol.2024.151517. | |
| 38735015 | 0 | Linder M, Ekbom A, Brobert G, et al. Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. J Thromb Thrombolysis. 2024 May 12. doi: 10.1007/s11239-024-02992-1. | |
| 38733981 | 0 | Bissola AL, Zhang Y, Cranstone M, et al. Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays. Semin Thromb Hemost. 2024 May 11. doi: 10.1055/s-0044-1786749. | |
| 38733980 | 0 | Schulman S. Recent Advances in Thrombosis and Hemostasis-Part X. Semin Thromb Hemost. 2024 May 11. doi: 10.1055/s-0044-1786753. | |
| 38733691 | 0 | Cenat JM, Dromer E, Farahi SMMM, et al. Venous thromboembolism in Black COVID-19 patients in a minority context compared to White, Asian and other racialized patients: A systematic review and meta-analysis. Thromb Res. 2024 May 7;238:197-205. doi: 10.1016/j.thromres.2024.05.007. | |
| 38729577 | 0 | Schreuder M, Jourdi G, Veizaj D, et al. Minimally Modified Human Blood Coagulation Factor X to Bypass Direct Factor Xa Inhibitors. J Thromb Haemost. 2024 May 8:S1538-7836(24)00254-X. doi: 10.1016/j.jtha.2024.04.022. | |
| 38706782 | 0 | Boukhatem I, Fleury S, Jourdi G, et al. The intriguing role of platelets as custodians of brain-derived neurotrophic factor. Res Pract Thromb Haemost. 2024 Apr 3;8(3):102398. doi: 10.1016/j.rpth.2024.102398. eCollection 2024 Mar. | |
| 38702341 | 0 | Fontyn S, Bai Y, Bolger S, et al. Inferior vena cava filter use at a large community hospital: a retrospective cohort study. Sci Rep. 2024 May 3;14(1):10192. doi: 10.1038/s41598-024-60868-z. | |
| 38692087 | 0 | Huroy M, Selby R, Sutradhar S, et al. Peak plasma anti-Xa direct oral anticoagulant levels after gastrointestinal surgeries: A retrospective cohort. Thromb Res. 2024 Apr 19;238:85-87. doi: 10.1016/j.thromres.2024.04.019. | |
| 38686174 | 0 | Ratnasekera A, Seng SS, Ciarmella M, et al. Thromboprophylaxis in hospitalized trauma patients: a systematic review and meta-analysis of implementation strategies. Trauma Surg Acute Care Open. 2024 Apr 25;9(1):e001420. doi: 10.1136/tsaco-2024-001420. eCollection 2024. | |
| 38663489 | 0 | Ferraresso F, Leung J, Kastrup CJ. RNA Therapeutics to Control Fibrinolysis: Review on Applications in Biology and Medicine. J Thromb Haemost. 2024 Apr 23:S1538-7836(24)00224-1. doi: 10.1016/j.jtha.2024.04.006. | |
| 38661514 | 0 | Harrigan AM, Carrier M, Wang TF. Primary prevention of venous thromboembolism in ambulatory cancer patients: recent advances and practical implications. Pol Arch Intern Med. 2024 Apr 25:16739. doi: 10.20452/pamw.16739. | |
| 38660318 | 0 | Kazi S, Othman M, Khoury R, et al. Report of the ISTH registry on pregnancy and COVID-19-associated coagulopathy (COV-PREG-COAG). Obstet Med. 2024 Mar;17(1):13-21. doi: 10.1177/1753495X231206931. Epub 2023 Oct 16. | |
| 38658484 | 0 | Adelakun AR, De Vera MA, McGrail K, et al. Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study. Adv Ther. 2024 Apr 24. doi: 10.1007/s12325-024-02859-0. | |
| 38657032 | 0 | Wendelboe A, Weitz JI. Global Health Burden of Venous Thromboembolism. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1007-1011. doi: 10.1161/ATVBAHA.124.320151. Epub 2024 Apr 24. | |
| 38639617 | 0 | Xu Y, Shao L, Huang Y, et al. Evaluating Adverse Reactions of Central Venous Catheter Placement in Patients with AIDS: A Meta-Analysis Approach. Altern Ther Health Med. 2024 Apr 18:AT10670. | |
| 38634415 | 0 | Horner DE, Davis S, Pandor A, et al. Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis. Health Technol Assess. 2024 Apr;28(20):1-166. doi: 10.3310/AWTW6200. | |
| 38623474 | 0 | Favaloro EJ, Pasalic L, Selby R. Testing for the lupus anticoagulant: the good, the bad, and the ugly. Res Pract Thromb Haemost. 2024 Mar 18;8(3):102385. doi: 10.1016/j.rpth.2024.102385. eCollection 2024 Mar. | |
| 38623473 | 0 | VanderMeulen H, Tang GH, Sholzberg M. Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use. Res Pract Thromb Haemost. 2024 Mar 19;8(3):102389. doi: 10.1016/j.rpth.2024.102389. eCollection 2024 Mar. | |
| 38620707 | 0 | Brenner B, Ay C, Gal GL, et al. Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need. Thromb Update. 2022 Mar;6:100098. doi: 10.1016/j.tru.2022.100098. Epub 2022 Jan 10. | |
| 38620086 | 0 | Siegal DM, Forbes N, Eikelboom J, et al. The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis. Circulation. 2024 Apr 16;149(16):1315-1318. doi: 10.1161/CIRCULATIONAHA.123.066933. Epub 2024 Apr 15. | |
| 38614162 | 0 | Klein P, Shu L, Lindgren E, et al. External Validation of the SI(2)NCAL(2)C Score for Outcomes Following Cerebral Venous Thrombosis. J Stroke Cerebrovasc Dis. 2024 Apr 11:107720. doi: 10.1016/j.jstrokecerebrovasdis.2024.107720. | |
| 38606547 | 0 | Waheed Z, Field TS, Zhou LW. Health Care Encounters Prior to Hospitalization for Cerebral Venous Thrombosis Patients. Can J Neurol Sci. 2024 Apr 12:1-20. doi: 10.1017/cjn.2024.48. | |
| 38604227 | 0 | El-Sherbini AH, Coroneos S, Zidan A, et al. Machine Learning as a Diagnostic and Prognostic Tool for Predicting Thrombosis in Cancer Patients: A Systematic Review. Semin Thromb Hemost. 2024 Apr 11. doi: 10.1055/s-0044-1785482. | |
| 38582384 | 0 | Potere N, Mahe I, Angchaisuksiri P, et al. Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: A global survey. J Thromb Haemost. 2024 Apr 4:S1538-7836(24)00177-6. doi: 10.1016/j.jtha.2024.03.019. | |
| 38574863 | 0 | Bindal P, Patell R, Chiasakul T, et al. Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy: A meta-analysis to assess the risk of bleeding and thrombosis following CAR T-cell therapy. J Thromb Haemost. 2024 Apr 2:S1538-7836(24)00180-6. doi: 10.1016/j.jtha.2024.03.021. | |
| 38573482 | 0 | Patriquin CJ, Bogdanovic A, Griffin M, et al. Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study. Adv Ther. 2024 Apr 4. doi: 10.1007/s12325-024-02827-8. | |
| 38563897 | 0 | Khan F, Tran A, Carrier M. ICU-specific factors associated with venous thromboembolism and bleeding. Intensive Care Med. 2024 Apr 2. doi: 10.1007/s00134-024-07395-7. | |
| 38559571 | 0 | de Winter MA, Xu Y, Stacey D, et al. Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding-"This pill will keep you alive tonight". Res Pract Thromb Haemost. 2024 Mar 1;8(2):102360. doi: 10.1016/j.rpth.2024.102360. eCollection 2024 Feb. | |
| 38557474 | 0 | Tapper EB, Warner MA, Shah RP, et al. Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi. Hepatology. 2024 Aug 1;80(2):488-499. doi: 10.1097/HEP.0000000000000856. Epub 2024 Apr 1. | |
| 38552497 | 0 | Douros A, Cui Y, Platt RW, et al. Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study. Thromb Res. 2024 Mar 25;237:71-78. doi: 10.1016/j.thromres.2024.03.024. | |
| 38548736 | 0 | Tran A, Fernando SM, Rochwerg B, et al. Prognostic Factors Associated with Venous Thromboembolism Following Traumatic Injury: A Systematic Review and Meta-Analysis. J Trauma Acute Care Surg. 2024 Mar 29. doi: 10.1097/TA.0000000000004326. | |
| 38518896 | 0 | Baker RI, Choi P, Curry N, et al. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH. J Thromb Haemost. 2024 Mar 20:S1538-7836(24)00163-6. doi: 10.1016/j.jtha.2024.03.005. | |
| 38510294 | 0 | Wang TF, Connors JM. The Pursuit of "Best" Anticoagulant for Cancer-Associated Thrombosis: Are We There Yet? JACC CardioOncol. 2024 Jan 9;6(1):114-116. doi: 10.1016/j.jaccao.2023.12.001. eCollection 2024 Feb. | |
| 38508830 | 0 | Sposato LA, Andrade JG, Field TS. Detection of atrial fibrillation in patients after stroke - Authors' reply. Lancet Neurol. 2024 Apr;23(4):336-337. doi: 10.1016/S1474-4422(24)00088-7. | |
| 38503600 | 0 | Schulman S, Arnold DM, Bradbury CA, et al. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2024 Mar 18:S1538-7836(24)00113-2. doi: 10.1016/j.jtha.2024.02.011. | |
| 38494462 | 0 | Coutinho JM, van de Munckhof A, Aguiar de Sousa D, et al. Reducing the global burden of cerebral venous thrombosis: an international research agenda. Int J Stroke. 2024 Mar 17:17474930241242266. doi: 10.1177/17474930241242266. | |
| 38484629 | 0 | Bosch A, Brunsvig Jarvis K, Brandao LR, et al. The role of coagulation factors VIII, IX and XI in the prediction and mediation of recurrent thrombotic events in children with non-central venous catheter deep vein thrombosis. Thromb Res. 2024 Mar 7;236:228-235. doi: 10.1016/j.thromres.2024.03.009. | |
| 38467823 | 0 | Yang Y, Du Y, Ivanov D, et al. Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4. Commun Biol. 2024 Mar 11;7(1):308. doi: 10.1038/s42003-024-05982-4. | |
| 38466279 | 0 | Khan F, Lun R, Hill MD. Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study. JAMA Intern Med. 2024 May 1;184(5):583-584. doi: 10.1001/jamainternmed.2024.0091. | |
| 38461064 | 0 | Di Nisio M, Lee AY. Direct oral anticoagulants: The new standard of care for cancer associated thrombosis. Eur J Intern Med. 2024 Mar 8:S0953-6205(24)00095-5. doi: 10.1016/j.ejim.2024.03.005. | |
| 38456355 | 0 | Seeburruth D, Tong XC, Kirwan C, et al. Eligibility for anticoagulation initiation in atrial fibrillation: Agreement between emergency physician and medical record review. Acad Emerg Med. 2024 Mar 8. doi: 10.1111/acem.14889. | |
| 38444614 | 0 | Chiang P, Robert-Ebadi H, Perrier A, et al. Pulmonary embolism risk stratification: external validation of the 4-level Clinical Pretest Probability Score (4PEPS). Res Pract Thromb Haemost. 2024 Feb 15;8(1):102348. doi: 10.1016/j.rpth.2024.102348. eCollection 2024 Jan. | |
| 38433976 | 0 | Selby R, Meijer P, Favaloro EJ. D-dimer diagnostics: can I use any D-dimer assay? Bridging the knowledge-to-action gap. Res Pract Thromb Haemost. 2024 Feb 1;8(1):102335. doi: 10.1016/j.rpth.2024.102335. eCollection 2024 Jan. | |
| 38429468 | 0 | Al-Tourah L, Mithoowani S, Lim W, et al. The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review. J Thromb Thrombolysis. 2024 Mar 1. doi: 10.1007/s11239-024-02956-5. | |
| 38426027 | 0 | Othman M, Nemeti G, Solow M, et al. Hematologic characteristics and coagulopathy in pregnancy with COVID-19 succeeding the first wave: a multicenter retrospective cross-sectional study. Res Pract Thromb Haemost. 2024 Feb 5;8(1):102339. doi: 10.1016/j.rpth.2024.102339. eCollection 2024 Jan. | |
| 38425173 | 0 | Tera Y, Suh YJ, Fainchtein K, et al. Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy. Am J Hematol. 2024 Feb 29. doi: 10.1002/ajh.27273. | |
| 38422980 | 0 | Bhangu G, Murray A, Qayyum A, et al. Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review. Thromb Res. 2024 Feb 19;236:108-116. doi: 10.1016/j.thromres.2024.02.012. | |
| 38408574 | 0 | Klein P, Shu L, Qureshi MM, et al. Trends in Cerebral Venous Thrombosis Before and During the COVID-19 Pandemic: Analysis of the National Inpatient Sample. J Stroke Cerebrovasc Dis. 2024 Feb 24:107651. doi: 10.1016/j.jstrokecerebrovasdis.2024.107651. | |
| 38401355 | 0 | Simard C, Poirier-Blanchette L, Rizzolo A, et al. Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: A quality improvement initiative. Thromb Res. 2024 Feb 16;236:68-73. doi: 10.1016/j.thromres.2024.02.015. | |
| 38398325 | 0 | Zhang Y, Bissola AL, Treverton J, et al. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders. J Clin Med. 2024 Feb 9;13(4):1012. doi: 10.3390/jcm13041012. | |
| 38389721 | 0 | Davis S, Goodacre S, Horner D, et al. Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study. BMJ Med. 2024 Feb 21;3(1):e000408. doi: 10.1136/bmjmed-2022-000408. eCollection 2024. | |
| 38389637 | 0 | James N, Reddy S, Maheshwari U, et al. Incidence of Cardiovascular Instability in Patients With Guillain-Barre Syndrome: A Retrospective Study. Cureus. 2024 Jan 23;16(1):e52778. doi: 10.7759/cureus.52778. eCollection 2024 Jan. | |
| 38388822 | 0 | Athale U, Halton J, Gayowsky A, et al. Development and validation of thromboembolism diagnostic algorithms in children with cancer from real-world data. Pediatr Res. 2024 Feb 22. doi: 10.1038/s41390-024-03082-x. | |
| 38382740 | 0 | Dai Y, Kretz CA, Kim PY, et al. A specific fluorescence resonance energy quenching-based biosensor for measuring thrombin activity in whole blood. J Thromb Haemost. 2024 Jun;22(6):1627-1639. doi: 10.1016/j.jtha.2024.02.007. Epub 2024 Feb 19. | |
| 38382168 | 0 | Penfound S, Lukey A, Hodgson J, et al. Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database. Gynecol Oncol. 2024 Feb 20;185:116-120. doi: 10.1016/j.ygyno.2024.02.011. | |
| 38381848 | 0 | Strilchuk AW, Hur WS, Batty P, et al. Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A. Sci Transl Med. 2024 Feb 21;16(735):eadh0027. doi: 10.1126/scitranslmed.adh0027. Epub 2024 Feb 21. | |
| 38381695 | 0 | Goodman SG, Roy D, Pollack CV Jr, et al. Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics. Crit Pathw Cardiol. 2024 Feb 21. doi: 10.1097/HPC.0000000000000351. | |
| 38375212 | 0 | Almanaseer A, Chin-Yee B, Ho J, et al. An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis. Adv Hematol. 2024 Feb 12;2024:3056216. doi: 10.1155/2024/3056216. eCollection 2024. | |
| 38365952 | 0 | Weitz JI, Tanko LB, Floege J, et al. Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nat Med. 2024 Feb;30(2):435-442. doi: 10.1038/s41591-023-02794-7. Epub 2024 Feb 16. | |
| 38335240 | 0 | Yaghi S, Shu L, Mandel D, et al. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024 Apr;55(4):908-918. doi: 10.1161/STROKEAHA.123.045731. Epub 2024 Feb 9. | |
| 38327612 | 0 | Wiggins M, Biss T, Raffini L, et al. Apixaban overdose in children: case report and proposed management. A brief communication from the Pediatric and Neonatal Thrombosis and Hemostasis SSC of ISTH. Res Pract Thromb Haemost. 2024 Jan 3;8(1):102312. doi: 10.1016/j.rpth.2023.102312. eCollection 2024 Jan. | |
| 38326711 | 0 | Nguyen TN, Qureshi MM, Klein P, et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J Stroke. 2024 Jan;26(1):129. doi: 10.5853/jos.2022.00752.e1. Epub 2024 Jan 30. | |
| 38324588 | 0 | Lun R, Siegal D, Ramsay T, et al. Synthetic data in cancer and cerebrovascular disease research: A novel approach to big data. PLoS One. 2024 Feb 7;19(2):e0295921. doi: 10.1371/journal.pone.0295921. eCollection 2024. | |
| 38321107 | 0 | England JT, Szuber N, Sirhan S, et al. Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study. Leukemia. 2024 Feb 6. doi: 10.1038/s41375-024-02155-4. | |
| 38320142 | 0 | Mottier D, Girard P, Couturaud F, et al. Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients. NEJM Evid. 2023 Aug;2(8):EVIDoa2200332. doi: 10.1056/EVIDoa2200332. Epub 2023 Jun 27. | |
| 38320119 | 0 | Le Gal G, Mottier D. Challenges Faced and Lessons Learned from Our Trial of VTE Prophylaxis. NEJM Evid. 2023 Sep;2(9):EVIDctcs2300050. doi: 10.1056/EVIDctcs2300050. Epub 2023 Aug 22. | |
| 38319277 | 0 | Fralick M, Sholzberg M. Pharmacologic Thromboprophylaxis for Patients Admitted to General Medicine - Is It Necessary? NEJM Evid. 2022 Jun;1(6):EVIDtt2200085. doi: 10.1056/EVIDtt2200085. Epub 2022 May 24. | |
| 38316416 | 0 | Harenberg J, Gosselin RC, Cuker A, et al. Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper. Thromb Haemost. 2024 Aug;124(8):770-777. doi: 10.1055/a-2261-1811. Epub 2024 Feb 5. | |
| 38315999 | 0 | van Zanten SV, Ritchie B. Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxis. Ann Intern Med. 2024 Feb;177(2):JC22. doi: 10.7326/J23-0121. Epub 2024 Feb 6. | |
| 38302339 | 0 | Schonborn L, Pavord S, Chen VMY, et al. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2024 Jan 31:S0264-410X(24)00057-4. doi: 10.1016/j.vaccine.2024.01.045. | |
| 38301711 | 0 | Cohen A, Wallenhorst C, Rivera M, et al. Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study. Thromb Haemost. 2024 Feb 1. doi: 10.1055/a-2259-0662. | |
| 38296660 | 0 | Godoy A, Carlin S, Douketis JD. Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time? Eur J Intern Med. 2024 Jan 30:S0953-6205(24)00039-6. doi: 10.1016/j.ejim.2024.01.032. | |
| 38292347 | 0 | Gresele P, Falcinelli E, Bury L, et al. Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC. Res Pract Thromb Haemost. 2023 Dec 20;8(1):102305. doi: 10.1016/j.rpth.2023.102305. eCollection 2024 Jan. | |
| 38291601 | 0 | Roy DC, Wang TF, Lun R, et al. Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis. Am J Hematol. 2024 Jan 30. doi: 10.1002/ajh.27222. | |
| 38284265 | 0 | Saposnik G, Bushnell C, Coutinho JM, et al. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association. Stroke. 2024 Jan 29. doi: 10.1161/STR.0000000000000456. | |
| 38272779 | 0 | Ades M, Simard C, Vanassche T, et al. Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease. Semin Nephrol. 2023 Nov;43(6):151484. doi: 10.1016/j.semnephrol.2023.151484. Epub 2024 Jan 24. | |
| 38266677 | 0 | Krmpotic K, Ramsay L, McMullen S, et al. Pediatric pulmonary thromboembolism: a 3-year Canadian Pediatric Surveillance Program Study. J Thromb Haemost. 2024 Jan 22:S1538-7836(24)00042-4. doi: 10.1016/j.jtha.2024.01.005. | |
| 38266535 | 0 | Gunka B, Mackenzie D, Hughes T, et al. Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study. Thromb Res. 2024 Jan 17;235:15-17. doi: 10.1016/j.thromres.2024.01.007. | |
| 38262288 | 0 | Abdulrehman J, Harrigan A, Simard C, et al. TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey. Thromb Res. 2024 Jan 17;235:11-14. doi: 10.1016/j.thromres.2024.01.009. | |
| 38233019 | 0 | Bejjani A, Khairani CD, Assi A, et al. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jan 23;83(3):444-465. doi: 10.1016/j.jacc.2023.10.038. | |
| 38222076 | 0 | de Winter MA, Thavorn K, Hageman SHJ, et al. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis. Res Pract Thromb Haemost. 2023 Nov 26;8(1):102274. doi: 10.1016/j.rpth.2023.102274. eCollection 2024 Jan. | |
| 38215970 | 0 | Carlin S, Eikelboom J. Restarting anticoagulation after major bleeding in patients with atrial fibrillation. Can J Cardiol. 2024 Jan 10:S0828-282X(24)00019-9. doi: 10.1016/j.cjca.2024.01.008. | |
| 38187827 | 0 | de Wit K. Deep vein thrombosis testing in pregnancy: where is the evidence? Commentary on "Use of single whole-leg ultrasound to exclude suspected deep vein thrombosis in pregnant patients". Res Pract Thromb Haemost. 2023 Nov 30;8(1):102283. doi: 10.1016/j.rpth.2023.102283. eCollection 2024 Jan. | |
| 38187826 | 0 | Mathieu ME, Duffett L, Caiano L, et al. Management and outcomes of superficial vein thrombosis: a single-center retrospective study. Res Pract Thromb Haemost. 2023 Nov 18;8(1):102263. doi: 10.1016/j.rpth.2023.102263. eCollection 2024 Jan. | |
| 38185079 | 0 | Yelnik CM, Erton ZB, Drumez E, et al. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry"). Semin Arthritis Rheum. 2023 Dec 20;65:152347. doi: 10.1016/j.semarthrit.2023.152347. | |
| 38183815 | 0 | Cohen O, Caiano LM, Levy-Mendelovich S. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations. Thromb Res. 2024 Jan 2;234:75-85. doi: 10.1016/j.thromres.2023.12.014. | |
| 38171625 | 0 | Abdulrehman J, Forte S, Tomlinson G, et al. THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol. BMJ Open. 2024 Jan 3;14(1):e079363. doi: 10.1136/bmjopen-2023-079363. | |
| 38170575 | 0 | Sultan N, Pelland-Marcotte MC, Remy M, et al. Real-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies. Leuk Lymphoma. 2024 Apr;65(4):538-540. doi: 10.1080/10428194.2023.2300719. Epub 2024 Jan 3. | |
| 38164978 | 0 | Pelland-Marcotte MC, Kulkarni K, Tran TH, et al. Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2024 Jan 2. doi: 10.1002/ajh.27171. | |
| 38160251 | 0 | Xu Y, Xu M, Zheng X, et al. Generation of a Predictive Clinical Model for Isolated Distal Deep Vein Thrombosis (ICMVT) Detection. Med Sci Monit. 2023 Dec 31;29:e942840. doi: 10.12659/MSM.942840. | |
| 38158198 | 0 | Johansson I, Benz AP, Kovalova T, et al. Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin. Thromb Haemost. 2023 Dec 29. doi: 10.1055/s-0043-1777827. | |
| 38153027 | 0 | Porres-Aguilar M, Najera C, Mares AC, et al. Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis. Angiology. 2023 Dec 28:33197231225291. doi: 10.1177/00033197231225291. | |
| 38150358 | 0 | Madarati H, Singh K, Sparring T, et al. Reviewing the dysregulation of ADAMTS13 and VWF in sepsis. Shock. 2023 Dec 12. doi: 10.1097/SHK.0000000000002291. | |
| 38149432 | 0 | Gabarin N, Hack M, Revilla R, et al. Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases. Expert Rev Hematol. 2023 Dec 27:1-7. doi: 10.1080/17474086.2023.2298333. | |
| 38142844 | 0 | Moroniti JJ, Vrbensky JR, Nazy I, et al. Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura. J Thromb Haemost. 2024 Apr;22(4):896-904. doi: 10.1016/j.jtha.2023.11.030. Epub 2023 Dec 22. | |
| 38104723 | 0 | Scarlatescu E, Kim PY, Marchenko SP, et al. Validation of the time to attain maximal clot amplitude after reaching maximal clot formation velocity parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: communication from the ISTH SSC Subcommittee on Fibrinolysis. J Thromb Haemost. 2024 Apr;22(4):1223-1235. doi: 10.1016/j.jtha.2023.12.012. Epub 2023 Dec 15. | |
| 38097360 | 0 | Siegal DM, Verbrugge FH, Martin AC, et al. Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke. Open Heart. 2023 Dec 14;10(2):e002506. doi: 10.1136/openhrt-2023-002506. | |
| 38089875 | 0 | Jerjes-Sanchez C, Porres-Aguilar M. Editorial: Pulmonary embolism-New diagnostic and therapeutic strategies. Front Med (Lausanne). 2023 Nov 28;10:1281073. doi: 10.3389/fmed.2023.1281073. eCollection 2023. | |
| 38087414 | 0 | Uminski K, Xu Y, Zahrai A, et al. Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review. Haemophilia. 2023 Dec 12. doi: 10.1111/hae.14906. | |
| 38084255 | 0 | Oliver M, Patriquin CJ. Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations. J Blood Med. 2023 Dec 6;14:613-628. doi: 10.2147/JBM.S431493. eCollection 2023. | |
| 38081629 | 0 | Hennawy M, Zhou LW, Field TS. Cerebral venous thrombosis should be considered in a postpartum patient with headache and seizure. CMAJ. 2023 Dec 10;195(48):E1663. doi: 10.1503/cmaj.149620. | |
| 38077822 | 0 | Olasupo OO, Nakar C, Haddix C, et al. Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study. Res Pract Thromb Haemost. 2023 Oct 14;7(7):102228. doi: 10.1016/j.rpth.2023.102228. eCollection 2023 Oct. | |
| 38065528 | 0 | Wang TF, Kou R, Carrier M, et al. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: A systematic review and meta-analysis. J Thromb Haemost. 2023 Dec 6:S1538-7836(23)00855-3. doi: 10.1016/j.jtha.2023.11.017. | |
| 38056405 | 0 | Zhou LW, Hennawy M, Ngo L, et al. Prognosis after cerebral venous thrombosis: Mortality during initial admission and at 30 days and one year after discharge in a large Canadian population-based cohort. Thromb Res. 2023 Nov 26;233:145-152. doi: 10.1016/j.thromres.2023.11.028. | |
| 38046038 | 0 | Villain C, Ebert N, Bothe T, et al. Kidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation. Clin Kidney J. 2023 Sep 4;16(12):2661-2671. doi: 10.1093/ckj/sfad218. eCollection 2023 Dec. | |
| 38039985 | 0 | Mithoowani S, Khattak S, Lieberman S, et al. Learning From Clinical Supervisor Practice Variability: Exploring Medical Resident and Fellow Experiences and Interpretations. Acad Med. 2023 Dec 1. doi: 10.1097/ACM.0000000000005573. | |
| 38035566 | 0 | Elenjickal EJ, Travlos CK, Marques P, et al. Anticoagulation in Patients with Chronic Kidney Disease. Am J Nephrol. 2024;55(2):146-164. doi: 10.1159/000535546. Epub 2023 Nov 30. | |
| 38030465 | 0 | Gal GL, Agnelli G, Darius H, et al. Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis. Eur J Intern Med. 2023 Nov 28:S0953-6205(23)00414-4. doi: 10.1016/j.ejim.2023.11.017. | |
| 38029549 | 0 | Elahi MM, Witt AN, Pryzdial ELG, et al. Thrombotic triad in microgravity. Thromb Res. 2023 Nov 22;233:82-87. doi: 10.1016/j.thromres.2023.11.020. | |
| 38011218 | 0 | Larreche S, Chevillard L, Jourdi G, et al. Bothrops venom-induced hemostasis disorders in the rat: Between Scylla and Charybdis. PLoS Negl Trop Dis. 2023 Nov 27;17(11):e0011786. doi: 10.1371/journal.pntd.0011786. | |
| 38008658 | 0 | Carrier M, Wang TF. Management of cancer-associated venous thromboembolism from diagnosis to treatment: State of the art and remaining unmet needs. Arch Cardiovasc Dis. 2023 Nov 21:S1875-2136(23)00510-7. doi: 10.1016/j.acvd.2023.11.003. | |
| 37984078 | 0 | Wang TF, Delluc A, Cervi A, et al. A survey of clinician perspectives on the management of catheter-related upper extremity deep vein thrombosis in patients with cancer. Thromb Res. 2023 Nov 16;233:10-13. doi: 10.1016/j.thromres.2023.11.012. | |
| 37976732 | 0 | Chen AC, Rao AS, Oropallo A, et al. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry. Thromb Res. 2023 Nov 9;232:123-132. doi: 10.1016/j.thromres.2023.11.008. | |
| 37949316 | 0 | Shaw JR, Li N, Abdulrehman J, et al. Periprocedural Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer. J Thromb Haemost. 2023 Nov 8:S1538-7836(23)00830-9. doi: 10.1016/j.jtha.2023.10.028. | |
| 37947131 | 0 | Prakash S, Mares AC, Porres-Aguilar M, et al. Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review. Vasc Med. 2023 Nov 10:1358863X231206778. doi: 10.1177/1358863X231206778. | |
| 37936980 | 0 | Negm AM, Yamaura L, Clarke A, et al. Effectiveness of Thromboprophylaxis Agents Following Hip Fracture: A Systematic Review and Network Meta-Analysis. JB JS Open Access. 2023 Nov 7;8(4):e23.00064. doi: 10.2106/JBJS.OA.23.00064. eCollection 2023 Oct-Dec. | |
| 37935936 | 0 | El-Sayed HA, Othman M, Azzam H, et al. Assessing the risk of venous thromboembolism in patients with haematological cancers using three prediction models. J Cancer Res Clin Oncol. 2023 Nov 7. doi: 10.1007/s00432-023-05475-7. | |
| 37932759 | 0 | Leon-Garcia M, Humphries B, Morales PR, et al. Assessment of a venous thromboembolism prophylaxis shared decision-making intervention (DASH-TOP) using the decisional conflict scale: a mixed-method study. BMC Med Inform Decis Mak. 2023 Nov 6;23(1):250. doi: 10.1186/s12911-023-02349-3. | |
| 37932591 | 0 | Prandoni P, Haas S, Fluharty ME, et al. Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry. J Thromb Thrombolysis. 2023 Nov 6. doi: 10.1007/s11239-023-02895-7. | |
| 37930424 | 0 | Sawant N, Gupta DK, Kumar V, et al. Unusual presentation of aneurysmal bone cyst (ABC) in children: pediatric intracranial osteosarcoma with secondary ABC. Childs Nerv Syst. 2023 Nov 6. doi: 10.1007/s00381-023-06197-4. | |
| 37910528 | 0 | Shaw JR, James T, Douxfils J, et al. Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS One. 2023 Nov 1;18(11):e0293632. doi: 10.1371/journal.pone.0293632. eCollection 2023. | |
| 37907305 | 0 | Makedonov I, Kahn S, Abdulrehman J, et al. TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 2023 Oct 31;13(10):e064715. doi: 10.1136/bmjopen-2022-064715. | |
| 37889146 | 0 | Carrier M, Verhamme P. The science and art of predicting recurrent VTE. Eur Heart J. 2024 Jan 1;45(1):54-56. doi: 10.1093/eurheartj/ehad712. | |
| 37888645 | 0 | Larreche S, Bousquet A, Chevillard L, et al. Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms. Toxins (Basel). 2023 Oct 16;15(10):614. doi: 10.3390/toxins15100614. | |
| 37871632 | 0 | Baumgartner C, Tritschler T, Aujesky D. Subsegmental Pulmonary Embolism. Hamostaseologie. 2023 Oct 23. doi: 10.1055/a-2163-3111. | |
| 37866514 | 0 | Avila L, Betensky M, Cohen C C, et al. Clinical Care of Pediatric Patients with or At-Risk of Post-Thrombotic Syndrome: Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Haemostasis. J Thromb Haemost. 2023 Oct 20:S1538-7836(23)00780-8. doi: 10.1016/j.jtha.2023.10.012. | |
| 37857226 | 0 | Wang TF, Hill M, Mallick R, et al. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies. Thromb Res. 2023 Oct 11;231:128-134. doi: 10.1016/j.thromres.2023.10.004. | |
| 37854455 | 0 | Walborn AT, Heath A, Neal MD, et al. Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial. Res Pract Thromb Haemost. 2023 Sep 16;7(7):102203. doi: 10.1016/j.rpth.2023.102203. eCollection 2023 Oct. | |
| 37850360 | 0 | Lun R, Cerasuolo JO, Carrier M, et al. Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. Stroke. 2023 Oct 18. doi: 10.1161/STROKEAHA.123.042993. | |
| 37839436 | 0 | Sposato LA, Field TS, Schnabel RB, et al. Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurol. 2023 Oct 11:S1474-4422(23)00326-5. doi: 10.1016/S1474-4422(23)00326-5. | |
| 37838241 | 0 | Malerba SA, Fumagalli RM, Ay C, et al. Availability of medical and endovascular therapies for venous thromboembolism: A global survey for World Thrombosis Day. J Thromb Haemost. 2023 Oct 12:S1538-7836(23)00765-1. doi: 10.1016/j.jtha.2023.10.002. | |
| 37838240 | 0 | Campbell AIK, Xu Y, Skeith L, et al. Racial and Ethnic Disparities in Eligibility for Postpartum Venous Thromboembolism Prophylaxis in the United States. J Thromb Haemost. 2023 Oct 12:S1538-7836(23)00769-9. doi: 10.1016/j.jtha.2023.10.004. | |
| 37827380 | 0 | Soff G, Leader A, Al-Samkari H, et al. Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2023 Oct 11:S1538-7836(23)00734-1. doi: 10.1016/j.jtha.2023.09.031. | |
| 37806116 | 0 | Rambaud G, Mai V, Motreff C, et al. Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial. Thromb Res. 2023 Sep 28;231:58-64. doi: 10.1016/j.thromres.2023.09.013. | |
| 37801772 | 0 | Xu Y, Khan F, Kovacs MJ, et al. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012. | |
| 37791298 | 0 | Potere N, Abbate A, Kanthi Y, et al. Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism. JACC Basic Transl Sci. 2023 Jun 7;8(9):1245-1261. doi: 10.1016/j.jacbts.2023.03.017. eCollection 2023 Sep. | |
| 37771138 | 0 | Weller J, Krzywicka K, van de Munckhof A, et al. Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur Stroke J. 2023 Sep 28:23969873231202363. doi: 10.1177/23969873231202363. | |
| 37768893 | 0 | Festa MC, Rasasingam S, Sharma A, et al. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis. Kidney360. 2023 Sep 1;4(9):e1245-e1256. doi: 10.34067/KID.0000000000000223. Epub 2023 Aug 1. | |
| 37757472 | 0 | Navi BB, Zhang C, Kaiser JH, et al. Cancer and the Risk of Perioperative Arterial Ischemic Events. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 26:qcad057. doi: 10.1093/ehjqcco/qcad057. | |
| 37751849 | 0 | Chessum JE, Shaya SA, Rajab D, et al. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model. J Thromb Haemost. 2023 Sep 24:S1538-7836(23)00718-3. doi: 10.1016/j.jtha.2023.09.016. | |
| 37751774 | 0 | Elsherif S, Zidan A, Saville O, et al. ABO Blood Group and the Risk of Thrombosis in Cancer Patients: A Mini-Review. Semin Thromb Hemost. 2023 Sep 26. doi: 10.1055/s-0043-1775568. | |
| 37745158 | 0 | Kocher B, Darbellay Farhoumand P, Pulver D, et al. Overuse and underuse of thromboprophylaxis in medical inpatients. Res Pract Thromb Haemost. 2023 Aug 23;7(6):102184. doi: 10.1016/j.rpth.2023.102184. eCollection 2023 Aug. | |
| 37739038 | 0 | Lee Cervi A, Applegate D, Stevens SM, et al. Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry. J Thromb Haemost. 2023 Sep 20:S1538-7836(23)00707-9. doi: 10.1016/j.jtha.2023.09.008. | |
| 37727196 | 0 | S D, Singh SK, Das A, et al. Adult Midgut Malrotation With Chronic Volvulus With Superior Mesenteric Artery (SMA) Thrombosis: A Recherche. Cureus. 2023 Aug 19;15(8):e43754. doi: 10.7759/cureus.43754. eCollection 2023 Aug. | |
| 37722206 | 0 | Tathireddy H, Rice D, Martens K, et al. Breaking down tumor thrombus: Current strategies for medical management. Thromb Res. 2023 Sep 13;230:144-151. doi: 10.1016/j.thromres.2023.09.004. | |
| 37675613 | 0 | Field TS, Dizonno V, Almekhlafi MA, et al. Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis. Stroke. 2023 Sep 7. doi: 10.1161/STROKEAHA.123.044113. | |
| 37675095 | 0 | Zhen L, Wang X, Li W, et al. Comparison between a dedicated stent positioning system and conventional stenting of aorto-ostial lesions: a prospective, multi-center, randomized controlled study. Cardiovasc Diagn Ther. 2023 Aug 31;13(4):650-659. doi: 10.21037/cdt-22-542. Epub 2023 Jul 25. | |
| 37674185 | 0 | Boonyawat K, Phojanasenee T, Noikongdee P, et al. Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais. Thromb J. 2023 Sep 6;21(1):92. doi: 10.1186/s12959-023-00533-z. | |
| 37666570 | 0 | Blunt J, Avila L, Temple M, et al. Exercise-induced deep vein thrombosis in the subclavian vein in an elite female athlete. BMJ Case Rep. 2023 Sep 4;16(9):e253751. doi: 10.1136/bcr-2022-253751. | |
| 37650326 | 0 | Chan NC, Weitz JI. New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors. Arterioscler Thromb Vasc Biol. 2023 Aug 31. doi: 10.1161/ATVBAHA.123.318781. | |
| 37641391 | 0 | Glise Sandblad K, Schulman S, Rosengren A, et al. Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based study. J Intern Med. 2023 Aug 28. doi: 10.1111/joim.13712. | |
| 37640450 | 0 | Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023 Aug 28:ard-2023-224609. doi: 10.1136/ard-2023-224609. | |
| 37640047 | 0 | Schulman S. Recent Advances in Thrombosis and Hemostasis-Part IX. Semin Thromb Hemost. 2023 Aug 28. doi: 10.1055/s-0043-1772839. | |
| 37635643 | 0 | Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023 Aug 28. doi: 10.1002/art.42624. | |
| 37634309 | 0 | Villiger R, Juillard P, Darbellay Farhoumand P, et al. Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score. Thromb Res. 2023 Aug 12;230:37-44. doi: 10.1016/j.thromres.2023.08.003. | |
| 37626267 | 0 | Lee A, Badgley C, Lo M, et al. Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients. Bone Marrow Transplant. 2023 Aug 25. doi: 10.1038/s41409-023-02039-8. | |
| 37614584 | 0 | Xu Y, Cole K, Collins E, et al. Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients: Systematic Review and Meta-Analysis. JACC CardioOncol. 2023 Jun 27;5(4):520-532. doi: 10.1016/j.jaccao.2023.04.003. eCollection 2023 Aug. | |
| 37598348 | 0 | Carter J, Kirwan C, Niaz S, et al. Anticoagulation prescription among atrial fibrillation patients managed with and without an anticoagulant initiation pathway: a cohort study. Eur J Emerg Med. 2023 Aug 18. doi: 10.1097/MEJ.0000000000001072. | |
| 37597893 | 0 | St Germain L, De Paula E, Ay C, et al. Moving against thrombosis: ISTH recognizes 10th anniversary of World Thrombosis Day and the leaders in the field who led the way - in memory of Claire McLintock, MD, World Thrombosis Day Steering Committee Vice Chair 2019 to 2022. J Thromb Haemost. 2023 Sep;21(9):2311-2312. doi: 10.1016/j.jtha.2023.06.006. | |
| 37594628 | 0 | Pelland-Marcotte MC, Stavrakoukas A, Wong G, et al. French Canadian cross-cultural adaptation of CAPTSure(c), an index for the Clinical Assessment of Post-Thrombotic Syndrome in children. J Patient Rep Outcomes. 2023 Aug 18;7(1):83. doi: 10.1186/s41687-023-00622-7. | |
| 37590457 | 0 | Warkentin TE, Baskin-Miller J, Raybould AL, et al. Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies. N Engl J Med. 2023 Aug 10;389(6):574-577. doi: 10.1056/NEJMc2307721. | |
| 37589970 | 0 | Gulati S, Hsu CY, Shah S, et al. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 Aug 17. doi: 10.1001/jamaoncol.2023.2934. | |
| 37583314 | 0 | Caroti KS, Khorana AA, Becattini C, et al. Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231189282. doi: 10.1177/10760296231189282. | |
| 37576730 | 0 | Dah K, Porres-Aguilar M, la Rosa A, et al. Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism. J Vasc Bras. 2023 Jun 30;22:e20230056. doi: 10.1590/1677-5449.202300562. eCollection 2023. | |
| 37551583 | 0 | Lavikainen LI, Guyatt GH, Sallinen VJ, et al. Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper-Gastrointestinal and Hepatopancreatobiliary Surgery. Ann Surg. 2023 Aug 8. doi: 10.1097/SLA.0000000000006059. | |
| 37544136 | 0 | Li A, Zhang MC, Li P, et al. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis - A systematic review and meta-analysis. Thromb Res. 2023 Jun 20;229:209-218. doi: 10.1016/j.thromres.2023.06.003. | |
| 37538494 | 0 | Kahn SR, Arnold DM, Casari C, et al. Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. Res Pract Thromb Haemost. 2023 Jun 21;7(4):100193. doi: 10.1016/j.rpth.2023.100193. eCollection 2023 May. | |
| 37538247 | 0 | Pennisi G, Enea M, Vigano M, et al. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease. JHEP Rep. 2023 Jun 7;5(9):100809. doi: 10.1016/j.jhepr.2023.100809. eCollection 2023 Sep. | |
| 37536569 | 0 | Roy DC, Wang TF, Carrier M, et al. Thrombophilia Gene Mutations Predict Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy. J Thromb Haemost. 2023 Aug 1:S1538-7836(23)00580-9. doi: 10.1016/j.jtha.2023.07.017. | |
| 37529087 | 0 | Smith EC, Kahwash N, Piran S. Management of Mixed Warm/Cold Autoimmune Hemolytic Anemia: A Case Report and Review of Current Literature. Case Rep Hematol. 2023 Jul 24;2023:1381861. doi: 10.1155/2023/1381861. eCollection 2023. | |
| 37526953 | 0 | Festa MC, Rasasingam S, Sharma A, et al. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease (CKD) Undergoing Percutaneous Coronary Intervention with a Drug Eluting Stent: A Meta-Analysis. Kidney360. 2023 Aug 1. doi: 10.34067/KID.0000000000000223. | |
| 37526722 | 0 | Goligher EC, Lawler PR, Zarychanski R. Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply. JAMA. 2023 Aug 1;330(5):472-473. doi: 10.1001/jama.2023.9538. | |
| 37523701 | 0 | Carlin S, Douketis J. In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level. Ann Intern Med. 2023 Aug;176(8):JC91. doi: 10.7326/J23-0054. Epub 2023 Aug 1. | |
| 37522480 | 0 | Bucciol R, Othman M. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review. Curr Opin Hematol. 2023 Sep 1;30(5):180-185. doi: 10.1097/MOH.0000000000000774. | |
| 37519483 | 0 | MacNeill M, Mansory EM, Lazo-Langner A, et al. Acquired Hemophilia A Masquerading as Bleeding on Anticoagulation: A Case Report Including Key Laboratory Considerations. Cureus. 2023 Jun 27;15(6):e41029. doi: 10.7759/cureus.41029. eCollection 2023 Jun. | |
| 37517478 | 0 | Marx CE, Schenker C, Xu Y, et al. Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort. J Thromb Haemost. 2023 Jul 28:S1538-7836(23)00577-9. doi: 10.1016/j.jtha.2023.07.015. | |
| 37494616 | 0 | Solh Z, Rajagopal R, Thachil J, et al. International Survey of the Management of Disseminated Intravascular Coagulation Among Pediatric and Neonatal Health Care Practitioners. J Pediatr Hematol Oncol. 2023 Aug 1;45(6):e784-e788. doi: 10.1097/MPH.0000000000002703. Epub 2023 Jul 7. | |
| 37481072 | 0 | Jourdi G, Ramstrom S, Sharma R, et al. Consensus report on flow cytometry for platelet function testing in thrombocytopenic patients: communication from the SSC of the ISTH. J Thromb Haemost. 2023 Jul 20:S1538-7836(23)00564-0. doi: 10.1016/j.jtha.2023.07.006. | |
| 37471683 | 0 | Galanaud JP, Trujillo-Santos J, Bikdeli B, et al. Clinical Presentation and Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis. J Clin Oncol. 2023 Jul 20:JCO2300429. doi: 10.1200/JCO.23.00429. | |
| 37463605 | 0 | Chan N, Germini F. Patterns and persistence of anticoagulant use in the treatment of venous thromboembolism: insights from South Korea. Thromb Haemost. 2023 Jul 18. doi: 10.1055/a-2131-7066. | |
| 37459107 | 0 | Rebchuk AD, Hill MD, Goyal M, et al. Exploring sex differences for acute ischemic stroke clinical, imaging and thrombus characteristics in the INTERRSeCT study. J Cereb Blood Flow Metab. 2023 Oct;43(10):1803-1809. doi: 10.1177/0271678X231189908. Epub 2023 Jul 17. | |
| 37458854 | 0 | Tc M, N K, Ss Y, et al. Transsplenic tract closure after transsplenic portalvenous access using gelfoam-based tract plugging. CVIR Endovasc. 2023 Jul 17;6(1):37. doi: 10.1186/s42155-023-00383-w. | |
| 37453256 | 0 | Benzidia I, Robitaille C, Abualsaud A, et al. Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension. Thromb Res. 2023 Jul 6;229:139-145. doi: 10.1016/j.thromres.2023.07.002. | |
| 37452732 | 0 | van Es N, Takada T, Kraaijpoel N, et al. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Heart J. 2023 Jul 15:ehad417. doi: 10.1093/eurheartj/ehad417. | |
| 37439553 | 0 | Gigante B, Levy JH, van Gorp E, et al. Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis. Eur Heart J. 2023 Jul 13:ehad388. doi: 10.1093/eurheartj/ehad388. | |
| 37438219 | 0 | Karkouti K, Gross PL. What can ex vivo experiments contribute to clinical haemostasis management? Br J Anaesth. 2023 Sep;131(3):424-425. doi: 10.1016/j.bja.2023.06.041. Epub 2023 Jul 10. | |
| 37437666 | 0 | Kumar M, Kenwar DB, Sekar A, et al. Circulating "Neutrophils extra-cellular traps" during the early post-renal transplant period and correlation with graft dysfunction and rejection. Transpl Immunol. 2023 Jul 10;80:101898. doi: 10.1016/j.trim.2023.101898. | |
| 37435565 | 0 | Caroti KS, Becattini C, Carrier M, et al. Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding. TH Open. 2023 Jul 10;7(3):e206-e216. doi: 10.1055/s-0043-1770783. eCollection 2023 Jul. | |
| 37434312 | 0 | Scutelnic A, van de Munckhof A, Krzywicka K, et al. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19. Eur Stroke J. 2023 Jul 11:23969873231185213. doi: 10.1177/23969873231185213. | |
| 37429508 | 0 | Eikelboom JW, Weitz JI. Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials. J Thromb Haemost. 2023 Nov;21(11):3067-3071. doi: 10.1016/j.jtha.2023.06.036. Epub 2023 Jul 8. | |
| 37421494 | 0 | Guan T, Laguna A, Soares A, et al. Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies. J Thromb Thrombolysis. 2023 Jul 8. doi: 10.1007/s11239-023-02858-y. | |
| 37416093 | 0 | Porres-Aguilar M. ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism. J Vasc Bras. 2023 Jun 19;22:e20230051. doi: 10.1590/1677-5449.202300512. eCollection 2023. | |
| 37397616 | 0 | Gilhofer TS, Nestelberger T, Kang M, et al. Stroke Prevention With Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Prior Intracranial Hemorrhage. CJC Open. 2023 Mar 10;5(6):404-411. doi: 10.1016/j.cjco.2023.03.004. eCollection 2023 Jun. | |
| 37394121 | 0 | Huynh A, Arnold DM, Ivetic N, et al. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. J Thromb Haemost. 2023 Jun 30:S1538-7836(23)00512-3. doi: 10.1016/j.jtha.2023.06.026. | |
| 37394119 | 0 | de Jong CMM, de Wit K, Black SA, et al. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. J Thromb Haemost. 2023 Jun 30:S1538-7836(23)00508-1. doi: 10.1016/j.jtha.2023.06.023. | |
| 37364263 | 0 | Khan F, Coyle D, Thavorn K, et al. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study. Ann Intern Med. 2023 Jun 27. doi: 10.7326/M22-3559. | |
| 37340812 | 0 | Wang TF, Grubic N, Carrier M, et al. Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty. Am J Hematol. 2023 Jun 21. doi: 10.1002/ajh.26994. | |
| 37310666 | 0 | Garabon JJW, Boffa MB. Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme. J Thromb Thrombolysis. 2023 Aug;56(2):283-290. doi: 10.1007/s11239-023-02837-3. Epub 2023 Jun 13. | |
| 37310606 | 0 | Burns KEA, Heels-Ansdell D, Thabane L, et al. Sex differences in thromboprophylaxis of the critically ill: a secondary analysis of a randomized trial. Can J Anaesth. 2023 Jun 13. doi: 10.1007/s12630-023-02457-8. | |
| 37308131 | 0 | Gaugler JO, Righini M, Robert-Ebadi H, et al. Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism. Thromb Haemost. 2023 Jun 12. doi: 10.1055/s-0043-57018. | |
| 37304933 | 0 | Schutgens REG, Jimenez-Yuste V, Escobar M, et al. Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance. Hemasphere. 2023 Jun 5;7(6):e900. doi: 10.1097/HS9.0000000000000900. eCollection 2023 Jun. | |
| 37301116 | 0 | Brown C, Brandt W, Wang TF, et al. Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis. Thromb Res. 2023 Jun 4;228:81-84. doi: 10.1016/j.thromres.2023.05.027. | |
| 37287631 | 0 | El Maamari J, Amid A, Pelland-Marcotte MC, et al. Between Scylla and Charybdis: thrombosis in children with hemophilia. Front Pediatr. 2023 May 23;11:1173549. doi: 10.3389/fped.2023.1173549. eCollection 2023. | |
| 37277922 | 0 | van de Munckhof A, Borhani-Haghighi A, Aaron S, et al. Cerebral Venous Sinus Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia in Middle-Income Countries. Int J Stroke. 2023 Jun 5:17474930231182901. doi: 10.1177/17474930231182901. | |
| 37275180 | 0 | Minford A, Brand Ao LR, Othman M, et al. Corrigendum to 'The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study' [Research and Practice in Thrombosis and Haemostasis, 6/2, (2022) e12690]. Res Pract Thromb Haemost. 2023 Apr 27;7(3):100157. doi: 10.1016/j.rpth.2023.100157. eCollection 2023 Mar. | |
| 37263381 | 0 | Maanen RV, Martens ESL, Takada T, et al. Accuracy of the Physicians' Intuitive Risk Estimation in the Diagnostic Management of Pulmonary Embolism: An Individual Patient Data Meta-Analysis. J Thromb Haemost. 2023 May 30:S1538-7836(23)00438-5. doi: 10.1016/j.jtha.2023.05.023. | |
| 37261191 | 0 | Vedantham S, Parpia S, Kahn SR. A Clinical Trial of Venous Stent Placement for Post-thrombotic Syndrome: Current Status and Pandemic-related Changes. Vasc Endovasc Rev. 2022 Feb;5:e06. doi: 10.15420/ver.2021.19. Epub 2022 Jun 21. | |
| 37235671 | 0 | Koulas I, Goldin M, Schulman S, et al. Antithrombotic therapy in the management of hospitalised patients with COVID-19. Br J Hosp Med (Lond). 2023 May 2;84(5):1-11. doi: 10.12968/hmed.2022.0519. Epub 2023 May 22. | |
| 37227729 | 0 | Berger JS, Neal MD, Kornblith LZ, et al. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial. JAMA Netw Open. 2023 May 1;6(5):e2314428. doi: 10.1001/jamanetworkopen.2023.14428. | |
| 37217241 | 0 | Duffy J, Berger FH, Cheng I, et al. Implementation of the YEARS algorithm to optimise pulmonary embolism diagnostic workup in the emergency department. BMJ Open Qual. 2023 May;12(2):e002119. doi: 10.1136/bmjoq-2022-002119. | |
| 37204707 | 0 | Othman M, Pradhan A. Laboratory Testing of Hemostasis in Pregnancy: A Brief Overview. Methods Mol Biol. 2023;2663:111-125. doi: 10.1007/978-1-0716-3175-1_7. | |
| 37196605 | 0 | Wang TF, Carrier M, Carney BJ, et al. Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis. Thromb Res. 2023 May 11;227:8-16. doi: 10.1016/j.thromres.2023.05.012. | |
| 37195076 | 0 | Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al. American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing. Blood Adv. 2023 May 17:bloodadvances.2023010177. doi: 10.1182/bloodadvances.2023010177. | |
| 37183930 | 0 | Aloe S, Filliter C, Salmasi S, et al. SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study. Br J Clin Pharmacol. 2023 May 15. doi: 10.1111/bcp.15787. | |
| 37182698 | 0 | Warkentin TE, Arnold DM, Sheppard JI, et al. Investigation of Anti-PF4 versus Anti-PF4/Heparin Reactivities by Fluid-Phase EIA for Four Anti-PF4 Disorders: Classic HIT, Autoimmune HIT, VITT, Spontaneous HIT. J Thromb Haemost. 2023 May 12:S1538-7836(23)00395-1. doi: 10.1016/j.jtha.2023.04.034. | |
| 37173706 | 0 | Zheng HT, Xu Y, Yan XY, et al. Pediatric hypereosinophilic syndrome associated with liver damage, portal vein, splenic vein and superior mesenteric vein thromboses: a case report. BMC Pediatr. 2023 May 12;23(1):233. doi: 10.1186/s12887-023-04014-0. | |
| 37171998 | 0 | Wang TF, Khorana AA, Agnelli G, et al. Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. Oncologist. 2023 May 12:oyad116. doi: 10.1093/oncolo/oyad116. | |
| 37168399 | 0 | Kim DJ, Honig A, Alimohammadi A, et al. Recanalization and outcomes after cerebral venous thrombosis: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2023 Apr 3;7(3):100143. doi: 10.1016/j.rpth.2023.100143. eCollection 2023 Mar. | |
| 37150028 | 0 | Chiu J, Lazo-Langner A. Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review. Thromb Res. 2023 Apr 26;226:141-149. doi: 10.1016/j.thromres.2023.04.019. | |
| 37144115 | 0 | Carlin S, Gross PL. Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients. JACC CardioOncol. 2023 Feb 7;5(2):201-202. doi: 10.1016/j.jaccao.2022.12.006. eCollection 2023 Apr. | |
| 37144109 | 0 | Coleman CI, Caroti KS, Abdelgawwad K, et al. Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism. JACC CardioOncol. 2023 Feb 7;5(2):189-200. doi: 10.1016/j.jaccao.2022.10.014. eCollection 2023 Apr. | |
| 37141788 | 0 | Savage JA, Hunt BJ, Stansby G, et al. A UK consensus statement on thromboprophylaxis for autologous breast reconstruction. J Plast Reconstr Aesthet Surg. 2023 Feb 7;81:138-148. doi: 10.1016/j.bjps.2023.01.020. | |
| 37139840 | 0 | Girardi L, Wang TF, Ageno W, et al. Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism. Arterioscler Thromb Vasc Biol. 2023 May 4. doi: 10.1161/ATVBAHA.123.318779. | |
| 37139498 | 0 | Kazi S, McLeod A, Berndl A. VTE prophylaxis in pregnant people with chronic physical disability: Data from a physicians survey and the need for guidance. Obstet Med. 2023 Mar;16(1):35-39. doi: 10.1177/1753495X221074616. Epub 2022 Jan 27. | |
| 37127507 | 0 | Carlin S, Chan NC, Douketis JD. Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time? Eur J Intern Med. 2023 Jul;113:18-19. doi: 10.1016/j.ejim.2023.04.024. Epub 2023 Apr 29. | |
| 37122531 | 0 | Candeloro M, Carlin S, Shapiro MJ, et al. Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review. Res Pract Thromb Haemost. 2023 Mar 28;7(3):100137. doi: 10.1016/j.rpth.2023.100137. eCollection 2023 Mar. | |
| 37121015 | 0 | Potere N, Di Nisio M, Porreca E, et al. Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial. Thromb Res. 2023 Apr 26;226:82-85. doi: 10.1016/j.thromres.2023.04.015. | |
| 37116752 | 0 | Fredenburgh JC, Weitz JI. News at XI: Moving Beyond Factor Xa Inhibitors. J Thromb Haemost. 2023 Apr 26:S1538-7836(23)00343-4. doi: 10.1016/j.jtha.2023.04.021. | |
| 37100783 | 0 | La CC, Smith SA, Vappala S, et al. Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design. Nat Commun. 2023 Apr 26;14(1):2177. doi: 10.1038/s41467-023-37709-0. | |
| 37091135 | 0 | Roberge G, Samson C, Le Gal G, et al. Prolonged Fasting as a Cause of Deep Vein Thrombosis: A Case Report. TH Open. 2023 Apr 20;7(2):e94-e96. doi: 10.1055/s-0043-57225. eCollection 2023 Apr. | |
| 37085036 | 0 | Swystun LL, Michels A, Lillicrap D. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis. J Thromb Haemost. 2023 Apr 19:S1538-7836(23)00332-X. doi: 10.1016/j.jtha.2023.04.014. | |
| 37075273 | 0 | Key NS, Khorana AA, Kuderer NM, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2023 Apr 19:JCO2300294. doi: 10.1200/JCO.23.00294. | |
| 37072207 | 0 | Bell A, Andrade JG, Macle L, et al. Approach to atrial fibrillation: Essentials for primary care. Can Fam Physician. 2023 Apr;69(4):245-256. doi: 10.46747/cfp.6904245. | |
| 37071625 | 0 | Selby R, Kaus L, Sealey F, et al. Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study. PLoS One. 2023 Apr 18;18(4):e0284425. doi: 10.1371/journal.pone.0284425. eCollection 2023. | |
| 37063772 | 0 | Merz LE, Siad FM, Creary M, et al. Laboratory-based inequity in thrombosis and hemostasis: review of the evidence. Res Pract Thromb Haemost. 2023 Mar 15;7(2):100117. doi: 10.1016/j.rpth.2023.100117. eCollection 2023 Feb. | |
| 37063770 | 0 | Bastas D, Brandao LR, Vincelli J, et al. Physical activity for children with deep vein thrombosis and pulmonary embolism on anticoagulation: a scoping review. Res Pract Thromb Haemost. 2023 Feb 27;7(2):100094. doi: 10.1016/j.rpth.2023.100094. eCollection 2023 Feb. | |
| 37063761 | 0 | Barca-Hernando M, Lopez-Ruz S, Marin-Romero S, et al. Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy. Res Pract Thromb Haemost. 2023 Mar 10;7(2):100115. doi: 10.1016/j.rpth.2023.100115. eCollection 2023 Feb. | |
| 37061138 | 0 | Ali-Mohamad N, Cau MF, Zenova V, et al. Self-propelling thrombin powder enables hemostasis with no observable rebleeding or thrombosis over three days in a porcine model of upper gastrointestinal bleeding. Gastrointest Endosc. 2023 Apr 13:S0016-5107(23)00393-0. doi: 10.1016/j.gie.2023.04.007. | |
| 37059362 | 0 | Mavrakanas TA. Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation. Kidney Int. 2023 Jun;103(6):1014-1017. doi: 10.1016/j.kint.2023.03.027. Epub 2023 Apr 12. | |
| 37042966 | 0 | Malik R, Liao P, Zhou J, et al. Histidine-rich glycoprotein attenuates catheter thrombosis. Blood Adv. 2023 Apr 12:bloodadvances.2022009236. doi: 10.1182/bloodadvances.2022009236. | |
| 37031753 | 0 | Vainder M, Ray JG, Lunsky Y, et al. Physical disability and venous thromboembolism during pregnancy and the postpartum period: A population-based cohort study. J Thromb Haemost. 2023 Apr 7:S1538-7836(23)00269-6. doi: 10.1016/j.jtha.2023.03.035. | |
| 37025893 | 0 | Tierney S, Deng Y, Geauvreau A, et al. Hormonal contraception and thrombosis: Identifying the gaps in knowledge among females in post-secondary education. Heliyon. 2023 Mar 25;9(4):e14867. doi: 10.1016/j.heliyon.2023.e14867. eCollection 2023 Apr. | |
| 37015326 | 0 | Gorman J, Candeloro M, Schulman S. Anticoagulant management and outcomes in non-traumatic intracranial hemorrhage complicated by venous thromboembolism: a retrospective chart review. Thromb Haemost. 2023 Apr 4. doi: 10.1055/a-2068-6464. | |
| 37002949 | 0 | Moroni A, Marin F, Venturi G, et al. Management of failed stenting of the unprotected left main coronary artery. Catheter Cardiovasc Interv. 2023 May;101(6):1001-1013. doi: 10.1002/ccd.30636. Epub 2023 Apr 1. | |
| 37001973 | 0 | You D, Xu Y, Krzyzaniak H, et al. Safety of expedited-surgery protocols in anticoagulant-treated patients with hip fracture: a systematic review and meta-analysis. Can J Surg. 2023 Mar 31;66(2):E170-E180. doi: 10.1503/cjs.010021. Print 2023 Mar-Apr. | |
| 36988142 | 0 | van Es N, De Caterina R, Weitz JI. Reversal agents for current and forthcoming direct oral anticoagulants. Eur Heart J. 2023 May 21;44(20):1795-1806. doi: 10.1093/eurheartj/ehad123. | |
| 36975443 | 0 | Wang TF, Carrier M. Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management. Curr Oncol. 2023 Mar 4;30(3):3032-3046. doi: 10.3390/curroncol30030230. | |
| 36972786 | 0 | Thachil J, Connors JM, Mahlangu J, et al. Reclassifying hemophilia to include definition of outcomes and phenotype as new targets. J Thromb Haemost. 2023 Mar 25:S1538-7836(23)00247-7. doi: 10.1016/j.jtha.2023.03.016. | |
| 36972785 | 0 | Samuelson Bannow B, Federspiel JJ, Abel DE, et al. Multidisciplinary Care of the Pregnant Patient with or At Risk for VTE: a Recommended Toolkit from the FWGBD Thrombosis Subcommittee. J Thromb Haemost. 2023 Mar 25:S1538-7836(23)00246-5. doi: 10.1016/j.jtha.2023.03.015. | |
| 36972714 | 0 | Bates SM. Superficial vein thrombosis in pregnancy: what we did not know could hurt our patients. Lancet Haematol. 2023 Mar 24:S2352-3026(23)00036-4. doi: 10.1016/S2352-3026(23)00036-4. | |
| 36971601 | 0 | Eikelboom R, Whitlock RP, Muzaffar R, et al. Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2023 Mar 27:ezad110. doi: 10.1093/ejcts/ezad110. | |
| 36970743 | 0 | Pop CT, Gu CS, Vedantham S, et al. Exploring the Villalta scale to capture postthrombotic syndrome using alternative approaches: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost. 2022 Dec 27;7(1):100032. doi: 10.1016/j.rpth.2022.100032. eCollection 2023 Jan. | |
| 36965242 | 0 | Suzon B, Riviere S, Schiffmann A, et al. Long-term home parenteral nutrition in systemic sclerosis-related intestinal failure is feasible but unveils occult cardiac disease. Nutrition. 2023 Jun;110:112009. doi: 10.1016/j.nut.2023.112009. Epub 2023 Feb 23. | |
| 36958517 | 0 | Pelland-Marcotte MC, Bouchard V, Begin E, et al. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. J Thromb Haemost. 2023 Mar 21:S1538-7836(23)00242-8. doi: 10.1016/j.jtha.2023.03.012. | |
| 36942550 | 0 | Goligher EC, Lawler PR, Jensen TP, et al. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19. JAMA. 2023 Apr 4;329(13):1066-1077. doi: 10.1001/jama.2023.3651. | |
| 36940444 | 0 | Wang TY, Wahed AS, Morris A, et al. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Ann Intern Med. 2023 Mar 21. doi: 10.7326/M22-3350. | |
| 36923708 | 0 | Agbani EO, Skeith L, Lee A. Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers. Res Pract Thromb Haemost. 2023 Feb 8;7(2):100075. doi: 10.1016/j.rpth.2023.100075. eCollection 2023 Feb. | |
| 36923287 | 0 | Bunch CM, Chang E, Moore EE, et al. SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock. Front Physiol. 2023 Feb 27;14:1094845. doi: 10.3389/fphys.2023.1094845. eCollection 2023. | |
| 36921919 | 0 | Whitworth H, Amankwah EK, Betensky M, et al. Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2023 Mar 13:S1538-7836(23)00230-1. doi: 10.1016/j.jtha.2023.03.004. | |
| 36912116 | 0 | Singh T, Lavikainen LI, Halme ALE, et al. Timing of symptomatic venous thromboembolism after surgery: meta-analysis. Br J Surg. 2023 Mar 13:znad035. doi: 10.1093/bjs/znad035. | |
| 36907985 | 0 | Alrohimi A, Rose DZ, Burgin WS, et al. Risk of hemorrhagic transformation with early use of direct oral anticoagulants after acute ischemic stroke: A pooled analysis of prospective studies and randomized trials. Int J Stroke. 2023 Aug;18(7):864-872. doi: 10.1177/17474930231164891. Epub 2023 Mar 26. | |
| 36907381 | 0 | Candeloro M, Valeriani E, Monreal M, et al. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis. J Thromb Haemost. 2023 Mar 10:S1538-7836(23)00176-9. doi: 10.1016/j.jtha.2023.03.002. | |
| 36905769 | 0 | Spenard E, Geerts W, Lin Y, et al. Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol. 2023 Mar 9;172:9-14. doi: 10.1016/j.ygyno.2023.02.012. | |
| 36896358 | 0 | Srinivasan S, Kumar PG, Govil D, et al. Competencies for Point-of-care Ultrasonography in ICU: An ISCCM Expert Panel Practice Recommendation. Indian J Crit Care Med. 2022 Oct;26(Suppl 2):S7-S12. doi: 10.5005/jp-journals-10071-24199. | |
| 36895083 | 0 | Shargall Y, Wiercioch W, Brunelli A, et al. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. J Thorac Cardiovasc Surg. 2023 Mar;165(3):794-824.e6. doi: 10.1016/j.jtcvs.2022.05.041. Epub 2022 Dec 15. | |
| 36894360 | 0 | Kotronias RA, Marin F, Emfietzoglou M, et al. Rationale and Design of a Randomized Controlled Pilot Trial to Assess Stent Retriever Thrombectomy for Thrombus Burden Reduction in Patients with Acute Myocardial Infarction: The RETRIEVE-AMI Study. Cardiovasc Revasc Med. 2023 Jul;52:75-85. doi: 10.1016/j.carrev.2023.02.012. Epub 2023 Mar 6. | |
| 36891522 | 0 | Shapiro AD, Hardesty BM, Peyvandi F, et al. Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review. Res Pract Thromb Haemost. 2022 Dec 9;7(1):100007. doi: 10.1016/j.rpth.2022.100007. eCollection 2023 Jan. | |
| 36863566 | 0 | Davis S, Goodacre S, Horner D, et al. Decision-analysis modelling of effectiveness and cost-effectiveness of pharmacological thromboprophylaxis for surgical inpatients, using variable risk assessment models or other strategies. J Thromb Haemost. 2023 Feb 28:S1538-7836(23)00166-6. doi: 10.1016/j.jtha.2023.02.018. | |
| 36858800 | 0 | Humphries B, Leon-Garcia M, Bates SM, et al. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study. BMJ Evid Based Med. 2023 Mar 1:bmjebm-2022-112098. doi: 10.1136/bmjebm-2022-112098. | |
| 36858345 | 0 | Schenker C, Marx CE, Kraaijpoel N, et al. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review. J Thromb Haemost. 2023 Feb 27:S1538-7836(23)00161-7. doi: 10.1016/j.jtha.2023.02.013. | |
| 36852972 | 0 | Medeiros SK, Sharma N, Dwivedi D, et al. The effects of DNase I and low-molecular-weight heparin in a murine model of polymicrobial abdominal sepsis. Shock. 2023 Mar 1. doi: 10.1097/SHK.0000000000002095. | |
| 36852262 | 0 | Bosch A, Uleryk E, Avila L. Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review. Res Pract Thromb Haemost. 2023 Feb 2;7(2):100064. doi: 10.1016/j.rpth.2023.100064. eCollection 2023 Feb. | |
| 36841648 | 0 | Mulder FI, Kraaijpoel N, Carrier M, et al. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study. J Thromb Haemost. 2023 Jan 11:S1538-7836(23)00031-4. doi: 10.1016/j.jtha.2023.01.003. | |
| 36820873 | 0 | Caiano LM, Riva N, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert Rev Hematol. 2023 Feb 23. doi: 10.1080/17474086.2023.2184340. | |
| 36809776 | 0 | Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388. | |
| 36798284 | 0 | Yang Y, Du Y, Ivanov D, et al. Molecular architecture and platelet-activating properties of small immune complexes assembled on intact heparin and their possible involvement in heparin-induced thrombocytopenia. bioRxiv. 2023 Feb 11:2023.02.11.528150. doi: 10.1101/2023.02.11.528150. Preprint. | |
| 36796485 | 0 | Barnes GD, Ageno W, Castellucci LA, et al. Recommendation on the Nomenclature for Anticoagulants: Updated Communication from the ISTH SSC Subcommittee on the Control of Anticoagulation. J Thromb Haemost. 2023 Feb 14:S1538-7836(23)00149-6. doi: 10.1016/j.jtha.2023.02.008. | |
| 36781052 | 0 | Kahn SR, Matino D, Carrier M, et al. First-Person Call to Attend 2023 Congress. J Thromb Haemost. 2023 Feb 11:S1538-7836(23)00117-4. doi: 10.1016/j.jtha.2023.01.039. | |
| 36777286 | 0 | Li PY, Yu P, Li A, et al. Convalescent Plasma Therapy for COVID-19 in Ambulatory vs Hospitalized Patients: Efficacy and Risk of Thromboembolism. Res Pract Thromb Haemost. 2023 Feb 6:100068. doi: 10.1016/j.rpth.2023.100068. | |
| 36775414 | 0 | Alsehly AA, Wang TF, Carrier M. Time to rethink extended thromboprophylaxis after cancer surgery? J Thromb Haemost. 2023 Feb;21(2):198-199. doi: 10.1016/j.jtha.2022.11.015. | |
| 36773014 | 0 | Krzywicka K, Aguiar de Sousa D, Cordonnier C, et al. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur J Neurol. 2023 Feb 11. doi: 10.1111/ene.15735. | |
| 36764659 | 0 | Kumar R, Bakeer N, Dawson J, et al. Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency - first analysis of the International Society on Thrombosis and Haemostasis (ISTH) Pediatric Antithrombin Deficiency Database and Biorepository. J Thromb Haemost. 2023 Feb 8:S1538-7836(23)00100-9. doi: 10.1016/j.jtha.2023.01.037. | |
| 36763520 | 0 | Avila L, Bentley RF, Bastas DM, et al. Unravelling the pathophysiology of lower limb post-thrombotic syndrome in adolescents: a proof-of-concept study. Blood Adv. 2023 Feb 10:bloodadvances.2022009599. doi: 10.1182/bloodadvances.2022009599. | |
| 36759279 | 0 | Zheng Z, Mukhametova L, Boffa MB, et al. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis. J Thromb Haemost. 2023 Jan 14:S1538-7836(23)00036-3. doi: 10.1016/j.jtha.2023.01.008. | |
| 36746545 | 0 | Horner D, Rex S, Reynard C, et al. Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals. BMJ Open. 2023 Feb 6;13(2):e069244. doi: 10.1136/bmjopen-2022-069244. | |
| 36740040 | 0 | Robin P, Le Pennec R, Eddy M, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data. J Thromb Haemost. 2023 Feb 3:S1538-7836(23)00084-3. doi: 10.1016/j.jtha.2023.01.030. | |
| 36739234 | 0 | Bastas D, Brandao LR, Allen DD, et al. Functional impact of pediatric postthrombotic syndrome. J Thromb Haemost. 2023 Jan 10:S1538-7836(23)00032-6. doi: 10.1016/j.jtha.2023.01.004. | |
| 36737374 | 0 | Megy K, Downes K, Morel-Kopp MC, et al. Corrigendum to GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis [J Thromb Haemost. 2021 Oct;19(10):2612-2617]. J Thromb Haemost. 2023 Feb 1:S1538-7836(23)00064-8. doi: 10.1016/j.jtha.2023.01.021. | |
| 36732162 | 0 | Shen C, Mackeigan DT, Shoara AA, et al. Dual roles of fucoidan-GPIbalpha interaction in thrombosis and hemostasis: implications for drug development targeting GPIbalpha. J Thromb Haemost. 2023 Jan 9:S1538-7836(23)00026-0. doi: 10.1016/j.jtha.2022.12.030. | |
| 36729882 | 0 | Ratnasekera A, Geerts W, Haut ER, et al. Implementation Science Approaches to Optimizing Venous Thromboembolism Prevention in Patients with Traumatic Injuries: Findings from the 2022 Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma. J Trauma Acute Care Surg. 2022 Dec 6. doi: 10.1097/TA.0000000000003850. | |
| 36724651 | 0 | Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study. Thromb Res. 2022 Dec 15;223:87-94. doi: 10.1016/j.thromres.2022.12.001. | |
| 36710196 | 0 | Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021. | |
| 36710195 | 0 | Maria A, Alessandro C, Declan N, et al. Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021. J Thromb Haemost. 2023 Mar;21(3):546-552. doi: 10.1016/j.jtha.2023.01.010. Epub 2023 Jan 16. | |
| 36709763 | 0 | Eikelboom JW, Weitz JI. Direct Oral Anticoagulants in the Very Elderly. Thromb Haemost. 2023 Apr;123(4):377-379. doi: 10.1055/a-2021-8910. Epub 2023 Jan 29. | |
| 36709677 | 0 | Roberge G, Carrier M. Long VITT: A case report. Thromb Res. 2023 Jan 24;223:78-79. doi: 10.1016/j.thromres.2023.01.017. | |
| 36707719 | 0 | Scherlinger M, Richez C, Tsokos GC, et al. The role of platelets in immune-mediated inflammatory diseases. Nat Rev Immunol. 2023 Jan 27. doi: 10.1038/s41577-023-00834-4. | |
| 36700178 | 0 | Chan N, Wheeler M, Bhagirath V, et al. Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers. CJC Open. 2022 Oct 12;5(1):1-7. doi: 10.1016/j.cjco.2022.09.006. eCollection 2023 Jan. | |
| 36696220 | 0 | Choi SJ, Dwyer CN, Rapkin L, et al. The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07636-X. doi: 10.1016/j.jtha.2022.11.022. | |
| 36696208 | 0 | de Winter MA, Uijl A, Buller HR, et al. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07627-9. doi: 10.1016/j.jtha.2022.11.013. | |
| 36696204 | 0 | Shaw JR, Castellucci LA, Siegal D, et al. DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature. J Thromb Haemost. 2023 Mar;21(3):433-452. doi: 10.1016/j.jtha.2022.11.029. Epub 2022 Dec 22. | |
| 36696189 | 0 | Stals MAM, Moumneh T, Ainle FN, et al. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07639-5. doi: 10.1016/j.jtha.2022.11.025. | |
| 36696186 | 0 | Caiano LM, Drury T, Zahrai A, et al. Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008. | |
| 36696183 | 0 | Aziz J, Wang TF, Siegal D, et al. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. J Thromb Haemost. 2022 Dec 27:S1538-7836(22)18255-3. doi: 10.1016/j.jtha.2022.12.016. | |
| 36695400 | 0 | Yin R, Patel V, Malik RA, et al. Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin. J Thromb Haemost. 2023 Jan;21(1):83-93. doi: 10.1016/j.jtha.2022.10.001. Epub 2022 Dec 22. | |
| 36695399 | 0 | Guan Z, Wang R, Hussain RH, et al. Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro. J Thromb Haemost. 2023 Jan;21(1):76-82. doi: 10.1016/j.jtha.2022.10.020. Epub 2022 Dec 22. | |
| 36695396 | 0 | Bistervels IM, Wiegers HMG, Ainle FN, et al. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study. J Thromb Haemost. 2023 Jan;21(1):57-67. doi: 10.1016/j.jtha.2022.11.004. Epub 2022 Dec 22. | |
| 36695378 | 0 | Miljic P, Noureldin A, Lavin M, et al. Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians' survey-communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023 Jan;21(1):154-163. doi: 10.1016/j.jtha.2022.10.019. Epub 2022 Dec 22. | |
| 36685003 | 0 | Saville O, Elbatarny M, Tera Y, et al. Sex Differences in D-Dimer and Critical Illness in COVID-19 Patients: A Systematic Review and Meta-analysis. Res Pract Thromb Haemost. 2023 Jan 14:100042. doi: 10.1016/j.rpth.2023.100042. | |
| 36649737 | 0 | Schenker C, Stalder O, Mean M, et al. Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials. Thromb Haemost. 2023 Jan 9. doi: 10.1055/s-0042-1760365. | |
| 36648242 | 0 | de Winter MA, Buller HR, Carrier M, et al. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score. Eur Heart J. 2023 Jan 17:ehac776. doi: 10.1093/eurheartj/ehac776. | |
| 36626707 | 0 | Li A, La J, May SB, et al. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. J Clin Oncol. 2023 Jan 10:JCO2201542. doi: 10.1200/JCO.22.01542. | |
| 36624252 | 0 | Lin K, Xu K, Daoust R, et al. Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study. CJEM. 2023 Jan 10. doi: 10.1007/s43678-022-00440-8. | |
| 36609323 | 0 | Khan F, Thavorn K, Coyle D, et al. Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism. BMJ Open. 2023 Jan 6;13(1):e053927. doi: 10.1136/bmjopen-2021-053927. | |
| 36603593 | 0 | Zidan A, Noureldin A, Kumar SA, et al. COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications. Semin Thromb Hemost. 2023 Feb;49(1):9-14. doi: 10.1055/s-0042-1759684. Epub 2023 Jan 5. | |
| 36601884 | 0 | Carlin S, de Vries TA, Budaj A, et al. Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances. Kardiol Pol. 2022;80(12):1200-1210. doi: 10.33963/KP.a2022.0283. | |
| 36594041 | 0 | Fraser DD, Patel MA, Van Nynatten LR, et al. Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients. Heliyon. 2023 Jan;9(1):e12704. doi: 10.1016/j.heliyon.2022.e12704. Epub 2022 Dec 29. | |
| 36574232 | 0 | Agbani EO, Hers I, Poole AW. Platelet Procoagulant Membrane Dynamics: A Key Distinction Between Thrombosis and Hemostasis? Blood Adv. 2022 Dec 27:bloodadvances.2022008122. doi: 10.1182/bloodadvances.2022008122. | |
| 36574172 | 0 | Venier LM, Clerici B, Bissola AL, et al. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder. Int J Hematol. 2022 Dec 27:1-8. doi: 10.1007/s12185-022-03516-4. | |
| 36565677 | 0 | Turpie AGG, Farjat AE, Haas S, et al. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb Res. 2022 Nov 25;222:31-39. doi: 10.1016/j.thromres.2022.11.016. | |
| 36556013 | 0 | Yamaura L, Young D, Skeith L, et al. Heightened Procoagulation after Post-Operative Thromboprophylaxis Completion in Patients with Metastatic Bone Disease from Primary Colorectal Cancer. J Clin Med. 2022 Dec 13;11(24):7397. doi: 10.3390/jcm11247397. | |
| 36534732 | 0 | Weitz JI, Eikelboom JW. What Is the Future of Factor XI Inhibitors? Circulation. 2022 Dec 20;146(25):1899-1902. doi: 10.1161/CIRCULATIONAHA.122.061132. Epub 2022 Dec 19. | |
| 36522193 | 0 | Porres-Aguilar M. Factor XI Inhibitors for the Prevention of Thrombosis: Towards Safer Anticoagulation Strategies. Arch Med Res. 2022 Dec 13:S0188-4409(22)00165-5. doi: 10.1016/j.arcmed.2022.11.018. | |
| 36521170 | 0 | Robert-Ebadi H, Roy PM, Sanchez O, et al. External validation of the PEGeD diagnostic algorithm for suspected pulmonary embolism in an independent cohort. Blood Adv. 2023 Aug 8;7(15):3946-3951. doi: 10.1182/bloodadvances.2022007729. | |
| 36519935 | 0 | Shargall Y, Wiercioch W, Brunelli A, et al. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. Eur J Cardiothorac Surg. 2022 Dec 2;63(1):ezac488. doi: 10.1093/ejcts/ezac488. | |
| 36514740 | 0 | Mavrakanas TA, Charytan DM. Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360. 2022 Aug 1;3(10):1769-1771. doi: 10.34067/KID.0003002022. eCollection 2022 Oct 27. | |
| 36514164 | 0 | Chornenki NLJ, Tritschler T, Stucki F, et al. All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis. Syst Rev. 2022 Dec 13;11(1):269. doi: 10.1186/s13643-022-02146-5. | |
| 36506517 | 0 | Yu YH, Oh IS, Jeong HE, et al. Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes. Front Pharmacol. 2022 Nov 24;13:1034636. doi: 10.3389/fphar.2022.1034636. eCollection 2022. | |
| 36498688 | 0 | Skeith L, Hurd K, Chaturvedi S, et al. Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise. J Clin Med. 2022 Nov 30;11(23):7115. doi: 10.3390/jcm11237115. | |
| 36495645 | 0 | Ramachandran D, R A, Panicker P, et al. The mucormycosis and stroke: The learning curve during the second COVID-19 pandemic. J Stroke Cerebrovasc Dis. 2023 Feb;32(2):106819. doi: 10.1016/j.jstrokecerebrovasdis.2022.106819. Epub 2022 Oct 12. | |
| 36485150 | 0 | Boonyawat K, Angchaisuksiri P. Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):474-480. doi: 10.1182/hematology.2022000383. | |
| 36485108 | 0 | Wang TF, Carrier M. The 5 most frequently asked questions about factor Xa inhibitors. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):515-521. doi: 10.1182/hematology.2022000385. | |
| 36481128 | 0 | Porres-Aguilar M, Ansell J, Mukherjee D, et al. Impact of Hospital-based Multidisciplinary Anticoagulation Stewardship Programs. Arch Med Res. 2022 Dec 5:S0188-4409(22)00163-1. doi: 10.1016/j.arcmed.2022.11.016. | |
| 36469448 | 0 | Iannattone PA, Yang SS, Koolian M, et al. Incidence of Venous Thromboembolism in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review. ASAIO J. 2022 Dec 1;68(12):1523-1528. doi: 10.1097/MAT.0000000000001694. Epub 2022 Mar 19. | |
| 36462135 | 0 | Siegal DM, Freedman D, Ansell J. Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review. J Thromb Thrombolysis. 2023 Feb;55(2):197-202. doi: 10.1007/s11239-022-02739-w. Epub 2022 Dec 3. | |
| 36455606 | 0 | Galanaud JP, Genty-Vermorel C, Barrellier MT, et al. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial. Lancet Haematol. 2022 Dec;9(12):e886-e896. doi: 10.1016/S2352-3026(22)00247-2. | |
| 36452204 | 0 | Haas S, Farjat AE, Pieper K, et al. On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease. TH Open. 2022 Nov 3;6(4):e354-e364. doi: 10.1055/s-0042-1757744. eCollection 2022 Oct. | |
| 36444228 | 0 | Papadopoulos E, Abdulrehman J, Alibhai SMH. The Value of Performance Status in Predicting Clinical Outcomes in Patients With Cancer-Associated Pulmonary Embolism. JACC CardioOncol. 2022 Nov 15;4(4):519-521. doi: 10.1016/j.jaccao.2022.10.001. eCollection 2022 Nov. | |
| 36434811 | 0 | Hansen-Barkun C, Martel M, Douketis J, et al. Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy. Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002076. | |
| 36428830 | 0 | Wauthier L, Favresse J, Hardy M, et al. D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review. Diagnostics (Basel). 2022 Nov 12;12(11):2770. doi: 10.3390/diagnostics12112770. | |
| 36427068 | 0 | Pelland-Marcotte MC, Tole S, Bouhelier E, et al. Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature. Pediatr Hematol Oncol. 2022 Nov 25:1-8. doi: 10.1080/08880018.2022.2150797. | |
| 36414382 | 0 | Favaloro EJ, Mohammed S, Donikian D, et al. Corrigendum to "A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia" [Pathology (53) (2021) 247-256]. Pathology. 2022 Dec;54(7):972. doi: 10.1016/j.pathol.2022.11.002. | |
| 36413608 | 0 | Afonso E, Bayat F, Ladouceur L, et al. Highly Stable Hierarchically Structured All-Polymeric Lubricant-Infused Films Prevent Thrombosis and Repel Multidrug-Resistant Pathogens. ACS Appl Mater Interfaces. 2022 Nov 22. doi: 10.1021/acsami.2c17309. | |
| 36413031 | 0 | Tran A, Fernando SM, Gates RS, et al. Efficacy and Safety of Anti-Xa Guided versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients - A Systematic Review and Meta-Analysis. Ann Surg. 2022 Nov 22. doi: 10.1097/SLA.0000000000005754. | |
| 36410399 | 0 | Fainchtein K, Tera Y, Kearn N, et al. Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography. Semin Thromb Hemost. 2022 Nov 21. doi: 10.1055/s-0042-1758116. | |
| 36409922 | 0 | Ding Z, Sherlock M, Chan AKC, et al. Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada. Blood Coagul Fibrinolysis. 2022 Dec 1;33(8):449-456. doi: 10.1097/MBC.0000000000001166. Epub 2022 Nov 7. | |
| 36405542 | 0 | Wright JM, Bottega N, Therrien J, et al. The multidisciplinary management of a mechanical mitral valve thrombosis in pregnancy: a case report and review of the literature. Eur Heart J Case Rep. 2022 Nov 1;6(11):ytac424. doi: 10.1093/ehjcr/ytac424. eCollection 2022 Nov. | |
| 36399203 | 0 | Bonsu KO, Young SW, Lee T, et al. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region. Eur J Clin Pharmacol. 2022 Nov 18. pii: 10.1007/s00228-022-03418-8. doi: 10.1007/s00228-022-03418-8. | |
| 36397933 | 0 | Ivankovic V, McAlpine K, Delic E, et al. Extended-duration thromboprophylaxis for abdominopelvic surgery: Development and evaluation of a risk-stratified patient decision aid to facilitate shared decision making. Res Pract Thromb Haemost. 2022 Nov 14;6(8):e12831. doi: 10.1002/rth2.12831. eCollection 2022 Nov. | |
| 36395818 | 0 | Foulon-Pinto G, Lafuente-Lafuente C, Jourdi G, et al. Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients. Thromb Haemost. 2023 Apr;123(4):402-414. doi: 10.1055/a-1981-1763. Epub 2022 Nov 17. | |
| 36382456 | 0 | Tang Y, Xu Y, Zhang X, et al. [Low molecular weight heparin combined with aspirin to prevent perioperative venous thromboembolism in patients with splenic rupture and lower extremity fracture]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Nov 15;36(11):1381-1387. doi: 10.7507/1002-1892.202207096. | |
| 36371248 | 0 | de Wit K, Al-Haimus F, Hu Y, et al. Comparison of YEARS and Adjust-Unlikely D-dimer Testing for Pulmonary Embolism in the Emergency Department. Ann Emerg Med. 2022 Nov 10. pii: S0196-0644(22)01118-0. doi: 10.1016/j.annemergmed.2022.09.014. | |
| 36371040 | 0 | Hunt A, Nguyen V, Bhandari S, et al. Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry. Ophthalmol Retina. 2023 Apr;7(4):338-345. doi: 10.1016/j.oret.2022.11.001. Epub 2022 Nov 9. | |
| 36368688 | 0 | Grandone E, Barcellona D, Intrieri M, et al. The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism. Semin Thromb Hemost. 2022 Nov 11. doi: 10.1055/s-0042-1758062. | |
| 36357215 | 0 | Tritschler T, Sadeghipour P, Bikdeli B. Subgroup analysis in randomized controlled trials: Useful or misleading? Thromb Res. 2022 Oct 18. pii: S0049-3848(22)00426-1. doi: 10.1016/j.thromres.2022.10.009. | |
| 36354038 | 0 | Bistervels IM, Buchmuller A, Wiegers HMG, et al. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial. Lancet. 2022 Oct 28. pii: S0140-6736(22)02128-6. doi: 10.1016/S0140-6736(22)02128-6. | |
| 36352844 | 0 | Jevtic SD, Arnold DM, Modi D, et al. Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Front Cardiovasc Med. 2022 Oct 24;9:1040196. doi: 10.3389/fcvm.2022.1040196. eCollection 2022. | |
| 36351906 | 0 | Buoninfante A, Andeweg A, Baker AT, et al. Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. NPJ Vaccines. 2022 Nov 9;7(1):141. doi: 10.1038/s41541-022-00569-8. | |
| 36343959 | 0 | Chornenki NLJ, Fralick M, Sholzberg M. Tests de depistage du rapport international normalise et du temps de cephaline activee. CMAJ. 2022 Nov 7;194(43):E1491-E1492. doi: 10.1503/cmaj.220629-f. | |
| 36341698 | 0 | Fu L, MacKeigan DT, Gong Q, et al. Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease. Br J Haematol. 2022 Nov 7. doi: 10.1111/bjh.18531. | |
| 36337926 | 0 | Jung RG, Duchez AC, Simard T, et al. Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype. JACC Basic Transl Sci. 2022 Sep 21;7(10):985-997. doi: 10.1016/j.jacbts.2022.05.002. eCollection 2022 Oct. | |
| 36337058 | 0 | Zhou LW, Yu AYX, Ngo L, et al. Incidence of Cerebral Venous Thrombosis: A Population-Based Study, Systematic Review, and Meta-Analysis. Stroke. 2022 Nov 7. doi: 10.1161/STROKEAHA.122.039390. | |
| 36326142 | 0 | Zabeida A, Winikoff R, Pelland-Marcotte MC, et al. COVID-19-associated coagulopathy in children: A multicenter observational cohort study. Pediatr Blood Cancer. 2022 Nov 3:e30079. doi: 10.1002/pbc.30079. | |
| 36325656 | 0 | Massicotte-Azarniouch D, Sood MM, Fergusson DA, et al. The association of venous thromboembolism with blood transfusion in kidney transplant patients. Transfusion. 2022 Nov 3. doi: 10.1111/trf.17154. | |
| 36323490 | 0 | Weitz JI, Szekanecz Z, Charles-Schoeman C, et al. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD Open. 2022 Nov;8(2). pii: rmdopen-2022-002571. doi: 10.1136/rmdopen-2022-002571. | |
| 36315952 | 0 | Shivakumar S. In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed. Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0089. | |
| 36302103 | 0 | Chornenki NLJ, Fralick M, Sholzberg M. International normalized ratio and activated partial thromboplastin time testing. CMAJ. 2022 Aug 29;194(33):E1135. doi: 10.1503/cmaj.220629. | |
| 36299837 | 0 | Farrugia S, Cachia M, Degaetano J, et al. Palmar Digital Vein Thrombosis: A Case Report and Review of 36 Cases. Eur J Case Rep Intern Med. 2022 Sep 21;9(9):003552. doi: 10.12890/2022_003552. eCollection 2022. | |
| 36299810 | 0 | Mansory EM, Abu-Farhaneh M, Iansavitchene A, et al. Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open. 2022 Sep 19;6(3):e276-e282. doi: 10.1055/a-1913-4377. eCollection 2022 Jul. | |
| 36294316 | 0 | Kyriakoulis KG, Dimakakos E, Kyriakoulis IG, et al. Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials. J Clin Med. 2022 Oct 11;11(20). pii: jcm11205997. doi: 10.3390/jcm11205997. | |
| 36268462 | 0 | Attard LM, Gatt A, Bertoletti L, et al. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis. Vasc Health Risk Manag. 2022 Oct 13;18:793-807. doi: 10.2147/VHRM.S271411. eCollection 2022. | |
| 36264575 | 0 | Ngamvichchukorn T, Ruengorn C, Noppakun K, et al. Association Between Pretransplant Dialysis Modality and Kidney Transplant Outcomes: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Oct 3;5(10):e2237580. doi: 10.1001/jamanetworkopen.2022.37580. | |
| 36262482 | 0 | Jessica B, Zayd A, Robert P, et al. Atraumatic Splenic Rupture on Direct Oral Anticoagulation. J Community Hosp Intern Med Perspect. 2022 Sep 9;12(5):84-87. doi: 10.55729/2000-9666.1098. eCollection 2022. | |
| 36248382 | 0 | Abuji K, Kumar D, Vaddavalli VV, et al. Giant cephalic venous aneurysm. J Vasc Surg Cases Innov Tech. 2022 Aug 27;8(4):592-595. doi: 10.1016/j.jvscit.2022.08.009. eCollection 2022 Dec. | |
| 36242733 | 0 | Liu S, McLeod SL, Atzema CL, et al. Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department. CJEM. 2022 Dec;24(8):853-861. doi: 10.1007/s43678-022-00392-z. Epub 2022 Oct 15. | |
| 36225436 | 0 | Ganta N, Prasad A, Kochhar S, et al. A Young Adult With Essential Thrombocythemia Presenting as Myocardial Infarction. Cureus. 2022 Sep 7;14(9):e28883. doi: 10.7759/cureus.28883. eCollection 2022 Sep. | |
| 36223804 | 0 | Ortega-Paz L, Talasaz AH, Sadeghipour P, et al. COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. Semin Thromb Hemost. 2022 Oct 12. doi: 10.1055/s-0042-1757634. | |
| 36217296 | 0 | Wang TF, Sanfilippo KM, Douketis J, et al. Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Sep 26. doi: 10.1111/jth.15896. | |
| 36213364 | 0 | Siegal DM, Leong DP. Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer: Challenges and Opportunities. JACC CardioOncol. 2022 Sep 20;4(3):351-353. doi: 10.1016/j.jaccao.2022.08.005. eCollection 2022 Sep. | |
| 36212651 | 0 | Heldner MR, Aguiar de Sousa D, Field TS, et al. Editorial: Cerebral venous thrombosis. Front Neurol. 2022 Sep 23;13:1021547. doi: 10.3389/fneur.2022.1021547. eCollection 2022. | |
| 36210563 | 0 | Wang TF. Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancer. Thromb Res. 2022 May;213 Suppl 1:S66-S71. doi: 10.1016/j.thromres.2021.11.026. Epub 2022 May 26. | |
| 36210560 | 0 | Delluc A, Robin P. (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know? Thromb Res. 2022 May;213 Suppl 1:S42-S45. doi: 10.1016/j.thromres.2022.01.018. Epub 2022 May 26. | |
| 36206783 | 0 | Aibar J, Schulman S. Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost. 2021 Sep;47(6):e1-e2. doi: 10.1055/s-0042-1757330. Epub 2022 Oct 7. | |
| 36205248 | 0 | Raskob GE, Ageno W, Albers G, et al. Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness. J Am Heart Assoc. 2022 Oct 7:e026229. doi: 10.1161/JAHA.122.026229. | |
| 36201366 | 0 | Potere N, Barco S, Mahe I, et al. Awareness of Venous Thromboembolism among Patients with Cancer: Preliminary Findings from a Global Initiative for World Thrombosis Day. J Thromb Haemost. 2022 Oct 6. doi: 10.1111/jth.15902. | |
| 36200348 | 0 | Shaw JR, Li N, Nixon J, et al. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J Thromb Haemost. 2022 Dec;20(12):2953-2963. doi: 10.1111/jth.15901. Epub 2022 Oct 18. | |
| 36199587 | 0 | AlEidan FAS, AlManea RK, AlMoneef AT, et al. Incidence and Predictors of Recurrence and Mortality Following First Venous Thromboembolism Among the Saudi Population: Single-Center Cohort Study. Int J Gen Med. 2022 Sep 28;15:7559-7568. doi: 10.2147/IJGM.S359893. eCollection 2022. | |
| 36199014 | 0 | Leon-Garcia M, Humphries B, Maraboto A, et al. Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review. BMC Pregnancy Childbirth. 2022 Oct 5;22(1):747. doi: 10.1186/s12884-022-05042-x. | |
| 36198021 | 0 | Srikajornlarp S, Amnueypol M, Vathesatogkit P, et al. Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221130058. doi: 10.1177/10760296221130058. | |
| 36186105 | 0 | Koolian M, Wiseman D, Mantzanis H, et al. Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription. Res Pract Thromb Haemost. 2022 Sep 25;6(6):e12758. doi: 10.1002/rth2.12758. eCollection 2022 Aug. | |
| 36174599 | 0 | Kwaan HC, Walsh M, Lindholm PF, et al. Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemostatic Function. Semin Thromb Hemost. 2022 Sep 29. doi: 10.1055/s-0042-1756700. | |
| 36161521 | 0 | Sabrina C, Laura M, Sabrina S, et al. Expect the unexpected: a case of spontaneous thrombosis of a pial arteriovenous fistula in a preterm newborn with review of the literature. Childs Nerv Syst. 2023 Mar;39(3):793-799. doi: 10.1007/s00381-022-05652-y. Epub 2022 Sep 26. | |
| 36158342 | 0 | Agarwal S A, Santhanam J, K A, et al. A Case of Type 2 Protein S Deficiency Presenting as Cerebral Venous Thrombosis (CVT) in an 18-Year-Old Female. Cureus. 2022 Aug 20;14(8):e28221. doi: 10.7759/cureus.28221. eCollection 2022 Aug. | |
| 36150513 | 0 | Douros A, Basedow F, Cui Y, et al. Effectiveness and safety of direct oral anticoagulants among octogenarians with venous thromboembolism: an international multi-database cohort study. Am J Med. 2022 Sep 20. pii: S0002-9343(22)00666-0. doi: 10.1016/j.amjmed.2022.08.033. | |
| 36135074 | 0 | Harrigan AM, Rioux J, Shivakumar S. Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner. Curr Oncol. 2022 Sep 8;29(9):6419-6432. doi: 10.3390/curroncol29090505. | |
| 36127405 | 0 | Dadgar K, Xue Y, Chung J, et al. Childhood nephrotic syndrome and the clinical profile of thromboembolism: a systematic review and meta-analysis. Pediatr Res. 2023 May;93(6):1463-1469. doi: 10.1038/s41390-022-02302-6. Epub 2022 Sep 20. | |
| 36122922 | 0 | Barber MRW, Clarke AE, Adams CD, et al. Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus. CMAJ. 2022 Sep 19;194(36):E1243-E1247. doi: 10.1503/cmaj.220491. | |
| 36122573 | 0 | Ziemba YC, Abdulrehman J, Hollestelle MJ, et al. Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade. Semin Thromb Hemost. 2022 Sep 19. doi: 10.1055/s-0042-1754332. | |
| 36121587 | 0 | Eikelboom R, Whitlock RP, Sibilio S, et al. Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study. Cardiovasc Drugs Ther. 2022 Sep 19. pii: 10.1007/s10557-022-07381-5. doi: 10.1007/s10557-022-07381-5. | |
| 36100263 | 0 | Auer RC, Ott M, Karanicolas P, et al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375. | |
| 36095313 | 0 | Duffett L. Deep Venous Thrombosis. Ann Intern Med. 2022 Sep 13. doi: 10.7326/AITC202209200. | |
| 36082668 | 0 | van de Munckhof A, Lindgren E, Kleinig TJ, et al. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke. 2022 Sep 9:101161STROKEAHA122039575. doi: 10.1161/STROKEAHA.122.039575. | |
| 36076354 | 0 | Porres-Aguilar M, Mukherjee D, Didia SC, et al. Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies. Vascular. 2022 Sep 8:17085381221126235. doi: 10.1177/17085381221126235. | |
| 36074019 | 0 | DeYoung V, Singh K, Kretz CA. Mechanisms of ADAMTS13 Regulation. J Thromb Haemost. 2022 Sep 8. doi: 10.1111/jth.15873. | |
| 36055334 | 0 | Gwozdz AM, de Jong CMM, Fialho LS, et al. Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. Lancet Haematol. 2022 Sep;9(9):e698-e706. doi: 10.1016/S2352-3026(22)00215-0. | |
| 36051542 | 0 | Simard C, Gerstein L, Cafaro T, et al. Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature. Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12801. doi: 10.1002/rth2.12801. eCollection 2022 Aug. | |
| 36051541 | 0 | Rinfret F, Gu CS, Vedantham S, et al. New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12796. doi: 10.1002/rth2.12796. eCollection 2022 Aug. | |
| 36046208 | 0 | Spyropoulos AC, Goldin M, Ageno W, et al. Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial. TH Open. 2022 Jul 11;6(3):e177-e183. doi: 10.1055/s-0042-1750379. eCollection 2022 Jul. | |
| 36033945 | 0 | Jin FM, Wang M, Wu XM, et al. Effects of wasp venom on venous thrombosis in rats. Iran J Basic Med Sci. 2022 Jul;25(7):822-826. doi: 10.22038/IJBMS.2022.63219.13962. | |
| 36032214 | 0 | Woller SC, de Wit K, Robert-Ebadi H, et al. A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH. Res Pract Thromb Haemost. 2022 Aug 26;6(6):e12786. doi: 10.1002/rth2.12786. eCollection 2022 Aug. | |
| 36032177 | 0 | Mah J, Lee A, Scott JN, et al. Pneumococcal otogenic meningitis complicated by pneumocephalus, seizures, right-sided hemiplegia and cortical venous thrombosis. IDCases. 2022 Aug 17;29:e01601. doi: 10.1016/j.idcr.2022.e01601. eCollection 2022. | |
| 36030069 | 0 | Ciuffini LA, Wang TF, Lodigiani C, et al. Thromboprophylaxis of cancer patients undergoing systemic therapy in the ambulatory setting. Best Pract Res Clin Haematol. 2022 Mar;35(1):101351. doi: 10.1016/j.beha.2022.101351. Epub 2022 Jun 6. | |
| 36030068 | 0 | Wang TF, Leader A, Sanfilippo KM. Thrombosis and bleeding in hematological malignancy. Best Pract Res Clin Haematol. 2022 Mar;35(1):101353. doi: 10.1016/j.beha.2022.101353. Epub 2022 Jun 16. | |
| 36028857 | 0 | Antic D, Milic N, Chatzikonstantinou T, et al. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0. | |
| 36016942 | 0 | Pryzdial ELG, Leatherdale A, Conway EM. Coagulation and complement: Key innate defense participants in a seamless web. Front Immunol. 2022 Aug 9;13:918775. doi: 10.3389/fimmu.2022.918775. eCollection 2022. | |
| 36010225 | 0 | Robert-Ebadi H, Moumneh T, Le Gal G, et al. Diagnosis of Pulmonary Embolism during Pregnancy. Diagnostics (Basel). 2022 Aug 3;12(8). pii: diagnostics12081875. doi: 10.3390/diagnostics12081875. | |
| 36002241 | 0 | Kirwan C, Ramsden S, Carter J, et al. Starting anticoagulation for atrial fibrillation in the emergency department safely. Emerg Med J. 2022 Aug 24. pii: emermed-2022-212487. doi: 10.1136/emermed-2022-212487. | |
| 35992565 | 0 | Bistervels IM, Bavalia R, Beyer-Westendorf J, et al. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin. Res Pract Thromb Haemost. 2022 Jul 1;6(5):e12748. doi: 10.1002/rth2.12748. eCollection 2022 Jul. | |
| 35977053 | 0 | Maria A, Lal BB, Khanna R, et al. Rotational thromboelastometry-guided blood component use in cirrhotic children undergoing invasive procedures: Randomized controlled trial. Liver Int. 2022 Nov;42(11):2492-2500. doi: 10.1111/liv.15398. Epub 2022 Aug 25. | |
| 35974661 | 0 | Candeloro M, Di Nisio M, Potere N, et al. Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants. J Am Geriatr Soc. 2022 Aug 16. doi: 10.1111/jgs.18001. | |
| 35967591 | 0 | Briller JE, Aggarwal NR, Davis MB, et al. Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections. JACC Adv. 2022 Aug 10:100057. doi: 10.1016/j.jacadv.2022.100057. | |
| 35960423 | 0 | Ikesaka R, Kaur B, Crowther M, et al. Efficacy and safety of pre-operative insertion of inferior vena cava filter in patients undergoing bariatric surgery: a systematic review. J Thromb Thrombolysis. 2022 Aug 12. pii: 10.1007/s11239-022-02689-3. doi: 10.1007/s11239-022-02689-3. | |
| 35938419 | 0 | Yaghi S, Saldanha IJ, Misquith C, et al. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke. 2022 Aug 8:101161STROKEAHA122039579. doi: 10.1161/STROKEAHA.122.039579. | |
| 35931818 | 0 | Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022 Aug 5. pii: 10.1038/s41577-022-00762-9. doi: 10.1038/s41577-022-00762-9. | |
| 35923661 | 0 | Bonsu KO, Young S, Lee T, et al. Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada - A Cross-Sectional Survey. Patient Prefer Adherence. 2022 Jul 26;16:1771-1780. doi: 10.2147/PPA.S367105. eCollection 2022. | |
| 35920155 | 0 | McCullough-Hicks ME, Halterman DJ, Anderson D, et al. High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients With COVID-19 Infection. Stroke. 2022 Aug 3:101161STROKEAHA122038955. doi: 10.1161/STROKEAHA.122.038955. | |
| 35919877 | 0 | Tanguay M, Seguin C. Recurrent thrombosis rescued by fondaparinux in high-risk patients: A case series. Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12773. doi: 10.1002/rth2.12773. eCollection 2022 Jul. | |
| 35919876 | 0 | Bastas D, Vincelli J, De R, et al. Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability. Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12779. doi: 10.1002/rth2.12779. eCollection 2022 Jul. | |
| 35918731 | 0 | Holbrook AM, Vidug K, Yoo L, et al. Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2022 Aug 2;8(1):166. doi: 10.1186/s40814-022-01130-z. | |
| 35914222 | 0 | Palareti G, Poli D, Ageno W, et al. D-dimer and reduced dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study. Blood Adv. 2022 Aug 1. pii: 486077. doi: 10.1182/bloodadvances.2022007973. | |
| 35906715 | 0 | Spyropoulos AC, Connors JM, Douketis JD, et al. Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Jul 7. doi: 10.1111/jth.15809. | |
| 35895858 | 0 | Porres-Aguilar M, Rosovsky RP, Rivera-Lebron BN, et al. Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism. J Thromb Haemost. 2022 Jul 27. doi: 10.1111/jth.15832. | |
| 35887951 | 0 | Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study. J Clin Med. 2022 Jul 19;11(14). pii: jcm11144188. doi: 10.3390/jcm11144188. | |
| 35877546 | 0 | Abdulrehman J, Elbaz C, Aziz D, et al. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol. 2022 Jul 25. doi: 10.1111/bjh.18331. | |
| 35867883 | 0 | Back V, Asgari A, Franczak A, et al. Inhibition of Platelet Aggregation by Activation of Platelet Intermediate Conductance Ca(2+) -Activated Potassium Channels. J Thromb Haemost. 2022 Jul 22. doi: 10.1111/jth.15827. | |
| 35863955 | 0 | K A, Ayyan SM, Ezhilkugan G, et al. A Rare Case of Limb-Threatening Injury Secondary to Extrinsic Vascular Compression Following Crocodile Bite. Wilderness Environ Med. 2022 Sep;33(3):355-360. doi: 10.1016/j.wem.2022.05.004. Epub 2022 Jul 19. | |
| 35852851 | 0 | Conway EM, Pryzdial ELG. Complement contributions to COVID-19. Curr Opin Hematol. 2022 Sep 1;29(5):259-265. doi: 10.1097/MOH.0000000000000724. Epub 2022 Jul 11. | |
| 35844166 | 0 | Leong R, Chu DK, Crowther MA, et al. Direct oral anticoagulants after bariatric surgery - what is the evidence? J Thromb Haemost. 2022 Jul 18. doi: 10.1111/jth.15823. | |
| 35830171 | 0 | Bikdeli B, Caraballo C, Trujillo-Santos J, et al. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry. JAMA Cardiol. 2022 Jul 13. pii: 2793876. doi: 10.1001/jamacardio.2022.1988. | |
| 35814801 | 0 | Ariens RA, Hunt BJ, Agbani EO, et al. Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress. Res Pract Thromb Haemost. 2022 Jul 6;6(5):e12747. doi: 10.1002/rth2.12747. eCollection 2022 Jul. | |
| 35809961 | 0 | Porres-Aguilar M, Mukherjee D, Lazo-Langner A. Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19. Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038. | |
| 35803552 | 0 | Thukral S, Salter A, Lancia S, et al. Predictors of Clinical Outcomes of Pharmacomechanical Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis - Analysis of a Multicenter Randomized Trial. J Vasc Interv Radiol. 2022 Jul 5. pii: S1051-0443(22)01050-8. doi: 10.1016/j.jvir.2022.05.030. | |
| 35793687 | 0 | Candeloro M, Schulman S. Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis. Semin Thromb Hemost. 2022 Jul 6. doi: 10.1055/s-0042-1749661. | |
| 35790272 | 0 | Dimakakos E, Gomatou G, Catalano M, et al. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815. | |
| 35787808 | 0 | Roberge G, Cote B, Calabrino A, et al. Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases. Thromb J. 2022 Jul 4;20(1):38. doi: 10.1186/s12959-022-00398-8. | |
| 35786365 | 0 | K T, Chan SJ, Varghese C, et al. A selective anticoagulation policy for splanchnic vein thrombosis in acute pancreatitis is associated with favourable outcomes: experience from a UK tertiary referral centre. HPB (Oxford). 2022 Nov;24(11):1937-1943. doi: 10.1016/j.hpb.2022.06.003. Epub 2022 Jun 16. | |
| 35780487 | 0 | Lavin M, Christopherson P, Grabell J, et al. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. J Thromb Haemost. 2022 Jul 3. doi: 10.1111/jth.15807. | |
| 35779962 | 0 | Mouta Nunes de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, et al. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil. Vaccine. 2022 Jun 16. pii: S0264-410X(22)00761-7. doi: 10.1016/j.vaccine.2022.06.014. | |
| 35772400 | 0 | Schulman S. Recent Advances in Thrombosis and Hemostasis-Part VIII. Semin Thromb Hemost. 2022 Jun;48(4):405-406. doi: 10.1055/s-0042-1748886. Epub 2022 Jun 30. | |
| 35759737 | 0 | Porres-Aguilar M, Anaya-Ayala JE. [Comment on article "Enoxaparin dose associated with decreased risk of death in COVID-19"]. Rev Med Inst Mex Seguro Soc. 2022 May 2;60(3):247-248. | |
| 35753074 | 0 | Chelle P, Iorio A, Edginton AN. A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates. J Thromb Haemost. 2022 Sep;20(9):2012-2021. doi: 10.1111/jth.15803. Epub 2022 Jul 7. | |
| 35748885 | 0 | Cuker A, Tseng EK, Schunemann HJ, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients Blood Adv. 2022 Jun 24. pii: 485690. doi: 10.1182/bloodadvances.2022007940. | |
| 35735219 | 0 | den Exter PL, Woller SC, Robert-Ebadi H, et al. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. J Thromb Haemost. 2022 Jun 4. doi: 10.1111/jth.15776. | |
| 35730241 | 0 | Genge L, Krala A, Tritschler T, et al. Evaluation of patients' experience and related qualitative outcomes in venous thromboembolism: A scoping review. J Thromb Haemost. 2022 Jun 22. doi: 10.1111/jth.15788. | |
| 35717670 | 0 | Tritschler T, Cusano E, Langlois N, et al. Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review. J Thromb Haemost. 2022 Jun 19. doi: 10.1111/jth.15787. | |
| 35716055 | 0 | Thachil J, Carrier M, Lisman T. Anticoagulation in thrombocytopenic patients - time to rethink? J Thromb Haemost. 2022 Jun 18. doi: 10.1111/jth.15789. | |
| 35707621 | 0 | Eagle GE, Schulman S. High Factor VIII Levels and Recurrent Thromboembolism in Patients with and without Inflammatory Bowel Disease: A Retrospective Comparative Study. TH Open. 2022 Jun 13;6(2):e147-e153. doi: 10.1055/a-1827-7464. eCollection 2022 Apr. | |
| 35697453 | 0 | Wang M, Paterson M, Thabane L, et al. Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open. 2022 Jun 13;12(6):e057991. doi: 10.1136/bmjopen-2021-057991. | |
| 35689346 | 0 | Scutelnic A, Krzywicka K, Mbroh J, et al. Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26431. | |
| 35679460 | 0 | Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027. | |
| 35677980 | 0 | Nguyen TN, Qureshi MM, Klein P, et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J Stroke. 2022 May;24(2):256-265. doi: 10.5853/jos.2022.00752. Epub 2022 May 31. | |
| 35677520 | 0 | Agrawal D, Gupta D, Nathani R, et al. Presence of Ascites at Presentation is Associated With Absence of Long-Term Response Amongst Patients With Budd-Chiari Syndrome When Treated With Medical Therapy Alone: A Single Centre Real-Life Experience. J Clin Exp Hepatol. 2022 May-Jun;12(3):861-870. doi: 10.1016/j.jceh.2021.10.148. Epub 2021 Nov 3. | |
| 35667069 | 0 | Mithoowani S, Lim W. Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis. Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0039. | |
| 35660801 | 0 | Brandt W, Brown C, Wang TF, et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014. | |
| 35653590 | 0 | Baumann Kreuziger L, Sholzberg M, Cushman M. Anticoagulation in Hospitalized Patients with COVID-19. Blood. 2022 Jun 2. pii: 485455. doi: 10.1182/blood.2021014527. | |
| 35648414 | 0 | Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, et al. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. JAMA Cardiol. 2022 Jun 1. pii: 2793119. doi: 10.1001/jamacardio.2022.1292. | |
| 35638475 | 0 | da Costa WL Jr, Guffey D, Oluyomi A, et al. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol. 2022 May 31. doi: 10.1002/ajh.26623. | |
| 35635332 | 0 | Sanfilippo KM, Wang TF, Carrier M, et al. Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. J Thromb Haemost. 2022 May 18. doi: 10.1111/jth.15759. | |
| 35621286 | 0 | Amenyogbe A, Lemire F, Yachnin D, et al. A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancer. Can Urol Assoc J. 2022 May 20. pii: cuaj.7865. doi: 10.5489/cuaj.7865. | |
| 35613465 | 0 | Candeloro M, Valeriani E, Monreal M, et al. Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis. Blood Adv. 2022 May 25. pii: 485361. doi: 10.1182/bloodadvances.2022007961. | |
| 35611985 | 0 | Sanfilippo KM, Moik F, Candeloro M, et al. Unanswered questions in cancer-associated thrombosis. Br J Haematol. 2022 May 25. doi: 10.1111/bjh.18276. | |
| 35611694 | 0 | Chang SJ, Rebchuk AD, Teal P, et al. COVID-19-Associated Cerebral Developmental Venous Anomaly Thrombosis With Hemorrhagic Transformation. Stroke. 2022 May 25:101161STROKEAHA122039534. doi: 10.1161/STROKEAHA.122.039534. | |
| 35609563 | 0 | Bissola AL, Daka M, Arnold DM, et al. The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Adv. 2022 Jul 26;6(14):4228-4235. doi: 10.1182/bloodadvances.2022007766. | |
| 35606788 | 0 | Young SW, Bonsu KO, Lee T, et al. Patient satisfaction with quality of care of a multidisciplinary thrombosis service - a cross sectional survey. BMC Health Serv Res. 2022 May 23;22(1):685. doi: 10.1186/s12913-022-08089-w. | |
| 35606079 | 0 | Boffa MB. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis. Atherosclerosis. 2022 May;349:72-81. doi: 10.1016/j.atherosclerosis.2022.04.009. | |
| 35599984 | 0 | Hernandez GE, Ma F, Martinez G, et al. Aortic intimal resident macrophages are essential for maintenance of the non-thrombogenic intravascular state. Nat Cardiovasc Res. 2022 Jan;1(1):67-84. doi: 10.1038/s44161-021-00006-4. Epub 2022 Jan 12. | |
| 35599706 | 0 | Lai CMB, Lee AYY, Parkin SBI. Vaccine-induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report. Res Pract Thromb Haemost. 2022 May 18;6(4):e12716. doi: 10.1002/rth2.12716. eCollection 2022 May. | |
| 35599704 | 0 | Nersesian S, Sholzberg M, Cushman M, et al. The Journey to a Successful Illustrated Review. Res Pract Thromb Haemost. 2022 May 18;6(4):e12721. doi: 10.1002/rth2.12721. eCollection 2022 May. | |
| 35587536 | 0 | Popov J, Coelho S, Carrier M, et al. Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study. J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760. | |
| 35582246 | 0 | Bayadinova JA, Sardo LA, Penton L, et al. 'Spot the CLOT': Awareness of cancer-associated thrombosis in healthcare providers. Can Oncol Nurs J. 2022 Apr 1;32(2):325-330. eCollection 2022 Spring. | |
| 35581123 | 0 | Garas SN, McAlpine K, Ross J, et al. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer. Urol Oncol. 2022 May 14. pii: S1078-1439(22)00116-8. doi: 10.1016/j.urolonc.2022.04.006. | |
| 35580465 | 0 | Mithoowani S, Moffat KA, Gupta A, et al. Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels. Thromb Res. 2022 Jul;215:1-4. doi: 10.1016/j.thromres.2022.05.005. Epub 2022 May 13. | |
| 35577768 | 0 | Kaushik R, Mani A, Ganapathi S, et al. Clinical outcomes of bileaflet St. Jude Medical and tilting disc TTK Chitra mechanical heart valve prosthesis: A comparative study. J Card Surg. 2022 Aug;37(8):2367-2374. doi: 10.1111/jocs.16605. Epub 2022 May 16. | |
| 35577738 | 0 | Yeap I, Karagiannis P, Ng SS, et al. A proven perioperative protocol for free flap surgery in a patient with heparin-induced thrombocytopenia. J Plast Reconstr Aesthet Surg. 2022 May 6. pii: S1748-6815(22)00282-0. doi: 10.1016/j.bjps.2022.04.090. | |
| 35577626 | 0 | Nicholson M, Goubran H, Chan N, et al. No apparent association between mRNA COVID-19 vaccination and venous thromboembolism. Blood Rev. 2022 May 11:100970. doi: 10.1016/j.blre.2022.100970. | |
| 35570324 | 0 | Minford A, Brandao LR, Othman M, et al. Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. J Thromb Haemost. 2022 Apr 17. doi: 10.1111/jth.15732. | |
| 35537232 | 0 | Bikdeli B, Piazza G, Jimenez D, et al. Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study. Thromb Res. 2022 May 4;214:122-131. doi: 10.1016/j.thromres.2022.04.019. | |
| 35531770 | 0 | Castaman G, Borchiellini A, Coppola A, et al. Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panel. Eur J Haematol. 2022 Aug;109(2):121-128. doi: 10.1111/ejh.13785. Epub 2022 May 24. | |
| 35520371 | 0 | Farrugia S, Micallef D, Pisani D, et al. Retiform Purpura of the Lower Limbs Associated with Levamisole-Adulterated Cocaine. Eur J Case Rep Intern Med. 2022 Apr 28;9(4):003353. doi: 10.12890/2022_003353. eCollection 2022. | |
| 35512906 | 0 | Gabarin N, Arnold DM, Nazy I, et al. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). Semin Hematol. 2022 Apr;59(2):89-96. doi: 10.1053/j.seminhematol.2022.03.002. Epub 2022 Mar 7. | |
| 35512903 | 0 | Pai M. Epidemiology of VITT. Semin Hematol. 2022 Apr;59(2):72-75. doi: 10.1053/j.seminhematol.2022.02.002. Epub 2022 Feb 8. | |
| 35506944 | 0 | Gupta D, Kedia S, Rath GP, et al. A Century With Craniopagus Twin Separation Surgeries: Nihilism to Optimism. Neurosurgery. 2022 May 6. pii: 00006123-990000000-00256. doi: 10.1227/neu.0000000000001962. | |
| 35503027 | 0 | Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Adv. 2022 May 3. pii: 485124. doi: 10.1182/bloodadvances.2022007561. | |
| 35498021 | 0 | Blondon M, Skeith L. Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review. Front Cardiovasc Med. 2022 Apr 12;9:886416. doi: 10.3389/fcvm.2022.886416. eCollection 2022. | |
| 35491501 | 0 | Sposato LA, Field TS. Atrial fibrillation detection after stroke: Is all created equal? Eur J Neurol. 2022 Jul;29(7):1869-1870. doi: 10.1111/ene.15375. Epub 2022 May 8. | |
| 35487054 | 0 | Grewal K, Atzema CL, Austin PC, et al. Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study. Thromb Res. 2022 Jun;214:47-52. doi: 10.1016/j.thromres.2022.04.007. Epub 2022 Apr 14. | |
| 35470213 | 0 | Mavrakanas TA. Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis. Clin J Am Soc Nephrol. 2022 Apr 25. pii: CJN.03410322. doi: 10.2215/CJN.03410322. | |
| 35468835 | 0 | Lamb T, Lenet T, Zahrai A, et al. Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis. World J Emerg Surg. 2022 Apr 25;17(1):19. doi: 10.1186/s13017-022-00423-1. | |
| 35462127 | 0 | Falanga A, Girvalaki C, Monreal M, et al. How well do European patients understand cancer-associated thrombosis? A patient survey. Cancer Treat Res Commun. 2022 Apr 10;31:100557. doi: 10.1016/j.ctarc.2022.100557. | |
| 35455936 | 0 | de Almeida LGN, Young D, Chow L, et al. Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia. Cells. 2022 Apr 7;11(8). pii: cells11081256. doi: 10.3390/cells11081256. | |
| 35452514 | 0 | Laroche A, Soulet D, Bazin M, et al. Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis. Blood Adv. 2022 Apr 22. pii: 485043. doi: 10.1182/bloodadvances.2021006728. | |
| 35445575 | 0 | Lillicrap D, Morrissey JH. Investment in the future of thrombosis and hemostasis science. J Thromb Haemost. 2022 May;20(5):1033. doi: 10.1111/jth.15710. | |
| 35443527 | 0 | S S. Assessment of INR to Albumin Ratio in Predicting Outcome During Hospital Stay in Patients with Cirrhosis of Liver with Sepsis. J Assoc Physicians India. 2022 Apr;70(4):11-12. | |
| 35439303 | 0 | Ageno W, Beyer-Westendorf J, Contino L, et al. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood Adv. 2022 Apr 19. pii: 484971. doi: 10.1182/bloodadvances.2022007397. | |
| 35436439 | 0 | Carrier M, Le Gal G. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation. Ann Intern Med. 2022 Apr;175(4):W43-W44. doi: 10.7326/L22-0038. | |
| 35429163 | 0 | Thomas CD, Franchi F, Keeley EC, et al. Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-site, Real-world Investigation. Clin Pharmacol Ther. 2022 Apr 16. doi: 10.1002/cpt.2612. | |
| 35428918 | 0 | S P, Kumar H, C R, et al. Protective Effects of Sauropus Androgynus Leaf Extract against Isoproterenol Induced Cardiotoxicity. Cardiovasc Toxicol. 2022 Jun;22(6):579-591. doi: 10.1007/s12012-022-09739-5. Epub 2022 Apr 15. | |
| 35399410 | 0 | Alnabwani D, Ganta N, Kochhar S, et al. Combined Oral Contraceptives Bringing to Light May-Thurner Syndrome. Cureus. 2022 Mar 4;14(3):e22839. doi: 10.7759/cureus.22839. eCollection 2022 Mar. | |
| 35398856 | 0 | Samji N, Twiss J, Chan AKC, et al. Successful Use of Thrombolysis in an Extremely Low Birth Weight, Premature Infant With Aortic Thrombosis. J Pediatr Hematol Oncol. 2022 Apr 8. pii: 00043426-990000000-00014. doi: 10.1097/MPH.0000000000002455. | |
| 35389229 | 0 | Spyropoulos AC, Raskob GE, Cohen AT, et al. Association of Bleeding Severity with Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Circulation. 2022 Apr 7. doi: 10.1161/CIRCULATIONAHA.121.057847. | |
| 35386738 | 0 | Furtado S, Dunogue B, Jourdi G, et al. High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular complications. J Scleroderma Relat Disord. 2021 Jun;6(2):178-186. doi: 10.1177/2397198320957558. Epub 2020 Sep 24. | |
| 35378030 | 0 | Mavrakanas TA. Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: COMMENTARY. Kidney360. 2021 Apr 9;2(9):1412-1414. doi: 10.34067/KID.0001372021. eCollection 2021 Sep 30. | |
| 35372933 | 0 | Ouellette AC, Darling EK, Sivapathasundaram B, et al. Incidence, Risk Factors, and Outcomes of Neonatal Renal Vein Thrombosis in Ontario: Population-Based Cohort Study. Kidney360. 2020 May 27;1(7):640-647. doi: 10.34067/KID.0000912019. eCollection 2020 Jul 30. | |
| 35371058 | 0 | Jevtic SD, Nazy I. The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19. Front Immunol. 2022 Mar 14;13:807934. doi: 10.3389/fimmu.2022.807934. eCollection 2022. | |
| 35363452 | 0 | Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMoa2201171. | |
| 35362102 | 0 | Schulman S, Carlson V, Serrano PE, et al. Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. J Surg Oncol. 2022 Apr 1. doi: 10.1002/jso.26876. | |
| 35360964 | 0 | Wei M, Xu Y, Xia D, et al. Care and Treatment for an Antiphospholipid Syndrome-Related Lower Limb Skin Ulcer Unhealed for 7 Years: A Case Report. Int J Low Extrem Wounds. 2022 Mar 31:15347346221090079. doi: 10.1177/15347346221090079. | |
| 35344784 | 0 | Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014. | |
| 35317220 | 0 | S SN, Saha S, Bhattacharjee A. A 2D FSI mathematical model of blood flow to analyze the hyper-viscous effects in atherosclerotic COVID patients. Results Eng. 2021 Dec;12:100275. doi: 10.1016/j.rineng.2021.100275. Epub 2021 Aug 24. | |
| 35315874 | 0 | Bradbury CA, Lawler PR, Stanworth SJ, et al. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910. | |
| 35309792 | 0 | Shivji S, Carrier M. Screening for cancer in unprovoked venous thromboembolism. Hemasphere. 2019 Jun 30;3(Suppl). pii: HemaSphere-2019-0011. doi: 10.1097/HS9.0000000000000205. eCollection 2019 Jun. | |
| 35298939 | 0 | Xu Y, Gomes T, Wells PS, et al. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study. Thromb Res. 2022 Feb 24;213:57-64. doi: 10.1016/j.thromres.2022.02.018. | |
| 35290837 | 0 | Abufarhaneh M, Pandya RK, Alkhaja A, et al. Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis. Thromb Res. 2022 Mar 4;213:47-56. doi: 10.1016/j.thromres.2022.02.022. | |
| 35289485 | 0 | Bhatia K, Solanki S, Paes B, et al. Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit. Pediatr Blood Cancer. 2022 Mar 15:e29668. doi: 10.1002/pbc.29668. | |
| 35285449 | 0 | Leong R, Patel J, Samji N, et al. Use of thrombolytic agents to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2022 Mar 11. pii: 00001721-900000000-98300. doi: 10.1097/MBC.0000000000001134. | |
| 35283031 | 0 | Ask A, Eltringham-Smith L, Bhakta V, et al. Spotlight on animal models of acute traumatic coagulopathy: an update. Transfus Apher Sci. 2022 Apr;61(2):103412. doi: 10.1016/j.transci.2022.103412. Epub 2022 Mar 10. | |
| 35282394 | 0 | You D, Maarouf N, Hildebrand K, et al. An in vivo rabbit joint injury model to measure trauma-induced coagulopathy and the effect of timing of administration of ketotifen fumarate on posttraumatic joint contracture. OTA Int. 2022 Mar 10;5(1 Suppl):e177. doi: 10.1097/OI9.0000000000000177. eCollection 2022 Mar. | |
| 35281583 | 0 | Tawhari M, Al Oudah N, Al Zahrani Y, et al. IgG4-Related Kidney Disease Associated With End-Stage Kidney Disease, Renal Pseudotumor, and Renal Vein Thrombosis. Cureus. 2022 Mar 4;14(3):e22837. doi: 10.7759/cureus.22837. eCollection 2022 Mar. | |
| 35278763 | 0 | Luisa V, Valentina P, Alessia G, et al. Ischemic stroke shortly after vaccination against SARS-CoV-2: A case-control study. J Neurol Sci. 2022 May 15;436:120209. doi: 10.1016/j.jns.2022.120209. Epub 2022 Feb 27. | |
| 35275495 | 0 | Roberge G, Carrier M. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221086283. doi: 10.1177/10760296221086283. | |
| 35268283 | 0 | Forte S, De Luna G, Abdulrehman J, et al. Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study. J Clin Med. 2022 Feb 23;11(5). pii: jcm11051193. doi: 10.3390/jcm11051193. | |
| 35264372 | 0 | Marcucci M, Etxeandia-Ikobaltzeta I, Yang S, et al. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials. BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785. | |
| 35263789 | 0 | Roy DC, Wang TF, Mallick R, et al. GDF-15, hs-TnT and NT proBNP for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy. Thromb Haemost. 2022 Mar 9. doi: 10.1055/a-1792-7720. | |
| 35260475 | 0 | Hasse S, Julien AS, Duchez AC, et al. Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus. Lupus Sci Med. 2022 Mar;9(1). pii: 9/1/e000605. doi: 10.1136/lupus-2021-000605. | |
| 35257736 | 0 | Saggu DK, Rangaswamy VV, Yalagudri S, et al. Prevalence, clinical profile, and stroke risk of atrial fibrillation in rural Andhra Pradesh, India (the AP-AF study). Indian Heart J. 2022 Mar-Apr;74(2):86-90. doi: 10.1016/j.ihj.2022.02.002. Epub 2022 Mar 4. | |
| 35226556 | 0 | Lawler PR, Hochman JS, Zarychanski R. What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine? Circulation. 2022 Mar;145(9):629-632. doi: 10.1161/CIRCULATIONAHA.121.058113. Epub 2022 Feb 28. | |
| 35224860 | 0 | Khan S, Jarad NA, Ladouceur L, et al. Transparent and Highly Flexible Hierarchically Structured Polydimethylsiloxane Surfaces Suppress Bacterial Attachment and Thrombosis Under Static and Dynamic Conditions. Small. 2022 Feb 28:e2108112. doi: 10.1002/smll.202108112. | |
| 35224414 | 0 | Candeloro M, Eikelboom JW, Chan N, et al. Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort. Res Pract Thromb Haemost. 2022 Feb 17;6(2):e12650. doi: 10.1002/rth2.12650. eCollection 2022 Feb. | |
| 35217534 | 0 | Cohen KR, Anderson D, Ren S, et al. Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study. BMJ Open. 2022 Feb 25;12(2):e051624. doi: 10.1136/bmjopen-2021-051624. | |
| 35217330 | 0 | Beaudoin E, Kaka S, Gagnon E, et al. Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study. Thromb Res. 2022 Feb 12;212:19-21. doi: 10.1016/j.thromres.2022.02.001. | |
| 35202841 | 0 | Bikdeli B, Khairani CD, Barns BM, et al. Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment. Contemp Clin Trials. 2022 Feb 21:106714. doi: 10.1016/j.cct.2022.106714. | |
| 35201292 | 0 | Lee AY, Al Moosawi M, Peterson EA, et al. Clinical Care Pathway for Suspected Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 vaccination. Blood Adv. 2022 Feb 24. pii: 484151. doi: 10.1182/bloodadvances.2021006862. | |
| 35189662 | 0 | Goldin M, Koulas I, Weitz JI, et al. State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism. Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1778-1083. | |
| 35177631 | 0 | Khorana AA, Mackman N, Falanga A, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022 Feb 17;8(1):11. doi: 10.1038/s41572-022-00336-y. | |
| 35174235 | 0 | Jurasz P, Ignjatovic V, Lordkipanidze M. Editorial: Established and Novel Roles of Platelets in Health and Disease. Front Cardiovasc Med. 2022 Jan 31;9:835615. doi: 10.3389/fcvm.2022.835615. eCollection 2022. | |
| 35167861 | 0 | Moores LK, Tritschler T, Brosnahan S, et al. Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12. | |
| 35157815 | 0 | Khan F, Tritschler T, Le Gal G, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731. | |
| 35150946 | 0 | Cook-Richardson S, Addo A, Kim P, et al. Show Me the Money, I'll Show You My Complications: Impacts of Incentivized Incident Self-Reporting Among Surgeons. J Surg Res. 2022 Feb 9;274:136-144. doi: 10.1016/j.jss.2021.12.012. | |
| 35143324 | 0 | Gorman JB, Field TS. ACTION-CVT: Are the Findings ACTIONable? Stroke. 2022 Feb 10:STROKEAHA122038564. doi: 10.1161/STROKEAHA.122.038564. | |
| 35142014 | 0 | Wang M, Swinton M, Troyan S, et al. Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management. J Eval Clin Pract. 2022 Feb 9. doi: 10.1111/jep.13665. | |
| 35124234 | 0 | Wang TF, Mallick R, Carrier M, et al. Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trial. Thromb Res. 2022 Jan 31;211:85-87. doi: 10.1016/j.thromres.2022.01.022. | |
| 35120747 | 0 | Bates SM. Pregnancy-related venous thromboembolism: Progress but questions remain. Eur J Intern Med. 2022 Feb 1. pii: S0953-6205(22)00050-4. doi: 10.1016/j.ejim.2022.01.034. | |
| 35106433 | 0 | de Wit K. Do physicians contribute to psychological distress after venous thrombosis? Res Pract Thromb Haemost. 2022 Jan 23;6(1):e12651. doi: 10.1002/rth2.12651. eCollection 2022 Jan. | |
| 35101871 | 0 | Lu C, Crowther MA, Mithoowani S. Management of intentional overdose of low-molecular-weight heparin. CMAJ. 2022 Jan 31;194(4):E122-E125. doi: 10.1503/cmaj.211083. | |
| 35101631 | 0 | Thangamathesvaran L, Miller SC, Tsou B, et al. Global Current Practice Patterns for the Management of Central Retinal Artery Occlusion. Ophthalmol Retina. 2022 May;6(5):429-431. doi: 10.1016/j.oret.2022.01.014. Epub 2022 Jan 31. | |
| 35100023 | 0 | Rivard L, Friberg L, Conen D, et al. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31. | |
| 35094650 | 0 | Anapalli SR, N HD, Sarma P, et al. Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience. Ren Fail. 2022 Dec;44(1):34-42. doi: 10.1080/0886022X.2021.2011746. | |
| 35060304 | 0 | Greinacher A, Langer F, Makris M, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al. J Thromb Haemost. 2022 Feb;20(2):542-543. doi: 10.1111/jth.15619. | |
| 35040805 | 0 | Grewal K, Atzema CL, Austin PC, et al. Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study. CMAJ. 2021 Oct 12;193(40):E1561-E1567. doi: 10.1503/cmaj.210811. | |
| 35040802 | 0 | Kimpton M, Kumar S, Wells PS, et al. Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer. CMAJ. 2021 Oct 12;193(40):E1551-E1560. doi: 10.1503/cmaj.210523. | |
| 35038272 | 0 | Warkentin TE, Pai M. The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia. Ann Intern Med. 2022 Jan 18. doi: 10.7326/M22-0118. | |
| 35036824 | 0 | Douros A, Basedow F, Cui Y, et al. Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi-database cohort study. Res Pract Thromb Haemost. 2022 Jan 10;6(1):e12643. doi: 10.1002/rth2.12643. eCollection 2022 Jan. | |
| 35028817 | 0 | Alimohammadi A, Kim DJ, Field TS. Updates in Cerebral Venous Thrombosis. Curr Cardiol Rep. 2022 Jan 13. pii: 10.1007/s11886-021-01622-z. doi: 10.1007/s11886-021-01622-z. | |
| 35028601 | 0 | Michels A, Lillicrap D, Yacob M. Role of von Willebrand factor in venous thromboembolic disease. JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022. | |
| 35028491 | 0 | Sanfilippo KM, Carson KR, Wang TF, et al. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma. Res Pract Thromb Haemost. 2022 Jan 9;6(1):e12634. doi: 10.1002/rth2.12634. eCollection 2022 Jan. | |
| 35023983 | 0 | Erez O, Othman M, Rabinovich A, et al. DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments. J Blood Med. 2022 Jan 6;13:21-44. doi: 10.2147/JBM.S273047. eCollection 2022. | |
| 35022931 | 0 | Mancuso M, Lauretti DL, Cecconi N, et al. Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report. Neurol Sci. 2022 Mar;43(3):2085-2089. doi: 10.1007/s10072-021-05800-3. Epub 2022 Jan 13. | |
| 35021257 | 0 | Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313. | |
| 35015038 | 0 | Goldenberg NA, Kittelson JM, Abshire TC, et al. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182. | |
| 35008518 | 0 | Carre J, Jourdi G, Gendron N, et al. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci. 2021 Dec 22;23(1). pii: ijms23010093. doi: 10.3390/ijms23010093. | |
| 35003481 | 0 | Nada A, Shabana A, Elsaadany A, et al. Superior mesenteric artery thrombosis and small bowel necrosis: An uncommon thromboembolic manifestation in COVID-19 pneumonia. Radiol Case Rep. 2022 Mar;17(3):821-824. doi: 10.1016/j.radcr.2021.11.069. Epub 2021 Dec 31. | |
| 35001043 | 0 | Paes B, Chan AKC, Shaik M, et al. Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study. Blood Coagul Fibrinolysis. 2022 Jan 6. pii: 00001721-900000000-98313. doi: 10.1097/MBC.0000000000001110. | |
| 34996086 | 0 | Selby R, Abdulrehman J. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic. J Appl Lab Med. 2022 Jan 5;7(1):373-378. doi: 10.1093/jalm/jfab134. | |
| 34992986 | 0 | Moores G, Warkentin TE, Farooqi MAM, et al. Spontaneous Heparin-Induced Thrombocytopenia Presenting as Cerebral Venous Sinus Thrombosis. Neurol Clin Pract. 2021 Dec;11(6):e929-e931. doi: 10.1212/CPJ.0000000000000805. | |
| 34980834 | 0 | Baumann Kreuziger L, Feng M, Bartosic A, et al. A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal. Blood Coagul Fibrinolysis. 2022 Jan 3. pii: 00001721-900000000-98316. doi: 10.1097/MBC.0000000000001122. | |
| 34967109 | 0 | Truong TK, Malik RA, Yao X, et al. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition. J Thromb Haemost. 2021 Dec 30. doi: 10.1111/jth.15631. | |
| 34963615 | 0 | Cook O, Cervi A, Laureano M, et al. Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease. Transfus Apher Sci. 2021 Dec 16:103345. doi: 10.1016/j.transci.2021.103345. | |
| 34962979 | 0 | Bonaca MP, Antman EM, Cunningham JW, et al. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):695-706. doi: 10.1093/ehjcvp/pvab089. | |
| 34958662 | 0 | Juang LJ, Hur WS, Silva LM, et al. Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA. Blood. 2021 Dec 27. pii: 483255. doi: 10.1182/blood.2021014559. | |
| 34955074 | 0 | Nochaiwong S, Ruengorn C, Awiphan R, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022 Dec;54(1):80-97. doi: 10.1080/07853890.2021.2017474. | |
| 34948552 | 0 | Lobbes H, Mainbourg S, Mai V, et al. Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies. Int J Environ Res Public Health. 2021 Dec 8;18(24). pii: ijerph182412944. doi: 10.3390/ijerph182412944. | |
| 34941394 | 0 | Silva LM, Doyle AD, Greenwell-Wild T, et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science. 2021 Dec 24;374(6575):eabl5450. doi: 10.1126/science.abl5450. Epub 2021 Dec 24. | |
| 34940092 | 0 | Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453. | |
| 34939141 | 0 | Bartoszko J, Li H, Fitzgerald J, et al. The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study. Can J Anaesth. 2022 Mar;69(3):311-322. doi: 10.1007/s12630-021-02165-1. Epub 2021 Dec 22. | |
| 34934895 | 0 | Kamin Mukaz D, Gergi M, Koh I, et al. Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study. Res Pract Thromb Haemost. 2021 Dec 7;5(8):e12632. doi: 10.1002/rth2.12632. eCollection 2021 Dec. | |
| 34921078 | 0 | Nasreen S, Calzavara AJ, Sundaram ME, et al. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open. 2021 Dec 17;11(12):e052019. doi: 10.1136/bmjopen-2021-052019. | |
| 34920389 | 0 | Angchaisuksiri P, Goto S, Farjat AE, et al. Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72]. Thromb Res. 2021 Dec 15;209:105. doi: 10.1016/j.thromres.2021.11.022. | |
| 34908543 | 0 | Blaine KP, Dudaryk R. Pro-Con Debate: Viscoelastic Hemostatic Assays Should Replace Fixed Ratio Massive Transfusion Protocols in Trauma. Anesth Analg. 2022 Jan 1;134(1):21-31. doi: 10.1213/ANE.0000000000005709. | |
| 34905618 | 0 | Hur WS, Paul DS, Bouck EG, et al. Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with a Fga truncation mutation. Blood. 2021 Dec 14. pii: 483059. doi: 10.1182/blood.2021012537. | |
| 34904857 | 0 | Stals MAM, Takada T, Kraaijpoel N, et al. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis. Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-2625. | |
| 34897975 | 0 | Collins A, Memtsa M, Kirk E, et al. The risk of Venous ThromboEmbolism (VTE) in Early Pregnancy Loss: Review of the Literature and Current Guidelines and the Need for Guidance Communication from the SSC on Women's Health Issues for Thrombosis and Haemostasis. J Thromb Haemost. 2021 Dec 12. doi: 10.1111/jth.15621. | |
| 34889418 | 0 | Skeith L. Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):559-569. doi: 10.1182/hematology.2021000291. | |
| 34884884 | 0 | Jourdi G, Lordkipanidze M, Philippe A, et al. Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases. Int J Mol Sci. 2021 Dec 3;22(23). pii: ijms222313079. doi: 10.3390/ijms222313079. | |
| 34878676 | 0 | Olasupo OO, Haddix C, Nakar C, et al. Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders. Eur J Haematol. 2021 Dec 8. doi: 10.1111/ejh.13731. | |
| 34877446 | 0 | Maraveyas A, Beyer-Westendorf J, Lee AY, et al. Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomes. Res Pract Thromb Haemost. 2021 Nov 30;5(8):e12604. doi: 10.1002/rth2.12604. eCollection 2021 Dec. | |
| 34863582 | 0 | Bounameaux H, Haas S, Farjat AE, et al. Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]. Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545-4. doi: 10.1016/j.thromres.2021.11.023. | |
| 34861200 | 0 | Edupuganti S, Li M, Wu Z, et al. Factors associated with inferior vena cava filter placement and retrieval for patients with cancer-associated thrombosis. Am J Med. 2021 Nov 30. pii: S0002-9343(21)00791-9. doi: 10.1016/j.amjmed.2021.11.006. | |
| 34852380 | 0 | Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263. | |
| 34847829 | 0 | Tafazoli A, Anil Kumar S, Othman M. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications. Platelets. 2021 Nov 30:1-6. doi: 10.1080/09537104.2021.1961718. | |
| 34845714 | 0 | Delluc A, Wang TF. How to treat incidental pulmonary embolism in cancer patients? Recent advances. Kardiol Pol. 2021 Nov 30. pii: VM/OJS/J/87173. doi: 10.33963/KP.a2021.0164. | |
| 34843861 | 0 | Wiercioch W, Nieuwlaat R, Zhang Y, et al. New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol. 2021 Nov 26. pii: S0895-4356(21)00389-9. doi: 10.1016/j.jclinepi.2021.11.031. | |
| 34826190 | 0 | Wendelboe AM, Langenfeld H, Ageno W, et al. Current practices of standardized risk assessment for venous thromboembolism: results from a global survey from the World Thrombosis Day steering committee. J Thromb Haemost. 2021 Nov 26. doi: 10.1111/jth.15608. | |
| 34822215 | 0 | Forgo G, Micieli E, Ageno W, et al. An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: systematic review and meta-analysis. J Thromb Haemost. 2021 Nov 25. doi: 10.1111/jth.15607. | |
| 34807722 | 0 | Le Gal G, Kovacs MJ, Bertoletti L, et al. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981. | |
| 34798446 | 0 | Lee A, Oley F Jr, Lo M, et al. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Thromb Res. 2021 Oct 29;208:148-155. doi: 10.1016/j.thromres.2021.10.023. | |
| 34795036 | 0 | Caiano L, Sharkey R, Rodger MA, et al. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism. Results from the REVERSE study. Eur Respir J. 2021 Nov 18. pii: 13993003.01801-2021. doi: 10.1183/13993003.01801-2021. | |
| 34788517 | 0 | Zarychanski R, Lawler PR, Goligher E. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply. N Engl J Med. 2021 Nov 18;385(21):2014. doi: 10.1056/NEJMc2115560. | |
| 34786471 | 0 | Sardo LA, Bayadinova JA, Jenkins S, et al. The significance of VTE in cancer: Introduction of the 'Spot the CLOT' series. Can Oncol Nurs J. 2021 Nov 1;31(4):500-503. eCollection 2021 Fall. | |
| 34780683 | 0 | Weitz JI, Strony J, Ageno W, et al. Milvexian for the Prevention of Venous Thromboembolism. N Engl J Med. 2021 Nov 15. doi: 10.1056/NEJMoa2113194. | |
| 34774202 | 0 | Klok FA, Pai M, Huisman MV, et al. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol. 2021 Nov 11. pii: S2352-3026(21)00306-9. doi: 10.1016/S2352-3026(21)00306-9. | |
| 34753191 | 0 | Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728. | |
| 34747320 | 0 | Pavenski K, Huang SS, Patriquin CJ. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2021 Nov 8. doi: 10.1080/17474086.2021.2003703. | |
| 34742140 | 0 | Nayak AL, Zahrai A, Mallick R, et al. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial. Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018. | |
| 34739003 | 0 | Esposito EC, Kufera JA, Wolff TW, et al. Factors associated with stroke formation in blunt cerebrovascular injury: An EAST multicenter study. J Trauma Acute Care Surg. 2022 Feb 1;92(2):347-354. doi: 10.1097/TA.0000000000003455. | |
| 34731547 | 0 | Weitz JI, Raskob GE, Yi BA. Abelacimab for Prevention of Venous Thromboembolism. Reply. N Engl J Med. 2021 Nov 4;385(19):1822-1823. doi: 10.1056/NEJMc2114895. | |
| 34730839 | 0 | Puhm F, Flamand L, Boilard E. Platelet extracellular vesicles in COVID-19: Potential markers and makers. J Leukoc Biol. 2021 Nov 3. doi: 10.1002/JLB.3MIR0221-100R. | |
| 34729724 | 0 | Agbani EO, Schneider P, McDonald B, et al. Activated Platelets Harbour SARS-CoV-2 During Severe COVID-19. Thromb Haemost. 2021 Nov 2. doi: 10.1055/a-1683-8455. | |
| 34729195 | 0 | Porres-Aguilar M, Auron M, de Leon MCG. Klippel-Trenaunay and pregnancy. Oxf Med Case Reports. 2021 Oct 26;2021(10):omab096. doi: 10.1093/omcr/omab096. eCollection 2021 Oct. | |
| 34727173 | 0 | Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis. Blood Adv. 2021 Nov 2. pii: 477753. doi: 10.1182/bloodadvances.2021005945. | |
| 34724403 | 0 | Chan NC, Weitz JI. In pregnant women with suspected VTE and low/intermediate or unlikely pretest probability, D-dimer rules out VTE at 3 mo. Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160-130. | |
| 34715510 | 0 | Li A, Brandt W, Brown C, et al. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis. Thromb Res. 2021 Oct 24;208:58-65. doi: 10.1016/j.thromres.2021.10.012. | |
| 34714962 | 0 | Cohen O, Ageno W, Farjat AE, et al. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE. J Thromb Haemost. 2021 Oct 29. doi: 10.1111/jth.15574. | |
| 34693641 | 0 | Greinacher A, Langer F, Makris M, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources. J Thromb Haemost. 2021 Oct 25. doi: 10.1111/jth.15572. | |
| 34677828 | 0 | McGinnis JM, Helpman L, Gundayao M, et al. Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project. J Surg Oncol. 2021 Oct 22. doi: 10.1002/jso.26728. | |
| 34671518 | 0 | A J, Malviya A, Thomas J, et al. Rationale, Design, and Implications of Bifurcation Coronary Stenting: Insight from the Indian Bifurcation Stenting (IBIS) Registry. Cureus. 2021 Sep 16;13(9):e18027. doi: 10.7759/cureus.18027. eCollection 2021 Sep. | |
| 34671466 | 0 | Akbari A, Kunkel E, Bota SE, et al. Proteinuria and venous thromboembolism in pregnancy: a population-based cohort study. Clin Kidney J. 2021 Jan 11;14(9):2101-2107. doi: 10.1093/ckj/sfaa278. eCollection 2021 Sep. | |
| 34668299 | 0 | Wang TF. Survival in patients with cancer-associated thrombosis in relation to anticoagulants: Re-vitalization of warfarin? J Thromb Haemost. 2021 Nov;19(11):2677-2679. doi: 10.1111/jth.15527. | |
| 34663971 | 0 | Kelton JG, Arnold DM, Nazy I. Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nat Rev Immunol. 2021 Dec;21(12):753-755. doi: 10.1038/s41577-021-00642-8. | |
| 34662892 | 0 | Carney BJ, Wang TF, Ren S, et al. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multi-center cohort study. Blood Adv. 2021 Oct 18. pii: 477385. doi: 10.1182/bloodadvances.2021005966. | |
| 34662890 | 0 | Woller SC, Stevens SM, Kaplan D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv. 2021 Oct 18. pii: 477384. doi: 10.1182/bloodadvances.2021005808. | |
| 34662498 | 0 | Mulder FI, Bosch FTM, Carrier M, et al. Growth differentiation factor-15 for prediction of bleeding in cancer patients. J Thromb Haemost. 2021 Oct 18. doi: 10.1111/jth.15559. | |
| 34661341 | 0 | Lavin M, Sanchez Luceros A, Kouides P, et al. Examining international practices in the management of pregnant women with von Willebrand disease. J Thromb Haemost. 2021 Oct 18. doi: 10.1111/jth.15561. | |
| 34649864 | 0 | Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. | |
| 34645539 | 0 | Zhou LW, Yu AYX, Hall W, et al. Validity of ICD 10 Codes for Cerebral Venous Thrombosis Depends on Clinical Context. Can J Neurol Sci. 2021 Oct 14:1-10. doi: 10.1017/cjn.2021.235. | |
| 34638997 | 0 | Moore SF, Agbani EO, Wersall A, et al. Opposing Roles of GSK3alpha and GSK3beta Phosphorylation in Platelet Function and Thrombosis. Int J Mol Sci. 2021 Sep 30;22(19). pii: ijms221910656. doi: 10.3390/ijms221910656. | |
| 34636806 | 0 | Tran A, Fernando SM, Rochwerg B, et al. Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis. Crit Care Med. 2021 Oct 12. pii: 00003246-900000000-95047. doi: 10.1097/CCM.0000000000005382. | |
| 34629257 | 0 | Caiano LM, Costanzo S, Panzera T, et al. Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism. Nutr Metab Cardiovasc Dis. 2021 Jul 30. pii: S0939-4753(21)00339-2. doi: 10.1016/j.numecd.2021.07.018. | |
| 34625202 | 0 | Violette PD. When to Start Pharmacologic Thromboprophylaxis. J Am Coll Surg. 2021 Nov;233(5):631-632. doi: 10.1016/j.jamcollsurg.2021.07.682. | |
| 34617959 | 0 | Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. 2021 Oct 7. pii: 2785004. doi: 10.1001/jamainternmed.2021.6203. | |
| 34613576 | 0 | Kwan V, Kaplovitch E, Selby R, et al. Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism. J Thromb Thrombolysis. 2021 Oct 6. pii: 10.1007/s11239-021-02578-1. doi: 10.1007/s11239-021-02578-1. | |
| 34607343 | 0 | Zhang Y, Begum HA, Grewal H, et al. Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review. Blood Adv. 2021 Oct 4. pii: 477147. doi: 10.1182/bloodadvances.2020003576. | |
| 34604803 | 0 | Davis MK, Lim H, Lee AYY. Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation. JACC CardioOncol. 2021 Sep 21;3(3):425-427. doi: 10.1016/j.jaccao.2021.07.003. eCollection 2021 Sep. | |
| 34604695 | 0 | Lee S, Shenoy A, Shi D, et al. Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review. TH Open. 2021 Sep 30;5(3):e461-e469. doi: 10.1055/s-0041-1736310. eCollection 2021 Jul. | |
| 34600964 | 0 | Eikelboom J, Floege J, Thadhani R, et al. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int. 2021 Sep 30. pii: S0085-2538(21)00870-X. doi: 10.1016/j.kint.2021.08.028. | |
| 34587197 | 0 | Holbrook A, Wang M, Swinton M, et al. Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers. PLoS One. 2021 Sep 29;16(9):e0257798. doi: 10.1371/journal.pone.0257798. eCollection 2021. | |
| 34581763 | 0 | Sanchez van Kammen M, Aguiar de Sousa D, Poli S, et al. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021 Sep 28. pii: 2784622. doi: 10.1001/jamaneurol.2021.3619. | |
| 34572833 | 0 | Wang TF, Khorana AA, Carrier M. Thrombotic Complications Associated with Immune Checkpoint Inhibitors. Cancers (Basel). 2021 Sep 14;13(18). pii: cancers13184606. doi: 10.3390/cancers13184606. | |
| 34571100 | 0 | Aguilar-Piedras MF, Porres-Aguilar M, Mukherjee D, et al. High Flow Nasal Cannula Oxygenation Successfully Used as Bridge Therapy for Systemic Thrombolysis in COVID-19 Associated Intermediate-high Risk Pulmonary Embolism. Curr Probl Cardiol. 2021 Sep 24:101000. doi: 10.1016/j.cpcardiol.2021.101000. | |
| 34564938 | 0 | Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537. | |
| 34558172 | 0 | Carlin S, Eikelboom JW. Direct oral anticoagulant dose selection: Challenging cases. J Thromb Haemost. 2021 Nov;19(11):2680-2686. doi: 10.1111/jth.15536. Epub 2021 Sep 28. | |
| 34556452 | 0 | Violette PD, Cartwright R, Devereaux PJ, et al. ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery. Eur Urol Focus. 2021 Sep 21. pii: S2405-4569(21)00225-X. doi: 10.1016/j.euf.2021.08.010. | |
| 34556430 | 0 | Shiff B, Breau RH, Mallick R, et al. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. Urol Oncol. 2021 Dec;39(12):836.e19-836.e27. doi: 10.1016/j.urolonc.2021.08.016. Epub 2021 Oct 20. | |
| 34555698 | 0 | Ray JG, Warkentin TE, Park AL. Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group. Thromb Res. 2021 Sep 17;207:62-65. doi: 10.1016/j.thromres.2021.09.008. | |
| 34547773 | 0 | Jiang D, Lim W, Crowther M, et al. A systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations. Blood Adv. 2021 Oct 26;5(20):3931-3936. doi: 10.1182/bloodadvances.2021005205. | |
| 34535301 | 0 | Grewal K, Atzema CL, Sutradhar R, et al. Venous Thromboembolism in Patients Discharged From the Emergency Department With Ankle Fractures: A Population-Based Cohort Study. Ann Emerg Med. 2021 Sep 14. pii: S0196-0644(21)00517-5. doi: 10.1016/j.annemergmed.2021.06.017. | |
| 34535289 | 0 | Pai M. Acquired Hemophilia A. Hematol Oncol Clin North Am. 2021 Dec;35(6):1131-1142. doi: 10.1016/j.hoc.2021.07.007. Epub 2021 Sep 15. | |
| 34535037 | 0 | Mahe I, Agnelli G, Ay C, et al. Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study. Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896. | |
| 34532632 | 0 | Page D, Zhu N, Sawler D, et al. Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count. Res Pract Thromb Haemost. 2021 Sep 14;5(6):e12596. doi: 10.1002/rth2.12596. eCollection 2021 Aug. | |
| 34521104 | 0 | Nieuwlaat R, Wiercioch W, Brozek JL, et al. How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Adv. 2021 Sep 14. pii: S2473-9529(21)00555-3. doi: 10.1182/bloodadvances.2020003577. | |
| 34518263 | 0 | Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557. | |
| 34517273 | 0 | Diwakar J, Samaddar A, Konar SK, et al. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. J Mycol Med. 2021 Dec;31(4):101203. doi: 10.1016/j.mycmed.2021.101203. Epub 2021 Sep 4. | |
| 34516270 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14. | |
| 34510039 | 0 | Plecash AR, Byrne D, Flexman A, et al. Stroke in Patients with Left Ventricular Assist Devices. Cerebrovasc Dis. 2021 Sep 10:1-11. doi: 10.1159/000517454. | |
| 34506346 | 0 | Chiocchi M, Pugliese L, D'Errico F, et al. Transcatheter aortic valve implantation in patients with unruptured aortic root pseudoaneurysm: an observational study. J Cardiovasc Med (Hagerstown). 2022 Mar 1;23(3):185-190. doi: 10.2459/JCM.0000000000001253. | |
| 34496121 | 0 | Robert-Ebadi H, Elias A, Sanchez O, et al. Assessing the clinical probability of pulmonary embolism during pregnancy: The Pregnancy-Adapted Geneva (PAG) score. J Thromb Haemost. 2021 Sep 8. doi: 10.1111/jth.15521. | |
| 34487616 | 0 | Weitz JI, Farjat AE, Ageno W, et al. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. J Thromb Haemost. 2021 Sep 6. doi: 10.1111/jth.15520. | |
| 34485812 | 0 | Falanga A, Gal GL, Carrier M, et al. Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives. TH Open. 2021 Aug 31;5(3):e376-e386. doi: 10.1055/s-0041-1736037. eCollection 2021 Jul. | |
| 34479364 | 0 | Schmidt RA, Lee AY. How I treat and prevent venous thrombotic complications in patients with lymphoma. Blood. 2021 Sep 3. pii: S0006-4971(21)01557-3. doi: 10.1182/blood.2019003689. | |
| 34474482 | 0 | Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021 Oct 26;5(20):3951-3959. doi: 10.1182/bloodadvances.2021005493. | |
| 34474480 | 0 | Avila L, Amiri N, De R, et al. Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children. Blood Adv. 2021 Oct 12;5(19):3737-3747. doi: 10.1182/bloodadvances.2021004727. | |
| 34474475 | 0 | Malik RA, Zhou J, Fredenburgh JC, et al. Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein. Blood Adv. 2021 Sep 28;5(18):3540-3551. doi: 10.1182/bloodadvances.2021004567. | |
| 34470058 | 0 | Schulman S. Recent Advances in Thrombosis and Hemostasis-Part VII. Semin Thromb Hemost. 2021 Sep;47(6):621-622. doi: 10.1055/s-0041-1725945. Epub 2021 Sep 1. | |
| 34464871 | 0 | Benmassaoud A, Rodger M. Challenging anticoagulation cases: Acute extensive portal vein thrombosis in a patient without cirrhosis - Evidence-based management of a rare clinical entity. Thromb Res. 2021 Oct;206:133-136. doi: 10.1016/j.thromres.2021.08.013. Epub 2021 Aug 18. | |
| 34456159 | 0 | LeBlanc R, Bergstrom DJ, Cote J, et al. Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium. Clin Lymphoma Myeloma Leuk. 2021 Aug 1. pii: S2152-2650(21)00311-6. doi: 10.1016/j.clml.2021.07.028. | |
| 34455706 | 0 | Bosch FTM, Mulder FI, Huisman MV, et al. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. J Thromb Haemost. 2021 Aug 29. doi: 10.1111/jth.15516. | |
| 34455654 | 0 | Abdulrehman J, Ziemba YC, Hsu P, et al. Diagnosis of von Willebrand disease: An assessment of the quality of testing in North American laboratories. Haemophilia. 2021 Nov;27(6):e713-e720. doi: 10.1111/hae.14397. Epub 2021 Aug 28. | |
| 34453675 | 0 | Goldhaber SZ, Ageno W, Casella IB, et al. Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Aug 28. pii: 10.1007/s11239-021-02463-x. doi: 10.1007/s11239-021-02463-x. | |
| 34438079 | 0 | McAlpine K, Breau RH, Werlang P, et al. Timing of Perioperative Pharmacologic Thromboprophylaxis Initiation and its Effect on Venous Thromboembolism and Bleeding Outcomes: A Systematic Review and Meta-Analysis. J Am Coll Surg. 2021 Nov;233(5):619-631.e14. doi: 10.1016/j.jamcollsurg.2021.07.687. Epub 2021 Aug 24. | |
| 34435431 | 0 | Vasanthamohan L, Boonyawat K, Chai-Adisaksopha C, et al. Reduced-dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta-analysis-Response to Commentary. J Thromb Haemost. 2021 Sep;19(9):2359-2360. doi: 10.1111/jth.15427. | |
| 34427894 | 0 | Hendin A, Castellucci L, Rosenberg H. Just the facts: how to assess for cerebral venous thrombosis. CJEM. 2021 Aug 24. pii: 10.1007/s43678-021-00194-9. doi: 10.1007/s43678-021-00194-9. | |
| 34419428 | 0 | Fernando SM, Tran A, Cheng W, et al. Venous Thromboembolism Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis. Chest. 2021 Aug 19. pii: S0012-3692(21)03688-6. doi: 10.1016/j.chest.2021.08.050. | |
| 34418289 | 0 | Avila L, Amiri N, De R, et al. Compression garments for the management of pediatric post-thrombotic syndrome: A prospective longitudinal study. J Thromb Haemost. 2021 Dec;19(12):3073-3079. doi: 10.1111/jth.15507. Epub 2021 Aug 30. | |
| 34415324 | 0 | Kizhakkedathu JN, Conway EM. Biomaterial and cellular implants: foreign surfaces where immunity and coagulation meet. Blood. 2022 Mar 31;139(13):1987-1998. doi: 10.1182/blood.2020007209. | |
| 34409636 | 0 | Douros A, Cui Y, Platt RW, et al. Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease. Br J Clin Pharmacol. 2021 Aug 19. doi: 10.1111/bcp.15046. | |
| 34403992 | 0 | De Maria C, Galante A, Fasoli A, et al. When and how to use direct oral anticoagulants in patients with advanced chronic liver disease? Curr Opin Pharmacol. 2021 Oct;60:111-116. doi: 10.1016/j.coph.2021.07.006. Epub 2021 Aug 14. | |
| 34403852 | 0 | Fernando SM, Mathew R, Munshi L, et al. Media portrayals of pulmonary embolism. Thromb Res. 2021 Oct;206:52-54. doi: 10.1016/j.thromres.2021.08.006. Epub 2021 Aug 11. | |
| 34401639 | 0 | Abdulrehman J, Zarabi S, Elbaz C, et al. Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals. Res Pract Thromb Haemost. 2021 Aug 7;5(5):e12535. doi: 10.1002/rth2.12535. eCollection 2021 Jul. | |
| 34399433 | 0 | Wang TF, Carrier M, Fournier K, et al. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155. | |
| 34391064 | 0 | Benipal H, Holbrook A, Paterson JM, et al. Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home. Thromb Res. 2021 Oct;206:18-28. doi: 10.1016/j.thromres.2021.07.016. Epub 2021 Aug 2. | |
| 34387202 | 0 | Tran A, Fernando SM, Carrier M, et al. Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-Analysis. Ann Surg. 2021 Aug 13. pii: 00000658-900000000-93329. doi: 10.1097/SLA.0000000000005157. | |
| 34384129 | 0 | Gabarin N, Patterson S, Pai M, et al. Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thromb Haemost. 2021 Aug 12. doi: 10.1055/a-1585-6182. | |
| 34379859 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22. | |
| 34355501 | 0 | Megy K, Downes K, Morel-Kopp MC, et al. GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis. J Thromb Haemost. 2021 Oct;19(10):2612-2617. doi: 10.1111/jth.15459. Epub 2021 Aug 5. | |
| 34353538 | 0 | Hsu C, Hutt E, Bloomfield DM, et al. Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Aug 10;78(6):625-631. doi: 10.1016/j.jacc.2021.06.010. | |
| 34351722 | 0 | Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4. | |
| 34351721 | 0 | Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. | |
| 34351057 | 0 | Othman M, Baker AT, Gupalo E, et al. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23. | |
| 34345092 | 0 | Gabara C, Solarat B, Castro P, et al. Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Med Intensiva (Engl Ed). 2021 Jul 30. pii: S0210-5691(21)00178-9. doi: 10.1016/j.medin.2021.07.004. | |
| 34342490 | 0 | Abdel-Rahman O, Wu C, Easaw J. Risk of arterial and venous thromboembolic events among patients with colorectal carcinoma: a real-world, population-based study. Future Oncol. 2021 Oct;17(30):3977-3986. doi: 10.2217/fon-2021-0252. Epub 2021 Aug 3. | |
| 34334192 | 0 | Ho LTS, McVey MJ, Kuiper GJAJM, et al. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro. Br J Anaesth. 2021 Oct;127(4):e128-e130. doi: 10.1016/j.bja.2021.06.037. Epub 2021 Jul 30. | |
| 34332213 | 0 | Cohen AT, Maraveyas A, Beyer-Westendorf J, et al. Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study. Thromb Res. 2021 Oct;206:1-4. doi: 10.1016/j.thromres.2021.06.021. Epub 2021 Jul 2. | |
| 34327829 | 0 | Roberge G. May-Thurner syndrome prevalence as a risk factor for acute deep vein thrombosis is unknown. J Thromb Haemost. 2021 Aug;19(8):2093. doi: 10.1111/jth.15398. | |
| 34327828 | 0 | van Galen KPM, d'Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Aug;19(8):1883-1887. doi: 10.1111/jth.15397. | |
| 34327827 | 0 | Roberge G, D'Astous J, Rodger M. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT): COMMENT from Roberge, et al. J Thromb Haemost. 2021 Aug;19(8):2091-2092. doi: 10.1111/jth.15369. | |
| 34327825 | 0 | Wang TF, Baumann Kreuziger L, Leader A, et al. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2021 Aug;19(8):2068-2081. doi: 10.1111/jth.15367. | |
| 34327824 | 0 | Sirotich E, Guyatt G, Gabe C, et al. Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021 Aug;19(8):2082-2088. doi: 10.1111/jth.15368. | |
| 34327823 | 0 | Lillicrap D, Morrissey JH. Evidence-based medicine in thrombosis and hemostasis: ISTH to the fore. J Thromb Haemost. 2021 Aug;19(8):1845-1846. doi: 10.1111/jth.15436. | |
| 34327817 | 0 | El-Khoury H, Saifi O, Haddad S, et al. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 Nov;68(11):e29210. doi: 10.1002/pbc.29210. Epub 2021 Jul 29. | |
| 34326045 | 0 | Pandor A, Tonkins M, Goodacre S, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672. | |
| 34318606 | 0 | Candeloro M, van Es N, Cantor N, et al. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021 Oct;19(10):2618-2628. doi: 10.1111/jth.15476. Epub 2021 Aug 8. | |
| 34314574 | 0 | Ageno W, Lopes RD, Goldin M, et al. Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older. J Thromb Haemost. 2021 Nov;19(11):2772-2780. doi: 10.1111/jth.15477. Epub 2021 Aug 17. | |
| 34311009 | 0 | Montalto C, Kotronias RA, Marin F, et al. Pre-procedural ATI score (age-thrombus burden-index of microcirculatory resistance) predicts long-term clinical outcomes in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiol. 2021 Sep 15;339:1-6. doi: 10.1016/j.ijcard.2021.07.040. Epub 2021 Jul 23. | |
| 34297496 | 0 | Verhamme P, Yi BA, Segers A, et al. Abelacimab for Prevention of Venous Thromboembolism. N Engl J Med. 2021 Aug 12;385(7):609-617. doi: 10.1056/NEJMoa2105872. Epub 2021 Jul 19. | |
| 34296056 | 0 | Krishnaswamy S, Ageno W, Arabi Y, et al. Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress. Res Pract Thromb Haemost. 2021 Jul 16;5(5):e12532. doi: 10.1002/rth2.12532. eCollection 2021 Jul. | |
| 34289981 | 0 | Weatherald J, Philipenko B, Montani D, et al. Ventilatory efficiency in pulmonary vascular diseases. Eur Respir Rev. 2021 Jul 20;30(161). pii: 30/161/200214. doi: 10.1183/16000617.0214-2020. Print 2021 Sep 30. | |
| 34288447 | 0 | Batty P, Lillicrap D. Gene therapy for hemophilia: Current status and laboratory consequences. Int J Lab Hematol. 2021 Jul;43 Suppl 1:117-123. doi: 10.1111/ijlh.13605. | |
| 34284102 | 0 | Morgano GP, Wiercioch W, Anderson DR, et al. A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. J Clin Epidemiol. 2021 Jul 18;140:69-78. doi: 10.1016/j.jclinepi.2021.07.010. | |
| 34278193 | 0 | Bavalia R, Bistervels IM, Boersma WG, et al. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12566. doi: 10.1002/rth2.12566. eCollection 2021 Jul. | |
| 34278190 | 0 | Asady E, Ghanima W, Jelsness-Jorgensen LP, et al. Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12556. doi: 10.1002/rth2.12556. eCollection 2021 Jul. | |
| 34278187 | 0 | Relke N, Chornenki NLJ, Sholzberg M. Tranexamic acid evidence and controversies: An illustrated review. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12546. doi: 10.1002/rth2.12546. eCollection 2021 Jul. | |
| 34274156 | 0 | Porres-Aguilar M, Perez-Nieto OR, Zamarron-Lopez EI, et al. Thromboprophylaxis strategies for COVID-19 patients. Arch Med Res. 2022 Jan;53(1):109-110. doi: 10.1016/j.arcmed.2021.06.011. Epub 2021 Jul 5. | |
| 34273241 | 0 | Xu Y, Siegal DM. Anticoagulant-associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants. J Thromb Haemost. 2021 Oct;19(10):2383-2393. doi: 10.1111/jth.15466. Epub 2021 Jul 29. | |
| 34272818 | 0 | Swan D, Carrier M, Lisman T, et al. Heparin - Messias or Verschlimmbesserung? J Thromb Haemost. 2021 Oct;19(10):2373-2382. doi: 10.1111/jth.15464. Epub 2021 Jul 29. | |
| 34270093 | 0 | You DZ, Krzyzaniak H, Viner B, et al. Thromboembolic complications after surgical fixation of bone metastases: A systematic review. J Surg Oncol. 2021 Dec;124(7):1182-1191. doi: 10.1002/jso.26601. Epub 2021 Jul 16. | |
| 34267078 | 0 | Makedonov I, Galanaud JP, Kahn SR. Significance and management of isolated distal deep vein thrombosis. Curr Opin Hematol. 2021 Sep 1;28(5):331-338. doi: 10.1097/MOH.0000000000000670. | |
| 34264267 | 0 | Houghton DE, Billett HH, Gaddh M, et al. Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis. Blood Adv. 2021 Jul 27;5(14):2807-2812. doi: 10.1182/bloodadvances.2021004698. | |
| 34263098 | 0 | Barco S, Valerio L, Gallo A, et al. Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Res Pract Thromb Haemost. 2021 Jun 15;5(5):e12520. doi: 10.1002/rth2.12520. eCollection 2021 Jul. | |
| 34260818 | 0 | Jevtic SD, Malinowski AK, Othman M, et al. Physician experiences in management of COVID-19-associated coagulopathy in pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis. J Thromb Haemost. 2021 Oct;19(10):2539-2545. doi: 10.1111/jth.15462. Epub 2021 Aug 5. | |
| 34255928 | 0 | Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1. | |
| 34255420 | 0 | Wik HS, Kahn SR, Eriksson H, et al. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost. 2021 Oct;19(10):2495-2503. doi: 10.1111/jth.15449. Epub 2021 Jul 28. | |
| 34253554 | 0 | Jevtic SD, Morris AM, Warkentin TE, et al. Thrombocytopenie induite par l'heparine. CMAJ. 2021 Jul 12;193(27):E1067-E1068. doi: 10.1503/cmaj.210637-f. | |
| 34249785 | 0 | Kumar S, Bansal YS, Mehta N, et al. Blunt-chest-trauma-induced acute myocardial infarction. Autops Case Rep. 2021 May 25;11:e2021263. doi: 10.4322/acr.2021.263. eCollection 2021. | |
| 34249330 | 0 | Lu M, Blaine KP, Cullinane A, et al. Pulmonary arterial hypertension patients display normal kinetics of clot formation using thrombelastography. Pulm Circ. 2021 Jun 24;11(3):20458940211022204. doi: 10.1177/20458940211022204. eCollection 2021 Jul-Sep. | |
| 34246011 | 0 | Deschenes-Simard X, Richard C, Galland L, et al. Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study. Thromb Res. 2021 Sep;205:29-39. doi: 10.1016/j.thromres.2021.06.018. Epub 2021 Jun 29. | |
| 34240001 | 0 | Mansory EM, Srigunapalan S, Lazo-Langner A. Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open. 2021 Jul 6;5(3):e286-e294. doi: 10.1055/s-0041-1730967. eCollection 2021 Jul. | |
| 34235393 | 0 | Porres-Aguilar M, Mukherjee D. May-Thurner Syndrome in Pregnancy-Associated Venous Thromboembolism. TH Open. 2021 Jul 4;5(3):e251-e252. doi: 10.1055/s-0041-1731710. eCollection 2021 Jul. | |
| 34233346 | 0 | Huynh A, Kelton JG, Arnold DM, et al. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature. 2021 Aug;596(7873):565-569. doi: 10.1038/s41586-021-03744-4. Epub 2021 Jul 7. | |
| 34233107 | 0 | Patriquin CJ, Laroche V, Selby R, et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 26;385(9):857-859. doi: 10.1056/NEJMc2109465. Epub 2021 Jul 7. | |
| 34232455 | 0 | Carlin S, Geerts W, Khosravani H. The clot thickens-enhanced integration of stroke and thrombosis training. J Thromb Thrombolysis. 2021 Jul 7. pii: 10.1007/s11239-021-02502-7. doi: 10.1007/s11239-021-02502-7. | |
| 34231501 | 0 | Chung J, Stevic I, Gantioqui J, et al. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography. Blood Coagul Fibrinolysis. 2021 Jul 1;32(5):305-311. doi: 10.1097/MBC.0000000000001023. | |
| 34226274 | 0 | Sholzberg M, Arnold DM, Laupacis A. Reconnaitre, traiter et signaler les cas de thrombocytopenie immunitaire thrombotique induite par un vaccin. CMAJ. 2021 Jul 5;193(26):E1031-E1033. doi: 10.1503/cmaj.210882-f. | |
| 34221576 | 0 | Galletta K, Alafaci C, D'Alcontres FS, et al. Imaging features of perineural and perivascular spread in rapidly progressive rhino-orbital-cerebral mucormycosis: A case report and brief review of the literature. Surg Neurol Int. 2021 May 31;12:245. doi: 10.25259/SNI_275_2021. eCollection 2021. | |
| 34213527 | 0 | Sanchez van Kammen M, Heldner MR, Brodard J, et al. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA. 2021 Jul 27;326(4):332-338. doi: 10.1001/jama.2021.9889. | |
| 34176221 | 0 | Weitz JI, Peyvandi F. International Society on Thrombosis and Haemostasis: Present and future. J Thromb Haemost. 2021 Jul;19(7):1599-1601. doi: 10.1111/jth.15325. | |
| 34175749 | 0 | Knoll W, Fergusson N, Ivankovic V, et al. Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature. Thromb Res. 2021 Aug;204:114-122. doi: 10.1016/j.thromres.2021.06.010. Epub 2021 Jun 19. | |
| 34161671 | 0 | Bellesini M, Robert-Ebadi H, Combescure C, et al. D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2454-2467. doi: 10.1111/jth.15432. Epub 2021 Jul 20. | |
| 34161655 | 0 | Caiano L, Carrier M, Marshall A, et al. Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2468-2479. doi: 10.1111/jth.15435. Epub 2021 Jul 12. | |
| 34152080 | 0 | Michels A, Swystun LL, Dwyer CN, et al. Stabilin-2 deficiency increases thrombotic burden and alters the composition of venous thrombi in a mouse model. J Thromb Haemost. 2021 Oct;19(10):2440-2453. doi: 10.1111/jth.15429. Epub 2021 Jul 19. | |
| 34130496 | 0 | Cooper C, Antle O, Lowerison J, et al. Impact of Weight-Band Dosing of Tinzaparin for Venous Thromboembolism Prophylaxis on Persistent Wound Drainage in Adult Patients Undergoing Hip and Knee Arthroplasty. Ann Pharmacother. 2021 Jun 16:10600280211024294. doi: 10.1177/10600280211024294. | |
| 34129893 | 0 | Lavi A, Breau RH, Mallick R, et al. Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes From the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort. Urology. 2021 Nov;157:168-173. doi: 10.1016/j.urology.2021.05.053. Epub 2021 Jun 12. | |
| 34126147 | 0 | Jourdi G, Abdoul J, Siguret V, et al. Induced forms of alpha2-macroglobulin neutralize heparin and direct oral anticoagulant effects. Int J Biol Macromol. 2021 Aug 1;184:209-217. doi: 10.1016/j.ijbiomac.2021.06.058. Epub 2021 Jun 11. | |
| 34119655 | 0 | Vedantham S, Salter A, Lancia S, et al. Clinical Outcomes of a Pharmacomechanical Catheter-Directed Venous Thrombolysis Strategy that Included Rheolytic Thrombectomy in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2021 Sep;32(9):1296-1309.e7. doi: 10.1016/j.jvir.2021.06.001. Epub 2021 Jun 11. | |
| 34117006 | 0 | Wan T, Rahmani A, Hanakova M, et al. Reducing emergency department visits in patients with deep vein thrombosis: introducing a standardised outpatient treatment pathway. BMJ Open Qual. 2021 Jun;10(2). pii: bmjoq-2020-001123. doi: 10.1136/bmjoq-2020-001123. | |
| 34116580 | 0 | Cohen O, Caiano LM, Tufano A, et al. Cancer-Associated Splanchnic Vein Thrombosis. Semin Thromb Hemost. 2021 Jun 11. doi: 10.1055/s-0040-1722607. | |
| 34114153 | 0 | McCurdy JD, Ellen Kuenzig M, Spruin S, et al. Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge. Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064-5. doi: 10.1007/s10620-021-07064-5. | |
| 34108229 | 0 | Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205. | |
| 34107198 | 0 | Bourguignon A, Arnold DM, Warkentin TE, et al. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 19;385(8):720-728. doi: 10.1056/NEJMoa2107051. Epub 2021 Jun 9. | |
| 34105140 | 0 | Louzada ML. Thrombosis and myeloma: it is time to get the elephant out of the room. Br J Haematol. 2021 Jun;193(6):1027-1029. doi: 10.1111/bjh.17507. Epub 2021 Jun 9. | |
| 34102656 | 0 | Ting J, Yeung K, Paes B, et al. How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2021 Jun 7. pii: 00001721-900000000-98373. doi: 10.1097/MBC.0000000000001052. | |
| 34097772 | 0 | Martens KL, Amos CI, Hernandez CR, et al. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol. 2021 Sep 1;96(9):1137-1146. doi: 10.1002/ajh.26268. Epub 2021 Jun 24. | |
| 34087481 | 0 | Mai V, Tan BK, Mainbourg S, et al. Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis. Vascul Pharmacol. 2021 Aug;139:106882. doi: 10.1016/j.vph.2021.106882. Epub 2021 Jun 2. | |
| 34086880 | 0 | Lorentz CU, Tucker EI, Verbout NG, et al. The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial. Blood. 2021 Dec 2;138(22):2173-2184. doi: 10.1182/blood.2021011725. | |
| 34085509 | 0 | You D, Skeith L, Korley R, et al. Identification of hypercoagulability with thrombelastography in patients with hip fracture receiving thromboprophylaxis. Can J Surg. 2021 Jun 4;64(3):E324-E329. doi: 10.1503/cjs.021019. | |
| 34083615 | 0 | Li BX, Dai X, Xu XR, et al. In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbalpha. Sci Rep. 2021 Jun 3;11(1):11663. doi: 10.1038/s41598-021-91165-8. | |
| 34053317 | 0 | Vinacci G, Tcheumeni CN, Coskun O, et al. White thrombus as a possible feature of atypical stroke etiology: Coxiella burnetii as the primary cause of acute ischemic stroke. Interv Neuroradiol. 2022 Apr;28(2):142-144. doi: 10.1177/15910199211021716. Epub 2021 May 29. | |
| 34039677 | 0 | Porres-Aguilar M, Tapson VF, Rivera-Lebron BN, et al. Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19. J Investig Med. 2021 Aug;69(6):1153-1155. doi: 10.1136/jim-2021-001856. Epub 2021 May 26. | |
| 34034648 | 0 | Chaterji S, Lian LG, Lee TY, et al. Factors influencing primary care physicians' prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study. BMC Fam Pract. 2021 May 25;22(1):101. doi: 10.1186/s12875-021-01453-5. | |
| 34027293 | 0 | Li KX, Diendere G, Galanaud JP, et al. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review. Res Pract Thromb Haemost. 2021 May 8;5(4):e12527. doi: 10.1002/rth2.12527. eCollection 2021 May. | |
| 34027291 | 0 | Ikesaka R, Siegal D, Mallick R, et al. Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): A two-center open-label pilot randomized controlled trial. Res Pract Thromb Haemost. 2021 May 5;5(4):e12517. doi: 10.1002/rth2.12517. eCollection 2021 May. | |
| 34023735 | 0 | Goto S, Turpie AGG, Farjat AE, et al. The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. Thromb Res. 2021 Jul;203:155-162. doi: 10.1016/j.thromres.2021.05.007. Epub 2021 May 15. | |
| 34018298 | 0 | Nazy I, Sachs UJ, Arnold DM, et al. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021 Jun;19(6):1585-1588. doi: 10.1111/jth.15341. Epub 2021 May 20. | |
| 34000493 | 0 | Rahme E, Godin R, Nedjar H, et al. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Thromb Res. 2021 Jul;203:121-130. doi: 10.1016/j.thromres.2021.05.005. Epub 2021 May 11. | |
| 33992716 | 0 | Wiercioch W, Nieuwlaat R, Dahm P, et al. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 May 13;138:115-127. doi: 10.1016/j.jclinepi.2021.04.016. | |
| 33990338 | 0 | Sholzberg M, Arnold DM, Laupacis A. Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia. CMAJ. 2021 Jun 14;193(24):E913-E915. doi: 10.1503/cmaj.210882. Epub 2021 May 14. | |
| 33984481 | 0 | Nykanen AI, Selby R, McRae KM, et al. Pseudo Heparin Resistance After Pulmonary Endarterectomy: Role of Thrombus Production of Factor VIII. Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):315-323. doi: 10.1053/j.semtcvs.2021.03.042. Epub 2021 May 10. | |
| 33984268 | 0 | Khan F, Tritschler T, Kahn SR, et al. Venous thromboembolism. Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10. | |
| 33971682 | 0 | Schellong S, Ageno W, Casella IB, et al. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost. 2021 May 10. doi: 10.1055/s-0041-1729169. | |
| 33971678 | 0 | Aibar J, Schulman S. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost. 2021 Sep;47(6):709-723. doi: 10.1055/s-0041-1725057. Epub 2021 May 10. | |
| 33959927 | 0 | Niaz S, Kirwan C, Clayton N, et al. Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding. CJEM. 2021 May;23(3):325-329. doi: 10.1007/s43678-020-00054-y. Epub 2021 Jan 20. | |
| 33949182 | 0 | Raslan OM, Lazo-Langner A. Treatment of retinal vein thrombosis: what about anticoagulants? Minerva Med. 2021 May 5. pii: S0026-4806.21.07474-7. doi: 10.23736/S0026-4806.21.07474-7. | |
| 33945392 | 0 | Nada A, Hassan MA, Fakhr MA, et al. Studying the effect of stent thickness and porosity on post-stent implantation hemodynamics. J Med Eng Technol. 2021 Jul;45(5):408-416. doi: 10.1080/03091902.2021.1912204. Epub 2021 May 4. | |
| 33940219 | 0 | Porres-Aguilar M, Lazo-Langner A, Panduro A, et al. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. Ann Hepatol. 2021 Jul-Aug;23:100356. doi: 10.1016/j.aohep.2021.100356. Epub 2021 Apr 30. | |
| 33930198 | 0 | Avila L, Amiri N, Pullenayegum E, et al. Diagnostic value of D-dimers for limb deep vein thrombosis in children: A prospective study. Am J Hematol. 2021 Aug 1;96(8):954-960. doi: 10.1002/ajh.26212. Epub 2021 May 15. | |
| 33906965 | 0 | Jevtic SD, Morris AM, Warkentin TE, et al. Heparin-induced thrombocytopenia. CMAJ. 2021 May 17;193(20):E736. doi: 10.1503/cmaj.210637. Epub 2021 Apr 27. | |
| 33900385 | 0 | Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism. Blood Adv. 2021 Apr 27;5(8):2237-2244. doi: 10.1182/bloodadvances.2020002398. | |
| 33881229 | 0 | Gendron N, Dragon-Durey MA, Chocron R, et al. Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 Nov;73(11):1976-1985. doi: 10.1002/art.41777. Epub 2021 Sep 22. | |
| 33872825 | 0 | Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15. | |
| 33872452 | 0 | Tardy-Poncet B, de Maistre E, Pouplard C, et al. Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation. J Thromb Haemost. 2021 Aug;19(8):1959-1972. doi: 10.1111/jth.15344. Epub 2021 Jun 14. | |
| 33866561 | 0 | Krzyzaniak H, You DZ, Mosca G, et al. Venous thromboembolism rates in patients with bone and soft tissue sarcoma of the extremities following surgical resection: A systematic review. J Surg Oncol. 2021 Sep;124(3):390-399. doi: 10.1002/jso.26499. Epub 2021 Apr 18. | |
| 33863794 | 0 | Holbrook A, Benipal H, Paterson JM, et al. Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study. CMAJ Open. 2021 Apr 16;9(2):E364-E375. doi: 10.9778/cmajo.20200138. Print 2021 Apr-Jun. | |
| 33862470 | 0 | Baumann Kreuziger L, Gaddh M, Onadeko O, et al. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study. Thromb Res. 2021 Jun;202:155-161. doi: 10.1016/j.thromres.2021.03.021. Epub 2021 Apr 6. | |
| 33860518 | 0 | Fredenburgh JC, Weitz JI. Factor XI as a Target for New Anticoagulants. Hamostaseologie. 2021 Apr;41(2):104-110. doi: 10.1055/a-1384-3715. Epub 2021 Apr 15. | |
| 33857789 | 0 | Ladha D, Mallick R, Wang TF, et al. Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial. Thromb Res. 2021 Jun;202:151-154. doi: 10.1016/j.thromres.2021.03.013. Epub 2021 Mar 21. | |
| 33856269 | 0 | Clifford CR, Jung RG, Hibbert B, et al. Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison. Platelets. 2021 Apr 15:1-6. doi: 10.1080/09537104.2021.1904134. | |
| 33848369 | 0 | Pelland-Marcotte MC, Kulkarni K, Athale UH, et al. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2021 Jul 1;96(7):796-804. doi: 10.1002/ajh.26193. Epub 2021 May 10. | |
| 33836493 | 0 | Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism? Thromb Res. 2021 Jun;202:134-138. doi: 10.1016/j.thromres.2021.03.012. Epub 2021 Mar 25. | |
| 33836492 | 0 | Douros A, Filliter C, Azoulay L, et al. Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism. Thromb Res. 2021 Jun;202:128-133. doi: 10.1016/j.thromres.2021.03.026. Epub 2021 Mar 29. | |
| 33835334 | 0 | Porres-Aguilar M, Hoeper MM, Rivera-Lebron BN, et al. Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis. 2021 Oct;52(3):791-796. doi: 10.1007/s11239-021-02445-z. Epub 2021 Apr 9. | |
| 33834620 | 0 | Xu K, de Wit K, Geersing GJ, et al. A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer. J Thromb Haemost. 2021 Jul;19(7):1752-1758. doi: 10.1111/jth.15337. Epub 2021 May 4. | |
| 33834605 | 0 | Allain Wouterlood M, Malhame I, Levesque K, et al. Pregnancy-associated pelvic vein thrombosis: Insights from a multicenter case series. J Thromb Haemost. 2021 Aug;19(8):1926-1931. doi: 10.1111/jth.15333. Epub 2021 May 5. | |
| 33832217 | 0 | Caiano LM, Riva N, Carrier M, et al. Treatment of portal vein thrombosis: an updated narrative review. Minerva Med. 2021 Apr 9. pii: S0026-4806.21.07526-1. doi: 10.23736/S0026-4806.21.07526-1. | |
| 33831962 | 0 | Mai V, Mainbourg S, Tan BK, et al. Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis. Thromb Haemost. 2021 Dec;121(12):1670-1673. doi: 10.1055/a-1477-4027. Epub 2021 Apr 8. | |
| 33830628 | 0 | Kapopara PR, Safikhan NS, Huang JL, et al. CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models. J Thromb Haemost. 2021 Aug;19(8):1932-1947. doi: 10.1111/jth.15338. Epub 2021 May 7. | |
| 33827287 | 0 | Ray JG, Vermeulen MJ, Schull MJ, et al. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211008986. doi: 10.1177/10760296211008986. | |
| 33826233 | 0 | Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021 Jun;19(6):1546-1557. doi: 10.1111/jth.15327. Epub 2021 May 1. | |
| 33823560 | 0 | Goldin M, Giannis D, Diab W, et al. Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Apr 6. doi: 10.1055/a-1475-2351. | |
| 33818240 | 0 | Agbani EO, Poole AW. Aquaporins in platelet function. Platelets. 2021 Oct 3;32(7):895-901. doi: 10.1080/09537104.2021.1904133. Epub 2021 Apr 4. | |
| 33812338 | 0 | Becattini C, Di Nisio M, Franco L, et al. Treatment of venous thromboembolism in cancer patients: The dark side of the moon. Cancer Treat Rev. 2021 May;96:102190. doi: 10.1016/j.ctrv.2021.102190. Epub 2021 Mar 23. | |
| 33806140 | 0 | Tardy-Poncet B, Montmartin A, Piot M, et al. Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 2021 Mar 25;9(4). pii: biomedicines9040332. doi: 10.3390/biomedicines9040332. | |
| 33798804 | 0 | Kawata E, Siew DA, Payne JG, et al. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes. Thromb Res. 2021 Jun;202:90-95. doi: 10.1016/j.thromres.2021.03.018. Epub 2021 Mar 21. | |
| 33794913 | 0 | Roberge G, Wells PS. Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report. Thromb J. 2021 Apr 1;19(1):23. doi: 10.1186/s12959-021-00277-8. | |
| 33792176 | 0 | van Ommen CH, Albisetti M, Bhatt M, et al. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost. 2021 Apr;19(4):1123-1129. doi: 10.1111/jth.15260. | |
| 33792175 | 0 | Khorsand N, Beyer-Westendorf J, Sarode R, et al. Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021 Apr;19(4):1112-1115. doi: 10.1111/jth.15222. | |
| 33781626 | 0 | Li Z, Chen C, Liu P, et al. Comparison of oncological outcomes and major complications between laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IB1 cervical cancer with a tumour size less than 2 cm. Eur J Surg Oncol. 2021 Aug;47(8):2125-2133. doi: 10.1016/j.ejso.2021.03.238. Epub 2021 Mar 22. | |
| 33779472 | 0 | D'Astous J, Liederman Z, Douketis JD. Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery. Postgrad Med. 2021 Aug;133(sup1):20-26. doi: 10.1080/00325481.2021.1891751. Epub 2021 Mar 28. | |
| 33769581 | 0 | Wang M, Zeraatkar D, Obeda M, et al. Drug-drug interactions with warfarin: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021 Nov;87(11):4051-4100. doi: 10.1111/bcp.14833. Epub 2021 May 16. | |
| 33753445 | 0 | Humphries B, Leon-Garcia M, Bates S, et al. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol. BMJ Open. 2021 Mar 22;11(3):e046021. doi: 10.1136/bmjopen-2020-046021. | |
| 33742436 | 0 | Douxfils J, Adcock DM, Bates SM, et al. 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost. 2021 Aug;121(8):1008-1020. doi: 10.1055/a-1450-8178. Epub 2021 Mar 19. | |
| 33741176 | 0 | Talasaz AH, Sadeghipour P, Kakavand H, et al. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Apr 20;77(15):1903-1921. doi: 10.1016/j.jacc.2021.02.035. Epub 2021 Mar 16. | |
| 33736865 | 0 | Griffiths CD, Simunovic M, Gafni A, et al. Posthospital discharge venous thromboembolism prophylaxis among colorectal and hepatobiliary surgeons: A practice survey. Surgery. 2021 Jul;170(1):173-179. doi: 10.1016/j.surg.2021.02.015. Epub 2021 Mar 15. | |
| 33733032 | 0 | Ageno W, Farjat A, Haas S, et al. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb. | |
| 33733030 | 0 | Boonyawat K, Lensing AWA, Prins MH, et al. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin. Res Pract Thromb Haemost. 2021 Feb 17;5(2):308-313. doi: 10.1002/rth2.12474. eCollection 2021 Feb. | |
| 33733029 | 0 | Tran A, Redley M, de Wit K. The psychological impact of pulmonary embolism: A mixed-methods study. Res Pract Thromb Haemost. 2021 Jan 28;5(2):301-307. doi: 10.1002/rth2.12484. eCollection 2021 Feb. | |
| 33733023 | 0 | Othman M, Cormier M, Barnes GD, et al. Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience. Res Pract Thromb Haemost. 2021 Mar 8;5(2):253-260. doi: 10.1002/rth2.12478. eCollection 2021 Feb. | |
| 33725410 | 0 | Thachil J, Khorana A, Carrier M. Similarities and perspectives on the two C's-Cancer and COVID-19. J Thromb Haemost. 2021 May;19(5):1161-1167. doi: 10.1111/jth.15294. Epub 2021 Mar 31. | |
| 33724705 | 0 | Aziz D, Skeith L, Rodger MA, et al. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21. | |
| 33719953 | 0 | Rodriguez JJ, Munoz OC, Porres-Aguilar M, et al. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives. Cardiovasc Hematol Disord Drug Targets. 2021;21(1):23-29. doi: 10.2174/1871529X21666210315123347. | |
| 33718937 | 0 | Bhatt MD, Chan AK. Venous thrombosis in neonates. Fac Rev. 2021 Feb 25;10:20. doi: 10.12703/r/10-20. eCollection 2021. | |
| 33713826 | 0 | Shargall Y, Schneider L, Linkins LA, et al. Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer. Semin Thorac Cardiovasc Surg. 2021 Mar 11. pii: S1043-0679(21)00112-X. doi: 10.1053/j.semtcvs.2021.02.032. | |
| 33706398 | 0 | Smith J, Thornhill D, Goldenberg NA, et al. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct;121(10):1367-1375. doi: 10.1055/s-0041-1725199. Epub 2021 Mar 11. | |
| 33691765 | 0 | Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0. | |
| 33658062 | 0 | Al Raizah A, Al Askar A, Shaheen N, et al. High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study. Thromb J. 2021 Mar 3;19(1):13. doi: 10.1186/s12959-021-00265-y. | |
| 33652328 | 0 | Angchaisuksiri P, Goto S, Farjat AE, et al. Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. Thromb Res. 2021 May;201:63-72. doi: 10.1016/j.thromres.2021.02.024. Epub 2021 Feb 24. | |
| 33651481 | 0 | Avila L, Cullinan N, White M, et al. Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis. J Thromb Haemost. 2021 May;19(5):1283-1293. doi: 10.1111/jth.15284. Epub 2021 Apr 1. | |
| 33650243 | 0 | Malhame I, Othman M, Casais P, et al. Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis: A Survey on Anticoagulation for Mechanical Heart Valves in Pregnancy. J Thromb Haemost. 2021 Mar;19(3):859-864. doi: 10.1111/jth.15213. | |
| 33649169 | 0 | Little DHW, Sutradhar R, Cerasuolo JO, et al. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CMAJ. 2021 Mar 1;193(9):E304-E309. doi: 10.1503/cmaj.201433. | |
| 33639297 | 0 | Healey JS, Roberts JD, Field TS. Who is at risk of atrial fibrillation? Heart Rhythm. 2021 Jun;18(6):853-854. doi: 10.1016/j.hrthm.2021.02.019. Epub 2021 Feb 24. | |
| 33639037 | 0 | Nazy I, Jevtic SD, Moore JC, et al. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia. J Thromb Haemost. 2021 May;19(5):1342-1347. doi: 10.1111/jth.15283. Epub 2021 Mar 14. | |
| 33634446 | 0 | Milling TJ Jr, King B, Yue P, et al. Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients. Thromb Haemost. 2021 Aug;121(8):1097-1106. doi: 10.1055/a-1400-6159. Epub 2021 Feb 25. | |
| 33618841 | 0 | Bates SM, Klok FA. Special series on challenging anticoagulation cases: Experience counts when guidelines fall short. Thromb Res. 2021 Feb 18. pii: S0049-3848(21)00057-8. doi: 10.1016/j.thromres.2021.02.009. | |
| 33611151 | 0 | Di Mario F, Regolisti G, Di Maria A, et al. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study. J Crit Care. 2021 Jun;63:22-25. doi: 10.1016/j.jcrc.2021.01.013. Epub 2021 Feb 3. | |
| 33593766 | 0 | Bose G, Graveline J, Yogendrakumar V, et al. Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review. BMJ Open. 2021 Feb 16;11(2):e040212. doi: 10.1136/bmjopen-2020-040212. | |
| 33586478 | 0 | Raskob GE, Spyropoulos AC, Cohen AT, et al. Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients. J Am Heart Assoc. 2021 Feb;10(5):e019459. doi: 10.1161/JAHA.120.019459. Epub 2021 Feb 15. | |
| 33585495 | 0 | Gross PL, Chan NC. Thromboembolism in Older Adults. Front Med (Lausanne). 2021 Jan 27;7:470016. doi: 10.3389/fmed.2020.470016. eCollection 2020. | |
| 33582956 | 0 | Lai CMB, Smith T, Lee AYY. Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series. J Thromb Thrombolysis. 2021 Apr;51(3):725-733. doi: 10.1007/s11239-020-02320-3. Epub 2021 Feb 13. | |
| 33577178 | 0 | El Enany G, Nagui N, Nada H, et al. Crystalglobulinemia: A Rare Presenting Manifestation of Multiple Myeloma. Am J Dermatopathol. 2021 Sep 1;43(9):653-655. doi: 10.1097/DAD.0000000000001919. | |
| 33570602 | 0 | Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442. | |
| 33560401 | 0 | Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763. | |
| 33558201 | 0 | Khalife R, Aw A, Duffett L, et al. To Treat or Not? Remission Induction of Acquired von Willebrand Syndrome Secondary to Chronic Lymphocytic Leukemia: A Case Report. Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):e493-e496. doi: 10.1016/j.clml.2021.01.007. Epub 2021 Jan 13. | |
| 33555020 | 0 | Fabritz L, Crijns HJGM, Guasch E, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace. 2021 Mar 8;23(3):329-344. doi: 10.1093/europace/euaa279. | |
| 33548928 | 0 | Bates SM. Pulmonary Embolism in Pregnancy. Semin Respir Crit Care Med. 2021 Apr;42(2):284-298. doi: 10.1055/s-0041-1722867. Epub 2021 Feb 6. | |
| 33548557 | 0 | Lee A, Gu CS, Vedantham S, et al. Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1257-1265.e2. doi: 10.1016/j.jvsv.2021.01.017. Epub 2021 Feb 4. | |
| 33546624 | 0 | Servante J, Swallow G, Thornton JG, et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth. 2021 Feb 5;21(1):108. doi: 10.1186/s12884-021-03568-0. | |
| 33544284 | 0 | Schaefer JK, Li M, Wu Z, et al. Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolism. J Thromb Thrombolysis. 2021 Jul;52(1):214-223. doi: 10.1007/s11239-021-02392-9. Epub 2021 Feb 5. | |
| 33537540 | 0 | Douketis JD, Syed S, Li N, et al. A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Res Pract Thromb Haemost. 2020 Dec 16;5(1):159-167. doi: 10.1002/rth2.12430. eCollection 2021 Jan. | |
| 33537525 | 0 | Baumgartner C, Tritschler T. Clinical significance of subsegmental pulmonary embolism: An ongoing controversy. Res Pract Thromb Haemost. 2020 Dec 9;5(1):14-16. doi: 10.1002/rth2.12464. eCollection 2021 Jan. | |
| 33532693 | 0 | Jerjes-Sanchez C, Rodriguez D, Farjat AE, et al. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH Open. 2021 Jan 27;5(1):e24-e34. doi: 10.1055/s-0040-1722611. eCollection 2021 Jan. | |
| 33529872 | 0 | Becattini C, Cimini LA, Carrier M. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding. Thromb Res. 2021 Apr;200:41-47. doi: 10.1016/j.thromres.2021.01.016. Epub 2021 Jan 26. | |
| 33506480 | 0 | Blanchette VS, Zunino L, Grassmann V, et al. A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects. Thromb Haemost. 2021 Oct;121(10):1326-1336. doi: 10.1055/a-1376-0970. Epub 2021 Jan 27. | |
| 33492016 | 0 | Sivasundaram L, Raji Y, Mengers SRP, et al. Investigating the International Normalized Ratio Thresholds for Complication in Shoulder Arthroplasty. J Am Acad Orthop Surg. 2021 Feb 1;29(3):131-137. doi: 10.5435/JAAOS-D-20-00280. | |
| 33487649 | 0 | Hache J, Bonsu KO, Chitsike R, et al. Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic. Can J Hosp Pharm. 2021 Winter;74(1):7-14. Epub 2021 Jan 1. | |
| 33486321 | 0 | Ayele HT, Brunetti VC, Renoux C, et al. Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials. Thromb Res. 2021 Mar;199:123-131. doi: 10.1016/j.thromres.2020.12.029. Epub 2021 Jan 6. | |
| 33476900 | 0 | Fitzpatrick T, Wong C, Shen C, et al. Quality of anticoagulation using intravenous unfractionated heparin for cerebrovascular indications. Thromb Res. 2021 Mar;199:79-81. doi: 10.1016/j.thromres.2020.12.027. Epub 2021 Jan 7. | |
| 33475238 | 0 | Fu RJ, Wang WX, Tao HJ, et al. Quantitative evaluation of Danqi tablet by ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry integrated with bioassay. J Sep Sci. 2021 Apr;44(7):1552-1563. doi: 10.1002/jssc.202000932. Epub 2021 Feb 2. | |
| 33472256 | 0 | Skeith L, Rodger MA, Bates SM, et al. "Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. Thromb Haemost. 2021 Oct;121(10):1353-1360. doi: 10.1055/a-1366-9261. Epub 2021 Jan 20. | |
| 33470781 | 0 | Kasapgil E, Badv M, Cantu CA, et al. Polysiloxane Nanofilaments Infused with Silicone Oil Prevent Bacterial Adhesion and Suppress Thrombosis on Intranasal Splints. ACS Biomater Sci Eng. 2021 Feb 8;7(2):541-552. doi: 10.1021/acsbiomaterials.0c01487. Epub 2021 Jan 20. | |
| 33470571 | 0 | Barrelet I, Mavrakanas T, Carballo S. [Oral anticoagulation in chronic kidney disease]. Rev Med Suisse. 2021 Jan 20;17(722):142-145. | |
| 33463024 | 0 | Konkle B, Pierce G, Coffin D, et al. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Nov;18(11):3074-3077. doi: 10.1111/jth.15023. | |
| 33459726 | 0 | Guillermo-Esposito C, Casais P, Cesarman-Maus G, et al. Guidelines for prophylaxis and anti-thrombotic treatment for patients with COVID-19. Consensus of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT) Arch Cardiol Mex. 2021 Dec 20;91(Suplemento COVID):047-054. doi: 10.24875/ACM.20000291. | |
| 33449299 | 0 | Philippe A, Chocron R, Gendron N, et al. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 Aug;24(3):505-517. doi: 10.1007/s10456-020-09762-6. Epub 2021 Jan 15. | |
| 33448602 | 0 | Tse B, Lim G, Sholzberg M, et al. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Nov;18(11):2870-2877. doi: 10.1111/jth.15027. Epub 2020 Aug 27. | |
| 33448547 | 0 | Leblanc K, Bell AD, Ezekowitz JA, et al. Non-vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme. Int J Clin Pract. 2020 Dec;74(12):e13625. doi: 10.1111/ijcp.13625. Epub 2020 Aug 27. | |
| 33444584 | 0 | Poirier-Blanchette L, Koolian M, Schwartz BC. Testosterone Replacement Therapy Causing Extensive Portal and Mesenteric Vein Thrombosis. Am J Med. 2021 Jul;134(7):e426-e427. doi: 10.1016/j.amjmed.2020.12.018. Epub 2021 Jan 11. | |
| 33444199 | 0 | Baumgartner C, Klok FA, Carrier M, et al. Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE). BMJ Open. 2020 Nov 19;10(11):e040151. doi: 10.1136/bmjopen-2020-040151. | |
| 33443455 | 0 | Kaliel H, Mior M, Quan S, et al. Retrospective Review of Prescribing Patterns in Cancer-Associated Thrombosis: A Single Center Experience in Edmonton, Alberta, Canada. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620975489. doi: 10.1177/1076029620975489. | |
| 33432589 | 0 | Bendayan M, Mardigyan V, Williamson D, et al. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation. J Am Geriatr Soc. 2021 Apr;69(4):1012-1018. doi: 10.1111/jgs.16992. Epub 2021 Jan 11. | |
| 33429125 | 0 | Alam AU, Karkhaneh M, Sun HL, et al. Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015. Thromb Res. 2021 Mar;199:59-66. doi: 10.1016/j.thromres.2020.12.021. Epub 2020 Dec 28. | |
| 33417801 | 0 | Badv M, Alonso-Cantu C, Shakeri A, et al. Biofunctional Lubricant-Infused Vascular Grafts Functionalized with Silanized Bio-Inks Suppress Thrombin Generation and Promote Endothelialization. ACS Biomater Sci Eng. 2019 Dec 9;5(12):6485-6496. doi: 10.1021/acsbiomaterials.9b01062. Epub 2019 Nov 8. | |
| 33412596 | 0 | Di Castelnuovo A, Costanzo S, Antinori A, et al. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug;121(8):1054-1065. doi: 10.1055/a-1347-6070. Epub 2021 Jan 7. | |
| 33410894 | 0 | Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021 Jan 7;137(1):103-114. doi: 10.1182/blood.2019002973. | |
| 33405381 | 0 | Le Gal G, Carrier M, Castellucci LA, et al. Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Jan;19(1):297-303. doi: 10.1111/jth.15138. | |
| 33403619 | 0 | Demir KK, Simard C, Lipes J, et al. Life and Limb: a Case of COVID-19-Associated Multisystem Thrombosis and Review of the Literature. J Gen Intern Med. 2021 Mar;36(3):802-806. doi: 10.1007/s11606-020-06496-5. Epub 2021 Jan 5. | |
| 33387395 | 0 | Rubino JG, Arnold DM, Warkentin TE, et al. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2021 Apr;19(4):1096-1102. doi: 10.1111/jth.15233. Epub 2021 Feb 19. | |
| 33378786 | 0 | Le Mao R, Jimenez D, Bikdeli B, et al. Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism. Thromb Haemost. 2021 Jun;121(6):808-815. doi: 10.1055/s-0040-1721506. Epub 2020 Dec 30. | |
| 33376944 | 0 | Weitz JI, Prandoni P, Verhamme P. Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required? TH Open. 2020 Dec 23;4(4):e446-e456. doi: 10.1055/s-0040-1721735. eCollection 2020 Oct. | |
| 33369212 | 0 | Foulon-Pinto G, Jourdi G, Perrin J, et al. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months. Int J Lab Hematol. 2021 Aug;43(4):821-830. doi: 10.1111/ijlh.13443. Epub 2020 Dec 28. | |
| 33368114 | 0 | Kearon C, Carrier M, Gu CS, et al. Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial. Semin Thromb Hemost. 2020 Nov;46(8):977-985. doi: 10.1055/s-0040-1718891. Epub 2020 Dec 23. | |
| 33368109 | 0 | Schulman S. Recent Advances in Thrombosis and Hemostasis: Part VI. Semin Thromb Hemost. 2020 Nov;46(8):863-864. doi: 10.1055/s-0040-1715794. Epub 2020 Dec 23. | |
| 33351119 | 0 | Siegal DM, Barnes GD, Langlois NJ, et al. A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies. Blood Adv. 2020 Dec 22;4(24):6259-6273. doi: 10.1182/bloodadvances.2020003269. | |
| 33331924 | 0 | Melki I, Allaeys I, Tessandier N, et al. FcgammaRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus. Blood. 2020 Dec 17;136(25):2933-2945. doi: 10.1182/blood.2020004974. | |
| 33326124 | 0 | Warkentin TE, Smythe MA, Ali MA, et al. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Am J Hematol. 2021 Mar 1;96(3):320-329. doi: 10.1002/ajh.26075. Epub 2020 Dec 29. | |
| 33317427 | 0 | Endres K, St Bernard R, Chin-Yee I, et al. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation. Hematology. 2020 Dec;25(1):489-493. doi: 10.1080/16078454.2020.1855745. | |
| 33316246 | 0 | Schmedt N, Enders D, Walker J, et al. Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study. Am J Med. 2021 May;134(5):606-613.e6. doi: 10.1016/j.amjmed.2020.10.046. Epub 2020 Dec 11. | |
| 33313465 | 0 | den Exter PL, Kroft LJM, Gonsalves C, et al. Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts. Res Pract Thromb Haemost. 2020 Oct 1;4(8):1251-1261. doi: 10.1002/rth2.12422. eCollection 2020 Nov. | |
| 33313464 | 0 | Galanaud JP, Genty-Vermorel C, Rolland C, et al. Compression stockings to prevent postthrombotic syndrome: Literature overview and presentation of the CELEST trial. Res Pract Thromb Haemost. 2020 Oct 30;4(8):1239-1250. doi: 10.1002/rth2.12445. eCollection 2020 Nov. | |
| 33306241 | 0 | Valeriani E, Di Nisio M, Riva N, et al. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost. 2021 Apr;19(4):983-991. doi: 10.1111/jth.15214. Epub 2021 Feb 24. | |
| 33302211 | 0 | de Wit K, Linkins LA. Challenging anticoagulation cases: A case of acute pulmonary embolism in a patient with chronic thrombocytopenia. Thromb Res. 2021 Feb;198:83-85. doi: 10.1016/j.thromres.2020.11.035. Epub 2020 Dec 3. | |
| 33293309 | 0 | Tritschler T, Langlois N, Hutton B, et al. Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults. BMJ Open. 2020 Dec 7;10(12):e040122. doi: 10.1136/bmjopen-2020-040122. | |
| 33292258 | 0 | Boonyawat K, Chantrathammachart P, Numthavaj P, et al. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thromb J. 2020 Nov 23;18(1):34. doi: 10.1186/s12959-020-00248-5. | |
| 33289557 | 0 | Bao HL, Ishizuka T, Yamashita A, et al. Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2'-deoxyguanosine. J Med Chem. 2021 Jan 14;64(1):711-718. doi: 10.1021/acs.jmedchem.0c01711. Epub 2020 Dec 8. | |
| 33280553 | 0 | Hussein HM, Anderson DC. Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation? Stroke. 2021 Jan;52(1):100-102. doi: 10.1161/STROKEAHA.120.032536. Epub 2020 Dec 7. | |
| 33278785 | 0 | Elias A, Schmidt J, Bellou A, et al. Opinion and practice survey about the use of prognostic models in acute pulmonary embolism. Thromb Res. 2021 Feb;198:40-48. doi: 10.1016/j.thromres.2020.10.027. Epub 2020 Nov 1. | |
| 33275705 | 0 | Selby R. "TEG talk": expanding clinical roles for thromboelastography and rotational thromboelastometry. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):67-75. doi: 10.1182/hematology.2020000090. | |
| 33275323 | 0 | Wang TF, Billett HH, Connors JM, et al. Approach to Cancer-Associated Thrombosis: Challenging Situations and Knowledge Gaps. Oncologist. 2021 Jan;26(1):e17-e23. doi: 10.1002/onco.13570. Epub 2020 Dec 4. | |
| 33269616 | 0 | Wells PS, Theberge I, Bowdridge J, et al. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases. J Am Heart Assoc. 2020 Dec 15;9(24):e016600. doi: 10.1161/JAHA.120.016600. Epub 2020 Dec 3. | |
| 33261531 | 0 | Chezar-Azerrad C, Garcia-Garcia HM, Dan K, et al. Optical Coherence Tomography based treatment approach for patients with Acute Coronary Syndrome. Expert Rev Cardiovasc Ther. 2021 Feb;19(2):141-149. doi: 10.1080/14779072.2021.1857732. Epub 2021 Jan 8. | |
| 33254037 | 0 | Riess H, Verhamme P, Weitz JI, et al. Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management. Crit Rev Oncol Hematol. 2021 Jan;157:103125. doi: 10.1016/j.critrevonc.2020.103125. Epub 2020 Oct 20. | |
| 33253514 | 0 | McAlpine K, Breau R, Carrier M, et al. Thromboprophylaxis practice patterns and beliefs among physicians treating patients with abdominopelvic cancers at a Canadian centre. Can J Surg. 2020 Nov 30;63(6):E562-E568. doi: 10.1503/cjs.015219. | |
| 33249076 | 0 | Atsou S, Furlan F, Duchemin J, et al. Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study. Eur J Pharmacol. 2021 Jan 15;891:173764. doi: 10.1016/j.ejphar.2020.173764. Epub 2020 Nov 27. | |
| 33247808 | 0 | Galanaud JP, Trujillo-Santos J, Bikdeli B, et al. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry. J Thromb Thrombolysis. 2021 Aug;52(2):532-541. doi: 10.1007/s11239-020-02347-6. Epub 2020 Nov 28. | |
| 33232187 | 0 | Cohen AJ, Boggio L, Billett HH, et al. North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. J Womens Health (Larchmt). 2021 Jun;30(6):829-836. doi: 10.1089/jwh.2020.8385. Epub 2020 Nov 24. | |
| 33231123 | 0 | Lemieux-Sarrasin D, Pelland-Marcotte MC, Simonyan D, et al. Distance to the pediatric oncology center does not affect survival in children with acute lymphoblastic leukemia: a report from CYP-C. Leuk Lymphoma. 2021 Apr;62(4):960-966. doi: 10.1080/10428194.2020.1849673. Epub 2020 Nov 24. | |
| 33229505 | 0 | Khorana AA, Cohen AT, Carrier M, et al. Prevention of venous thromboembolism in ambulatory patients with cancer. ESMO Open. 2020 Nov;5(6):e000948. doi: 10.1136/esmoopen-2020-000948. | |
| 33216354 | 0 | Patel SH, George TL, Wang TF, et al. Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin. Cancer. 2021 Mar 15;127(6):938-945. doi: 10.1002/cncr.33337. Epub 2020 Nov 20. | |
| 33208779 | 0 | Chan KYT, Yong ASM, Wang X, et al. The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII. Sci Rep. 2020 Nov 18;10(1):20116. doi: 10.1038/s41598-020-76782-z. | |
| 33202772 | 0 | Nemecz D, Ostrowski M, Ravatin M, et al. Crystal Structure of Isoform CBd of the Basic Phospholipase A(2) Subunit of Crotoxin: Description of the Structural Framework of CB for Interaction with Protein Targets. Molecules. 2020 Nov 13;25(22):5290. doi: 10.3390/molecules25225290. | |
| 33196511 | 0 | Wang TF, Waller AP, Lin E, et al. A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):16-22. doi: 10.1097/MBC.0000000000000968. | |
| 33191198 | 0 | Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2020 Dec;36(12):1847-1948. doi: 10.1016/j.cjca.2020.09.001. Epub 2020 Oct 22. | |
| 33190023 | 0 | Roberge G, Delluc A. Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer. Thromb Res. 2021 Jan;197:77-83. doi: 10.1016/j.thromres.2020.10.033. Epub 2020 Nov 6. | |
| 33174815 | 0 | Shoamanesh A, Patrice Lindsay M, Castellucci LA, et al. Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020. Int J Stroke. 2021 Apr;16(3):321-341. doi: 10.1177/1747493020968424. Epub 2020 Nov 11. | |
| 33174368 | 0 | Chiasakul T, Patell R, Maraveyas A, et al. Discordant reporting of VTE in pancreatic cancer: A systematic review and meta-analysis of thromboprophylaxis versus chemotherapeutic trials. J Thromb Haemost. 2021 Feb;19(2):489-501. doi: 10.1111/jth.15175. Epub 2020 Dec 3. | |
| 33170819 | 0 | Lillicrap D. Evaluating the potential benefits of the extravascular pool of factor IX. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):68-69. doi: 10.1097/MBC.0000000000000969. | |
| 33160117 | 0 | Payne JG, Tagalakis V, Wu C, et al. Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis. Thromb Res. 2021 Jan;197:8-12. doi: 10.1016/j.thromres.2020.10.030. Epub 2020 Nov 1. | |
| 33160115 | 0 | Knoll W, Mallick R, Wells PS, et al. Safety and efficacy of apixaban thromboprophylaxis in cancer patients with metastatic disease: A post-hoc analysis of the AVERT trial. Thromb Res. 2021 Jan;197:13-15. doi: 10.1016/j.thromres.2020.10.026. Epub 2020 Nov 1. | |
| 33138326 | 0 | Liederman Z, Chan N, Bhagirath V. Current Challenges in Diagnosis of Venous Thromboembolism. J Clin Med. 2020 Oct 29;9(11). pii: jcm9113509. doi: 10.3390/jcm9113509. | |
| 33134787 | 0 | Galanaud JP, Sevestre MA, Pernod G, et al. Epidemiology and 3-year outcomes of combined oral contraceptive-associated distal deep vein thrombosis. Res Pract Thromb Haemost. 2020 Sep 15;4(7):1216-1223. doi: 10.1002/rth2.12409. eCollection 2020 Oct. | |
| 33134784 | 0 | Riva N, Carrier M, Gatt A, et al. Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey. Res Pract Thromb Haemost. 2020 Sep 11;4(7):1192-1202. doi: 10.1002/rth2.12424. eCollection 2020 Oct. | |
| 33119197 | 0 | Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J Thromb Haemost. 2021 Jan;19(1):46-50. doi: 10.1111/jth.15156. Epub 2020 Nov 18. | |
| 33112399 | 0 | Goto S, Haas S, Ageno W, et al. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. JAMA Netw Open. 2020 Oct 1;3(10):e2022886. doi: 10.1001/jamanetworkopen.2020.22886. | |
| 33104289 | 0 | Schaefer JK, Li M, Wu Z, et al. Anticoagulant medication adherence for cancer-associated thrombosis: A comparison of LMWH to DOACs. J Thromb Haemost. 2021 Jan;19(1):212-220. doi: 10.1111/jth.15153. Epub 2020 Nov 21. | |
| 33099284 | 0 | Schulman S, Hu Y, Konstantinides S. Venous Thromboembolism in COVID-19. Thromb Haemost. 2020 Dec;120(12):1642-1653. doi: 10.1055/s-0040-1718532. Epub 2020 Oct 24. | |
| 33086918 | 0 | Chaudhary H, Jindal P, Pandiarajan V, et al. Portal vein thrombosis, livedo reticularis, polymicrobial sepsis and high antiphospholipid antibody titers in a newborn: A clinicopathological conference of antiphospholipid-associated neonatal syndrome. Lupus. 2021 Jan;30(1):141-148. doi: 10.1177/0961203320967418. Epub 2020 Oct 22. | |
| 33082930 | 0 | Chan NC, Weitz JI. Recent advances in understanding, diagnosing and treating venous thrombosis. F1000Res. 2020 Oct 6;9. doi: 10.12688/f1000research.27115.1. eCollection 2020. | |
| 33079379 | 0 | Zhang J, Atalla M, Mallick R, et al. Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial. J Thromb Thrombolysis. 2021 Apr;51(3):720-724. doi: 10.1007/s11239-020-02317-y. Epub 2020 Oct 20. | |
| 33078911 | 0 | Xu Y, Siegal DM, Anand SS. Ethnoracial variations in venous thrombosis: Implications for management, and a call to action. J Thromb Haemost. 2021 Jan;19(1):30-40. doi: 10.1111/jth.15140. Epub 2020 Nov 20. | |
| 33075181 | 0 | O'Brien HER, Zhang XF, Sanz-Hernandez M, et al. Blocking von Willebrand factor free thiols inhibits binding to collagen under high and pathological shear stress. J Thromb Haemost. 2021 Feb;19(2):358-369. doi: 10.1111/jth.15142. Epub 2020 Nov 18. | |
| 33074284 | 0 | Shoamanesh A, Hart RG, Connolly SJ, et al. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol. 2021 Jan 1;78(1):11-20. doi: 10.1001/jamaneurol.2020.3836. | |
| 33065408 | 0 | Shaw JR, Kumar V, Mallick R, et al. Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer. Thromb Res. 2020 Dec;196:437-443. doi: 10.1016/j.thromres.2020.09.035. Epub 2020 Oct 8. | |
| 33064698 | 0 | Carrillo-Esper R, Melgar-Bieberach RE, Tapia-Salazar M, et al. Manifestaciones extrapulmonares de la infeccion por SARS-CoV-2. Cir Cir. 2020;88(5):654-663. doi: 10.24875/CIRU.20000363. | |
| 33064561 | 0 | Mian O, Matino D, Roberts R, et al. Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962226. doi: 10.1177/1076029620962226. | |
| 33049056 | 0 | Darzi AJ, Repp AB, Spencer FA, et al. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews. Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482. | |
| 33048811 | 0 | Porres-Aguilar M, Heresi GA, Anaya-Ayala JE, et al. [Pulmonary embolism or pulmonary thrombosis in situ in severe pneumonic COVID-19 associated coagulopathy: does systemic thrombolysis have a role?] Medicina (B Aires). 2020;80(5):581-582. | |
| 33048461 | 0 | Germini F, Zarabi S, Eventov M, et al. Pulmonary embolism prevalence among emergency department cohorts: A systematic review and meta-analysis by country of study. J Thromb Haemost. 2021 Jan;19(1):173-185. doi: 10.1111/jth.15124. Epub 2020 Nov 18. | |
| 33047462 | 0 | Fredenburgh JC, Weitz JI. New anticoagulants: Moving beyond the direct oral anticoagulants. J Thromb Haemost. 2021 Jan;19(1):20-29. doi: 10.1111/jth.15126. Epub 2020 Nov 3. | |
| 33033370 | 0 | Valeria C, Carmine S, Valentina M, et al. The need of a multicomponent guiding approach to personalize clopidogrel treatment. Pharmacogenomics J. 2021 Apr;21(2):116-127. doi: 10.1038/s41397-020-00189-2. Epub 2020 Oct 9. | |
| 33032809 | 0 | Favaloro EJ, Mohammed S, Donikian D, et al. A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. Pathology. 2021 Feb;53(2):247-256. doi: 10.1016/j.pathol.2020.07.012. Epub 2020 Oct 5. | |
| 33027169 | 0 | MacDonald DRW, Neilly D, Schneider PS, et al. Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials. J Orthop Trauma. 2020 Nov;34 Suppl 3:S70-S75. doi: 10.1097/BOT.0000000000001939. | |
| 33014332 | 0 | Underwood B, Zhao Q, Walker AR, et al. Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia. Int J Hematol Oncol. 2020 Sep 4;9(3):IJH28. doi: 10.2217/ijh-2020-0009. | |
| 33007077 | 0 | Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830. | |
| 33002131 | 0 | Thom K, Lensing AWA, Nurmeev I, et al. Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE). Blood Adv. 2020 Oct 13;4(19):4632-4639. doi: 10.1182/bloodadvances.2020002637. | |
| 33000892 | 0 | Little DHW, Robertson T, Douketis J, et al. Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health-care providers. J Thromb Haemost. 2021 Jan;19(1):153-160. doi: 10.1111/jth.15111. Epub 2020 Oct 21. | |
| 32976752 | 0 | Schunemann HJ, Ventresca M, Crowther M, et al. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis. Lancet Haematol. 2020 Oct;7(10):e746-e755. doi: 10.1016/S2352-3026(20)30293-3. | |
| 32969580 | 0 | Kumar V, Shaw JR, Key NS, et al. D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer. Oncologist. 2020 Dec;25(12):1075-1083. doi: 10.1002/onco.13540. Epub 2020 Oct 12. | |
| 32969288 | 0 | Tafur AJ, Clark NP, Spyropoulos AC, et al. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. J Am Heart Assoc. 2020 Oct 20;9(19):e017316. doi: 10.1161/JAHA.120.017316. Epub 2020 Sep 24. | |
| 32968991 | 0 | Aibar J, Schulman S. New-Onset Atrial Fibrillation in Sepsis: A Narrative Review. Semin Thromb Hemost. 2021 Feb;47(1):18-25. doi: 10.1055/s-0040-1714400. Epub 2020 Sep 23. | |
| 32967458 | 0 | Michels A, Dwyer CN, Mewburn J, et al. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity. Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2860-2874. doi: 10.1161/ATVBAHA.120.314690. Epub 2020 Sep 24. | |
| 32951663 | 0 | Sun LR, Linds A, Sharma M, et al. Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study. Pediatr Neurol. 2020 Oct;111:59-65. doi: 10.1016/j.pediatrneurol.2020.06.002. Epub 2020 Jun 10. | |
| 32948386 | 0 | Razavi MK, Salter A, Goldhaber SZ, et al. Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2020 Oct;31(10):1517-1528.e2. doi: 10.1016/j.jvir.2020.07.010. Epub 2020 Sep 15. | |
| 32938299 | 0 | Zaid Y, Puhm F, Allaeys I, et al. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ Res. 2020 Sep 17. doi: 10.1161/CIRCRESAHA.120.317703. | |
| 32935073 | 0 | Maria ATJ, Diaz-Cau I, Benejean JM, et al. Flare of Antiphospholipid Syndrome in the Course of COVID-19. TH Open. 2020 Sep 11;4(3):e207-e210. doi: 10.1055/s-0040-1716735. eCollection 2020 Jul. | |
| 32932543 | 0 | Jourdi G, Lobies S, Kosmider O, et al. Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases. Thromb Haemost. 2021 Feb;121(2):246-249. doi: 10.1055/s-0040-1716541. Epub 2020 Sep 15. | |
| 32929876 | 0 | Chau AS, Weber AG, Maria NI, et al. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm. Arthritis Rheumatol. 2021 Jan;73(1):23-35. doi: 10.1002/art.41526. Epub 2020 Dec 1. | |
| 32914582 | 0 | Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Oct;18(10):2486-2495. doi: 10.1111/jth.15006. Epub 2020 Sep 11. | |
| 32911392 | 0 | Pizzi R, Gini G, Caiano L, et al. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency. Thromb Res. 2020 Dec;196:209-212. doi: 10.1016/j.thromres.2020.09.004. Epub 2020 Sep 3. | |
| 32898930 | 0 | Galanaud JP, Ducruet T, Kahn SR. Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis. J Thromb Haemost. 2020 Dec;18(12):3309-3315. doi: 10.1111/jth.15091. Epub 2020 Oct 15. | |
| 32888372 | 0 | Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1. | |
| 32881339 | 0 | Favaloro EJ, Amgalan A, Allen T, et al. "Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendation from the women's SSC of the ISTH": Response to comment from Kitchen et al. J Thromb Haemost. 2020 Sep;18(9):2420-2422. doi: 10.1111/jth.15007. | |
| 32881337 | 0 | Zuily S, Cohen H, Isenberg D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020 Sep;18(9):2126-2137. doi: 10.1111/jth.14935. | |
| 32881334 | 0 | Lillicrap D, Morrissey JH. 2020 - Year of COVID-19. J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041. | |
| 32881272 | 0 | Thachil J, Longstaff C, Favaloro EJ, et al. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis. J Thromb Haemost. 2020 Sep;18(9):2408-2411. doi: 10.1111/jth.14956. | |
| 32877956 | 0 | Picker N, Lee AY, Cohen AT, et al. Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study). Thromb Haemost. 2021 Feb;121(2):206-215. doi: 10.1055/s-0040-1714739. Epub 2020 Sep 2. | |
| 32869501 | 0 | Eddy M, Robert-Ebadi H, Richardson L, et al. External validation of the YEARS diagnostic algorithm for suspected pulmonary embolism. J Thromb Haemost. 2020 Dec;18(12):3289-3295. doi: 10.1111/jth.15083. Epub 2020 Oct 23. | |
| 32866823 | 0 | Peterson W, Liederman Z, Baker J, et al. Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thromb Res. 2020 Dec;196:127-129. doi: 10.1016/j.thromres.2020.08.028. Epub 2020 Aug 19. | |
| 32864557 | 0 | Koster A, Nazy I, Birschmann IE, et al. High-dose IVIG plus cangrelor platelet "anesthesia" during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodies. Res Pract Thromb Haemost. 2020 Jul 23;4(6):1060-1064. doi: 10.1002/rth2.12348. eCollection 2020 Aug. | |
| 32853584 | 0 | Arnold DM, Heddle NM, Cook RJ, et al. Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. Lancet Haematol. 2020 Sep;7(9):e640-e648. doi: 10.1016/S2352-3026(20)30227-1. | |
| 32851572 | 0 | Ageno W, Casella IB, Chee KH, et al. Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Apr;51(3):561-570. doi: 10.1007/s11239-020-02239-9. | |
| 32846051 | 0 | Kadir RA, Kobayashi T, Iba T, et al. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry-Communication from the ISTH SSC for Women's Health. J Thromb Haemost. 2020 Nov;18(11):3086-3098. doi: 10.1111/jth.15072. Epub 2020 Oct 14. | |
| 32838111 | 0 | Rosovsky RP, Sanfilippo KM, Wang TF, et al. Anticoagulation Practice Patterns in COVID-19: A Global Survey. Res Pract Thromb Haemost. 2020 Jul 9. pii: RTH212414. doi: 10.1002/rth2.12414. | |
| 32816822 | 0 | Godoy LC, Goligher EC, Lawler PR, et al. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16. | |
| 32815416 | 0 | Houston BL, Lawler PR, Goligher EC, et al. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20. | |
| 32815198 | 0 | Biswas M, Ryan PM, Nakrani R, et al. Central venous catheters are an important factor in paediatric thrombosis. Acta Paediatr. 2021 Mar;110(3):1001-1008. doi: 10.1111/apa.15543. Epub 2020 Sep 16. | |
| 32799129 | 0 | Kovacs MR, Lazo-Langner A, Louzada ML, et al. Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism. Thromb Res. 2020 Nov;195:231-232. doi: 10.1016/j.thromres.2020.07.052. Epub 2020 Jul 30. | |
| 32798962 | 0 | Patterson S, Al Nabhani I, Linkins LA. Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill. Thromb Res. 2020 Sep;193:218-220. doi: 10.1016/j.thromres.2020.08.011. Epub 2020 Aug 6. | |
| 32788108 | 0 | Robin P, van Es N, Le Roux PY, et al. Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. Thromb Res. 2020 Oct;194:153-157. doi: 10.1016/j.thromres.2020.06.034. Epub 2020 Jun 23. | |
| 32788105 | 0 | Huynh A, Arnold DM, Smith JW, et al. The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia. Thromb Res. 2020 Oct;194:135-141. doi: 10.1016/j.thromres.2020.06.012. Epub 2020 Jun 6. | |
| 32788103 | 0 | Kovacs MR, Lazo-Langner A, Kovacs MJ. Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive? Thromb Res. 2020 Oct;194:119-120. doi: 10.1016/j.thromres.2020.06.031. Epub 2020 Jun 19. | |
| 32762455 | 0 | Siegal DM, Gross PL. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):1958-1960. doi: 10.1161/ATVBAHA.120.314977. Epub 2020 Jul 30. | |
| 32762081 | 0 | Conway EM, Pryzdial ELG. Is the COVID-19 thrombotic catastrophe complement-connected? J Thromb Haemost. 2020 Nov;18(11):2812-2822. doi: 10.1111/jth.15050. Epub 2020 Sep 18. | |
| 32759284 | 0 | Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020 Aug 5;370:m2177. doi: 10.1136/bmj.m2177. | |
| 32757722 | 0 | Barrett TJ, Lee AH, Xia Y, et al. Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ Res. 2020 Sep 11;127(7):945-947. doi: 10.1161/CIRCRESAHA.120.317803. Epub 2020 Aug 6. | |
| 32756938 | 0 | Shaw JR, Li N, Vanassche T, et al. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Adv. 2020 Aug 11;4(15):3520-3527. doi: 10.1182/bloodadvances.2020002335. | |
| 32740218 | 0 | Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):489-496. doi: 10.1097/MNH.0000000000000634. | |
| 32738644 | 0 | Andrew L, Ni Ainle F, Blondon M, et al. Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality. Thromb Res. 2020 Sep;193:190-197. doi: 10.1016/j.thromres.2020.07.007. Epub 2020 Jul 7. | |
| 32736776 | 0 | Ilich A, Kumar V, Henderson M, et al. Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study. Thromb Res. 2020 Jul;191 Suppl 1:S31-S36. doi: 10.1016/S0049-3848(20)30394-7. | |
| 32736774 | 0 | Selby R, Duffy ER, Berny-Lang MA, et al. Impact of specific preclinical variables on coagulation biomarkers in cancer-associated thrombosis. Thromb Res. 2020 Jul;191 Suppl 1:S26-S30. doi: 10.1016/S0049-3848(20)30393-5. | |
| 32735828 | 0 | Schulman S. Is venous thromboembolism a preventable cause of death? Lancet Haematol. 2020 Aug;7(8):e555-e556. doi: 10.1016/S2352-3026(20)30219-2. | |
| 32732928 | 0 | Ma Y, Chen F, Liu C, et al. A novel predictive score for citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation. Sci Rep. 2020 Jul 30;10(1):12861. doi: 10.1038/s41598-020-69902-2. | |
| 32726911 | 0 | D'Astous J, Carrier M. Screening for Occult Cancer in Patients with Venous Thromboembolism. J Clin Med. 2020 Jul 27;9(8). pii: jcm9082389. doi: 10.3390/jcm9082389. | |
| 32726824 | 0 | Giustozzi M, Castellucci LA, Barnes GD. Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians. Hamostaseologie. 2020 Aug;40(3):292-300. doi: 10.1055/a-1174-1290. Epub 2020 Jul 29. | |
| 32723607 | 0 | Malhame I, Tagalakis V, Dayan N. Diagnosing Pulmonary Embolism in Pregnancy: Synthesis of Current Guidelines and New Evidence. J Obstet Gynaecol Can. 2020 Dec;42(12):1546-1549. doi: 10.1016/j.jogc.2020.03.025. Epub 2020 Apr 28. | |
| 32702124 | 0 | Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. 2020 Jul 23;136(4):381-383. doi: 10.1182/blood.2020007335. | |
| 32692888 | 0 | Rudzinski JK, Govindasamy NP, Lewis JD, et al. The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion. J Thromb Haemost. 2020 Nov;18(11):2976-2986. doi: 10.1111/jth.15020. Epub 2020 Aug 24. | |
| 32685899 | 0 | van Ommen CH, Albisetti M, Chan AK, et al. The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease. Res Pract Thromb Haemost. 2020 May 25;4(5):886-892. doi: 10.1002/rth2.12352. eCollection 2020 Jul. | |
| 32685890 | 0 | Mazinani N, Strilchuk AW, Baylis JR, et al. Bleeding is increased in amyloid precursor protein knockout mouse. Res Pract Thromb Haemost. 2020 Jun 14;4(5):823-828. doi: 10.1002/rth2.12375. eCollection 2020 Jul. | |
| 32685885 | 0 | Elbaz C, Sholzberg M. An illustrated review of bleeding assessment tools and common coagulation tests. Res Pract Thromb Haemost. 2020 Jul 6;4(5):761-773. doi: 10.1002/rth2.12339. eCollection 2020 Jul. | |
| 32685588 | 0 | Peacock WF, Coleman CI, Wells P, et al. Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. J Health Econ Outcomes Res. 2019 Oct 2;6(3):160-173. doi: 10.36469/9936. eCollection 2019. | |
| 32683148 | 0 | Ripsman D, Fergusson DA, Montroy J, et al. A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models. Thromb Res. 2020 Nov;195:103-113. doi: 10.1016/j.thromres.2020.07.008. Epub 2020 Jul 8. | |
| 32680646 | 0 | Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Aug 4;76(5):594-622. doi: 10.1016/j.jacc.2020.04.053. Epub 2020 Jul 14. | |
| 32678949 | 0 | D'Souza R, Malhame I, Teshler L, et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020 Sep;99(9):1110-1120. doi: 10.1111/aogs.13962. Epub 2020 Aug 5. | |
| 32676543 | 0 | Wang YP, Kehar R, Iansavitchene A, et al. Bleeding Risk in Nonvalvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies. TH Open. 2020 Jul 13;4(3):e145-e152. doi: 10.1055/s-0040-1714918. eCollection 2020 Jul. | |
| 32658609 | 0 | Spyropoulos AC, Weitz JI. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm. Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13. | |
| 32654348 | 0 | Mulder FI, Carrier M, van Doormaal F, et al. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. J Thromb Haemost. 2020 Oct;18(10):2622-2628. doi: 10.1111/jth.15001. Epub 2020 Aug 4. | |
| 32654308 | 0 | AlBader M, Le Gal G, Rodger MA, et al. Yield of ultrasonography in patients with or without post-thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis. J Thromb Haemost. 2020 Oct;18(10):2654-2657. doi: 10.1111/jth.14996. Epub 2020 Aug 28. | |
| 32645667 | 0 | Shaw JR, Carrier M, Dowlatshahi D, et al. Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes. Thromb Res. 2020 Nov;195:21-28. doi: 10.1016/j.thromres.2020.06.044. Epub 2020 Jul 1. | |
| 32640269 | 0 | Avila L, Amiri N, Yenson P, et al. Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing. J Pediatr. 2020 Jul 5. pii: S0022-3476(20)30835-0. doi: 10.1016/j.jpeds.2020.06.081. | |
| 32619348 | 0 | Rabinovich A, Abdul-Kadir R, Thachil J, et al. Reply to "Errors in the diagnosis for DIC due to a statistical misunderstanding". J Thromb Haemost. 2020 Jul;18(7):1792-1793. doi: 10.1111/jth.14831. | |
| 32619346 | 0 | Di Nisio M, Valeriani E, Riva N, et al. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost. 2020 Jul;18(7):1562-1568. doi: 10.1111/jth.14836. | |
| 32594508 | 0 | Weitz JI, Angiolillo DJ, Geisler T, et al. Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence. Thromb Haemost. 2020 Aug;120(8):1147-1158. doi: 10.1055/s-0040-1713376. Epub 2020 Jun 28. | |
| 32586587 | 0 | Spyropoulos AC, Ageno W, Albers GW, et al. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol. 2020 Jun 30;75(25):3140-3147. doi: 10.1016/j.jacc.2020.04.071. | |
| 32583306 | 0 | Weitz JI, Haas S, Ageno W, et al. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. | |
| 32579570 | 0 | Yogendrakumar V, Lun R, Khan F, et al. Venous thromboembolism prevention in intracerebral hemorrhage: A systematic review and network meta-analysis. PLoS One. 2020 Jun 24;15(6):e0234957. doi: 10.1371/journal.pone.0234957. eCollection 2020. | |
| 32578414 | 0 | Hwang HG, Kim YK, Kim MS, et al. Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease. Tuberc Respir Dis (Seoul). 2020 Jul;83(3):255-256. doi: 10.4046/trd.2020.0029. Epub 2020 Apr 29. | |
| 32576089 | 0 | Lu N, Smith JMC, Andrade JG, et al. Considerations in Adult Congenital Heart Disease and Stroke: A Case Report. Stroke. 2020 Aug;51(8):e148-e150. doi: 10.1161/STROKEAHA.119.028605. Epub 2020 Jun 24. | |
| 32575112 | 0 | Carrier M, Wang TF. Direct oral anticoagulants and cancer-associated VTE: good for all, or just some? Blood. 2020 Aug 6;136(6):669-673. doi: 10.1182/blood.2019004177. | |
| 32574420 | 0 | Xu Y, You D, Krzyzaniak H, et al. Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta-analysis. J Thromb Haemost. 2020 Oct;18(10):2566-2581. doi: 10.1111/jth.14977. Epub 2020 Jul 23. | |
| 32574367 | 0 | Yepes-Nunez JJ, Rajasekhar A, Rahman M, et al. Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism. Blood Adv. 2020 Jun 23;4(12):2798-2809. doi: 10.1182/bloodadvances.2020002195. | |
| 32573898 | 0 | Jackson Chornenki NL, Dwivedi DJ, Kwong AC, et al. Identification of hemostatic markers that define the pre-DIC state: A multi-center observational study. J Thromb Haemost. 2020 Oct;18(10):2524-2531. doi: 10.1111/jth.14973. Epub 2020 Jul 23. | |
| 32569377 | 0 | Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis. Blood Adv. 2020 Jun 23;4(12):2779-2788. doi: 10.1182/bloodadvances.2020001558. | |
| 32563061 | 0 | Murthy SK, Robertson McCurdy AB, Carrier M, et al. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting. Thromb Res. 2020 Oct;194:26-32. doi: 10.1016/j.thromres.2020.06.005. Epub 2020 Jun 3. | |
| 32561453 | 0 | Violette PD, Vernooij RWM, Aoki Y, et al. An International Survey on the Use of Thromboprophylaxis in Urological Surgery. Eur Urol Focus. 2021 May;7(3):653-658. doi: 10.1016/j.euf.2020.05.015. Epub 2020 Jun 16. | |
| 32557627 | 0 | Pelland-Marcotte MC, Amiri N, Avila ML, et al. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Cochrane Database Syst Rev. 2020 Jun 18;6:CD005982. doi: 10.1002/14651858.CD005982.pub3. | |
| 32548552 | 0 | Bauersachs R, Khorana AA, Lee AYY, et al. Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban. Res Pract Thromb Haemost. 2020 Apr 4;4(4):532-549. doi: 10.1002/rth2.12327. eCollection 2020 May. | |
| 32542391 | 0 | Darzi AJ, Karam SG, Spencer FA, et al. Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment. Blood Adv. 2020 Jun 23;4(12):2557-2566. doi: 10.1182/bloodadvances.2020001937. | |
| 32539500 | 0 | Kimpton M, Rodger MA. Web Exclusive. Annals for Hospitalists Inpatient Notes - Can I Withdraw Anticoagulants in This Patient With Prior Venous Thromboembolism? Ann Intern Med. 2020 Jun 16;172(12):HO2-HO3. doi: 10.7326/M20-1253. | |
| 32526791 | 0 | Schulman S, Konstantinides S, Hu Y, et al. Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158]. Thromb Haemost. 2020 Aug;120(8):1143-1146. doi: 10.1055/s-0040-1712913. Epub 2020 Jun 11. | |
| 32511715 | 0 | Patel P, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy. Blood Adv. 2020 Jun 9;4(11):2516-2522. doi: 10.1182/bloodadvances.2019001409. | |
| 32511684 | 0 | Hill K, Sucha E, Rhodes E, et al. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants. JAMA Intern Med. 2020 Aug 1;180(8):1052-1060. doi: 10.1001/jamainternmed.2020.1835. | |
| 32506822 | 0 | Ni R, Neves MAD, Wu C, et al. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets. J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950. | |
| 32506364 | 0 | Chibane S, Gibeau G, Poulin F, et al. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report. J Thromb Thrombolysis. 2021 Jan;51(1):25-28. doi: 10.1007/s11239-020-02173-w. | |
| 32505262 | 0 | Shaw JR, Kaplovitch E, Douketis J. Periprocedural Management of Oral Anticoagulation. Med Clin North Am. 2020 Jul;104(4):709-726. doi: 10.1016/j.mcna.2020.02.005. Epub 2020 May 12. | |
| 32502594 | 0 | Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2. | |
| 32497628 | 0 | Porres-Aguilar M, Anaya-Ayala JE, Mukherjee D, et al. Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19. J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):898-899. doi: 10.1016/j.jvsv.2020.04.032. Epub 2020 Jun 1. | |
| 32497167 | 0 | Mirza R, Nieuwlaat R, Lopez-Nunez JJ, et al. Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry). Blood Adv. 2020 Jun 9;4(11):2460-2467. doi: 10.1182/bloodadvances.2019001373. | |
| 32496023 | 0 | Tritschler T, Kraaijpoel N, Girard P, et al. Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Jun;18(6):1495-1500. doi: 10.1111/jth.14769. | |
| 32485418 | 0 | Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020 Aug;192:152-160. doi: 10.1016/j.thromres.2020.05.039. Epub 2020 May 27. | |
| 32474619 | 0 | Mulas O, Caocci G, Stagno F, et al. Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors. Ann Hematol. 2020 Jul;99(7):1525-1530. doi: 10.1007/s00277-020-04102-6. Epub 2020 May 30. | |
| 32473692 | 0 | Kaplovitch E, Shaw JR, Douketis J. Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli. Crit Care Clin. 2020 Jul;36(3):465-480. doi: 10.1016/j.ccc.2020.02.004. | |
| 32473596 | 0 | Bikdeli B, Madhavan MV, Gupta A, et al. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul;120(7):1004-1024. doi: 10.1055/s-0040-1713152. Epub 2020 May 30. | |
| 32467044 | 0 | Leighton JL, You D, Schneider P. Limiting Blood Loss in Orthopaedic Trauma: Strategies and Effects. Injury. 2020 May;51 Suppl 2:S123-S127. doi: 10.1016/j.injury.2020.04.040. Epub 2020 May 11. | |
| 32456506 | 0 | Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets. 2020 Aug 17;31(6):740-745. doi: 10.1080/09537104.2020.1768523. Epub 2020 May 26. | |
| 32454394 | 0 | Nassabein R, Routy B, Blais N, et al. Arterial thrombosis and coronavirus disease 2019 in a patient with cancer. Eur J Cancer. 2020 Jul;134:1-2. doi: 10.1016/j.ejca.2020.05.002. Epub 2020 May 18. | |
| 32453843 | 0 | Wiercioch W, Nieuwlaat R, Akl EA, et al. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020 May 26;4(10):2351-2365. doi: 10.1182/bloodadvances.2020001768. | |
| 32444398 | 0 | Mavrakanas TA, Garlo K, Charytan DM. Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1146-1154. doi: 10.2215/CJN.11650919. Epub 2020 May 22. | |
| 32433797 | 0 | Takada T, van Doorn S, Parpia S, et al. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis. J Thromb Haemost. 2020 Sep;18(9):2245-2252. doi: 10.1111/jth.14900. Epub 2020 Jul 8. | |
| 32430965 | 0 | Lefler DS, Cuker A, Linkins LA, et al. Maximum 24-hour platelet count fall: Metric for improving the diagnosis of heparin-induced thrombocytopenia among patients with intermediate probability 4Ts scores. J Thromb Haemost. 2020 Aug;18(8):2018-2024. doi: 10.1111/jth.14897. Epub 2020 Jun 25. | |
| 32428195 | 0 | Paquette M, Mbuagbaw L, Iorio A, et al. Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):251-260. doi: 10.1093/ehjcvp/pvaa052. | |
| 32422442 | 0 | Bounameaux H, Haas S, Farjat AE, et al. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Thromb Res. 2020 Jul;191:103-112. doi: 10.1016/j.thromres.2020.04.036. Epub 2020 Apr 28. | |
| 32416310 | 0 | Delluc A, Lacut K, Rodger MA. Arterial and venous thrombosis: What's the link? A narrative review. Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27. | |
| 32414520 | 0 | Amgalan A, Othman M. TEG in pregnancy: Current challenges and future potential applications. Thromb Res. 2020 Jul;191:140-141. doi: 10.1016/j.thromres.2020.03.017. Epub 2020 Mar 24. | |
| 32396939 | 0 | Mulder FI, Bosch FTM, Young AM, et al. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis. Blood. 2020 Sep 17;136(12):1433-1441. doi: 10.1182/blood.2020005819. | |
| 32396622 | 0 | Izcovich A, Cuker A, Kunkle R, et al. A user guide to the American Society of Hematology clinical practice guidelines. Blood Adv. 2020 May 12;4(9):2095-2110. doi: 10.1182/bloodadvances.2020001755. | |
| 32395827 | 0 | Wang TF, Delluc A. Thromboprophylaxis in patients with multiple myeloma. Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12. | |
| 32392613 | 0 | Schulman S. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism. Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11. | |
| 32375490 | 0 | Henke PK, Kahn SR, Pannucci CJ, et al. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation. 2020 Jun 16;141(24):e914-e931. doi: 10.1161/CIR.0000000000000769. Epub 2020 May 7. | |
| 32369855 | 0 | Giustozzi M, Curcio A, Weijs B, et al. Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. 2020 May;120(5):847-856. doi: 10.1055/s-0040-1709527. Epub 2020 May 5. | |
| 32369854 | 0 | Montroy J, Lalu MM, Auer RC, et al. The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients: A Systematic Review and Meta-Analysis. Thromb Haemost. 2020 May;120(5):832-846. doi: 10.1055/s-0040-1709712. Epub 2020 May 5. | |
| 32356929 | 0 | Amgalan A, Allen T, Othman M, et al. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women's SSC of the ISTH. J Thromb Haemost. 2020 Aug;18(8):1813-1838. doi: 10.1111/jth.14882. | |
| 32346486 | 0 | Legault K, Blostein M, Carrier M, et al. A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud. 2020 Apr 25;6:52. doi: 10.1186/s40814-020-00594-1. eCollection 2020. | |
| 32339233 | 0 | Juang LJ, Mazinani N, Novakowski SK, et al. Coagulation factor XII contributes to hemostasis when activated by soil in wounds. Blood Adv. 2020 Apr 28;4(8):1737-1745. doi: 10.1182/bloodadvances.2019000425. | |
| 32336010 | 0 | van Es N, Ventresca M, Di Nisio M, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis. J Thromb Haemost. 2020 Aug;18(8):1940-1951. doi: 10.1111/jth.14824. Epub 2020 Jul 8. | |
| 32334825 | 0 | McAlpine K, Lavallee LT. Reply to: Re: Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2020 Jun;167(6):1026. doi: 10.1016/j.surg.2020.02.030. Epub 2020 Apr 22. | |
| 32333946 | 0 | Ashley J, McArthur E, Bota S, et al. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 Sep;76(3):311-320. doi: 10.1053/j.ajkd.2020.02.446. Epub 2020 Apr 22. | |
| 32325043 | 0 | Goldhaber SZ, Ageno W, Casella IB, et al. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE Study. Am J Med. 2020 Aug;133(8):936-945. doi: 10.1016/j.amjmed.2020.03.036. Epub 2020 Apr 20. | |
| 32323192 | 0 | Zhang L, Yan X, Fox KAA, et al. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. J Thromb Thrombolysis. 2020 Jul;50(1):20-29. doi: 10.1007/s11239-020-02077-9. | |
| 32323191 | 0 | Solms A, Willmann S, Reinecke I, et al. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul;50(1):1-11. doi: 10.1007/s11239-020-02073-z. | |
| 32323190 | 0 | Reinecke I, Solms A, Willmann S, et al. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul;50(1):12-19. doi: 10.1007/s11239-020-02078-8. | |
| 32320170 | 0 | Holbrook A, Morrow R, Lee AYY, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study. J Popul Ther Clin Pharmacol. 2020 Apr 13;27(2):e28-e44. doi: 10.15586/jptcp.v27i2.662. | |
| 32311448 | 0 | Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. | |
| 32299756 | 0 | Gruel Y, De Maistre E, Pouplard C, et al. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020 Apr;39(2):291-310. doi: 10.1016/j.accpm.2020.03.012. Epub 2020 Apr 13. | |
| 32289865 | 0 | Abdulla A, Davis WM, Ratnaweera N, et al. A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer. Thromb Haemost. 2020 Apr;120(4):702-713. doi: 10.1055/s-0040-1708481. Epub 2020 Apr 14. | |
| 32289164 | 0 | Izcovich A, Criniti JM, Popoff F, et al. Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis. Blood Adv. 2020 Apr 14;4(7):1539-1553. doi: 10.1182/bloodadvances.2020001513. | |
| 32289163 | 0 | Neumann I, Izcovich A, Zhang Y, et al. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv. 2020 Apr 14;4(7):1512-1517. doi: 10.1182/bloodadvances.2019000840. | |
| 32284189 | 0 | Bungard TJ, Ritchie B, Bolt J, et al. Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian Hospitals. Clin Ther. 2020 May;42(5):873-881. doi: 10.1016/j.clinthera.2020.03.001. Epub 2020 Apr 10. | |
| 32273924 | 0 | Siddiqui NA, Moosa MA, Shaikh FA, et al. Predictors of Poor Quality of Life after Primary Lower Limb Deep Venous Thrombosis: A Perspective from a Developing Nation. Ann Vasc Dis. 2020 Mar 25;13(1):63-68. doi: 10.3400/avd.oa.19-00126. | |
| 32262660 | 0 | Leung JM, Berry LR, Atkinson HM, et al. Surface modification of poly(dimethylsiloxane) with a covalent antithrombin-heparin complex for the prevention of thrombosis: use of polydopamine as bonding agent. J Mater Chem B. 2015 Aug 7;3(29):6032-6036. doi: 10.1039/c5tb00808e. Epub 2015 Jun 29. | |
| 32250366 | 0 | Vergallo R, De Maria GL, Annibali G, et al. [Use of intravascular ultrasound for the assessment and treatment of left main disease]. G Ital Cardiol (Rome). 2020 Apr;21(4 Suppl 2):22S-28S. doi: 10.1714/3336.33070. | |
| 32246743 | 0 | Young G, Lensing AWA, Monagle P, et al. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation. J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4. | |
| 32237599 | 0 | Le Collen L, Quere I, Galanaud JP. [Deep-vein thrombosis and pulmonary embolism]. Rev Prat. 2019 Dec;69(10):e327-e336. | |
| 32230912 | 0 | Makedonov I, Kahn SR, Galanaud JP. Prevention and Management of the Post-Thrombotic Syndrome. J Clin Med. 2020 Mar 27;9(4). pii: jcm9040923. doi: 10.3390/jcm9040923. | |
| 32227213 | 0 | Bhatt M, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy. Blood Adv. 2020 Apr 14;4(7):1250-1264. doi: 10.1182/bloodadvances.2019000960. | |
| 32223115 | 0 | Lee AYY. Anticoagulant Therapy for Venous Thromboembolism in Cancer. N Engl J Med. 2020 Apr 23;382(17):1650-1652. doi: 10.1056/NEJMe2004220. Epub 2020 Mar 29. | |
| 32219982 | 0 | Mithoowani S, Cervi A, Shah N, et al. Management of major bleeds in patients with immune thrombocytopenia. J Thromb Haemost. 2020 Jul;18(7):1783-1790. doi: 10.1111/jth.14809. Epub 2020 May 6. | |
| 32211571 | 0 | Kahn SR, Shivakumar S. What's new in VTE risk and prevention in orthopedic surgery. Res Pract Thromb Haemost. 2020 Mar 9;4(3):366-376. doi: 10.1002/rth2.12323. eCollection 2020 Mar. | |
| 32205598 | 0 | Fernando SM, Mok G, Castellucci LA, et al. Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding. Crit Care Med. 2020 Apr;48(4):515-524. doi: 10.1097/CCM.0000000000004206. | |
| 32205131 | 0 | Chen Y, Chen H, Yang J, et al. Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy. J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):919-929. doi: 10.1016/j.jvsv.2020.01.010. Epub 2020 Mar 21. | |
| 32202042 | 0 | Valeriani E, Porreca E, Weitz JI, et al. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis. J Thromb Haemost. 2020 Jul;18(7):1661-1671. doi: 10.1111/jth.14807. Epub 2020 Apr 16. | |
| 32197256 | 0 | De Maria GL, Lee R, Alkhalil M, et al. Reflectance spectral analysis for novel characterization and clinical assessment of aspirated coronary thrombi in patients with ST elevation myocardial infarction. Physiol Meas. 2020 May 7;41(4):045001. doi: 10.1088/1361-6579/ab81de. | |
| 32171947 | 0 | Schmidt RA, Al Zaki A, Desilet N, et al. Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism. Thromb Res. 2020 Apr;188:106-114. doi: 10.1016/j.thromres.2020.02.005. Epub 2020 Feb 13. | |
| 32168402 | 0 | Moumneh T, Riou J, Douillet D, et al. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study. J Thromb Haemost. 2020 Jun;18(6):1398-1407. doi: 10.1111/jth.14796. Epub 2020 Apr 16. | |
| 32167669 | 0 | Warkentin TE, Sheppard JI, Smith JW, et al. Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT). J Thromb Haemost. 2020 Jun;18(6):1435-1446. doi: 10.1111/jth.14794. Epub 2020 Apr 27. | |
| 32150614 | 0 | Lee AYY. The changing landscape of anticoagulation in cancer-associated thrombosis. Blood Adv. 2020 Mar 10;4(5):969. doi: 10.1182/bloodadvances.2019000842. | |
| 32146068 | 0 | Siegal DM, Healey JS. Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen? Can J Cardiol. 2020 Apr;36(4):459-461. doi: 10.1016/j.cjca.2019.11.008. Epub 2019 Nov 15. | |
| 32145144 | 0 | Rabinovich A, Gu CS, Vedantham S, et al. External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost. 2020 Jun;18(6):1381-1389. doi: 10.1111/jth.14791. Epub 2020 Apr 9. | |
| 32142099 | 0 | Siegal DM, Eikelboom JW, Lee SF, et al. Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries. Cardiovasc Res. 2021 Jan 21;117(2):576-584. doi: 10.1093/cvr/cvaa044. | |
| 32133581 | 0 | Fitzgerald J, McMonnies R, Sharkey A, et al. Thrombin generation and bleeding in cardiac surgery: a clinical narrative review. Can J Anaesth. 2020 Jun;67(6):746-753. doi: 10.1007/s12630-020-01609-4. Epub 2020 Mar 4. | |
| 32132678 | 0 | Mackman N, Bergmeier W, Stouffer GA, et al. Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discov. 2020 May;19(5):333-352. doi: 10.1038/s41573-020-0061-0. Epub 2020 Mar 4. | |
| 32130721 | 0 | Nazy I, Elliott TD, Arnold DM. Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor. Br J Haematol. 2020 Aug;190(4):594-598. doi: 10.1111/bjh.16553. Epub 2020 Mar 4. | |
| 32125293 | 0 | Tritschler T, Castellucci LA, Van Es N, et al. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants. Pol Arch Intern Med. 2020 Jun 6;130(6):529-538. doi: 10.20452/pamw.15225. Epub 2020 Mar 3. | |
| 32115919 | 0 | Yu QB, E ZK, Xin HW, et al. [Effect of total knee arthroplasty under computer navigation on intraoperative blood loss and joint function recovery]. Zhongguo Gu Shang. 2020 Jan 25;33(1):15-20. doi: 10.3969/j.issn.1003-0034.2020.01.004. | |
| 32112537 | 0 | Porres-Aguilar M, Kahn SR, Hirsch AM. Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020 Mar;18(3):755-756. doi: 10.1111/jth.14705. | |
| 32112441 | 0 | Avram AT, Blostein MD, Hirsch AM, et al. Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery. Am J Hematol. 2020 Jun;95(6):712-717. doi: 10.1002/ajh.25768. Epub 2020 Mar 20. | |
| 32110758 | 0 | Dawson AJ, Akaberi A, Galanaud JP, et al. Patient-reported reasons for and predictors of noncompliance with compression stockings in a randomized trial of stockings to prevent postthrombotic syndrome. Res Pract Thromb Haemost. 2019 Dec 29;4(2):269-277. doi: 10.1002/rth2.12296. eCollection 2020 Feb. | |
| 32098609 | 0 | Butcher KS, Ng K, Sheridan P, et al. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. Stroke. 2020 Apr;51(4):1190-1198. doi: 10.1161/STROKEAHA.119.027569. Epub 2020 Feb 26. | |
| 32097460 | 0 | Skeith L, Baumann Kreuziger L, Crowther MA, et al. A practical approach to evaluating postoperative thrombocytopenia. Blood Adv. 2020 Feb 25;4(4):776-783. doi: 10.1182/bloodadvances.2019001414. | |
| 32092132 | 0 | Darzi AJ, Karam SG, Charide R, et al. Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603. | |
| 32091505 | 0 | Roberge G, Carrier M. How to manage patients with symptomatic subsegmental pulmonary embolism? Pol Arch Intern Med. 2020 Apr 30;130(4):310-316. doi: 10.20452/pamw.15211. Epub 2020 Feb 24. | |
| 32073218 | 0 | Tritschler T, Kraaijpoel N, Langlois N, et al. Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts. J Thromb Haemost. 2020 Jun;18(6):1415-1420. doi: 10.1111/jth.14775. Epub 2020 Mar 30. | |
| 32064713 | 0 | Biffi M, Iori M, De Maria E, et al. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry. J Cardiovasc Electrophysiol. 2020 Apr;31(4):846-853. doi: 10.1111/jce.14396. Epub 2020 Feb 25. | |
| 32056070 | 0 | Roberge G, Tritschler T, MacGillivray C, et al. Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report. J Thromb Thrombolysis. 2020 Oct;50(3):674-677. doi: 10.1007/s11239-020-02062-2. | |
| 32045437 | 0 | Kraaijpoel N, Carrier M, Le Gal G, et al. Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis. PLoS One. 2020 Feb 11;15(2):e0228788. doi: 10.1371/journal.pone.0228788. eCollection 2020. | |
| 32040553 | 0 | Khatib R, Ross S, Kennedy SA, et al. Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis. Blood Adv. 2020 Feb 11;4(3):500-513. doi: 10.1182/bloodadvances.2019001223. | |
| 32037570 | 0 | Lee A, Mendoza J, Brubaker AL, et al. Eliminating international normalized ratio threshold for transfusion in pediatric patients with acute liver failure. Clin Transplant. 2020 Apr;34(4):e13819. doi: 10.1111/ctr.13819. Epub 2020 Feb 28. | |
| 32036158 | 0 | Robin P, Grewal RK, Le Roux PY, et al. Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism. Thromb Res. 2020 Apr;188:25-27. doi: 10.1016/j.thromres.2020.01.028. Epub 2020 Jan 30. | |
| 32028109 | 0 | Calais C, Mercier G, Meusy A, et al. Pulmonary embolism home treatment: What GP want? Thromb Res. 2020 Mar;187:180-185. doi: 10.1016/j.thromres.2020.01.015. Epub 2020 Jan 16. | |
| 32012138 | 0 | Chiocchi M, Ricci F, Pasqualetto M, et al. Role of computed tomography in transcatheter aortic valve implantation and valve-in-valve implantation: complete review of preprocedural and postprocedural imaging. J Cardiovasc Med (Hagerstown). 2020 Mar;21(3):182-191. doi: 10.2459/JCM.0000000000000899. | |
| 32011635 | 0 | Spyropoulos AC, Schulman S, Douketis JD. Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-Reply. JAMA Intern Med. 2020 Feb 1;180(2):333-334. doi: 10.1001/jamainternmed.2019.5851. | |
| 32008258 | 0 | Olesen KKW, Wheeler M, Eikelboom JW. Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer. Thromb Haemost. 2020 Feb;120(2):194-196. doi: 10.1055/s-0039-3402809. Epub 2020 Feb 2. | |
| 31999844 | 0 | Li A, Carlson JJ, Kuderer NM, et al. Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States. Cancer. 2020 Apr 15;126(8):1736-1748. doi: 10.1002/cncr.32724. Epub 2020 Jan 30. | |
| 31999063 | 0 | Zwicker JI, Wang TF, DeAngelo DJ, et al. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. J Thromb Haemost. 2020 Feb;18(2):278-284. doi: 10.1111/jth.14671. | |
| 31999061 | 0 | Lillicrap D, Morrissey JH. Hemostasis and thrombosis 101-A challenge to energize. J Thromb Haemost. 2020 Feb;18(2):269. doi: 10.1111/jth.14731. | |
| 31999058 | 0 | Horner D, Stevens JW, Pandor A, et al. Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care. J Thromb Haemost. 2020 Feb;18(2):519-520. doi: 10.1111/jth.14708. |